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Abstract	Tendon	 injury	 is	 a	 common	 problem	 in	 both	 human	 and	 veterinary	medicine,	which	impacts	on	the	both	the	quality	of	life	of	the	individual	in	question	but	also	a	 financial	 implication	on	 the	supporting	health	system.	Previous	research	 into	the	 pathogenesis	 of	 tendon	 injury	 and	 also	 the	 healing	 and	 treatment	 options	available	are	limited.	This	one	year	project	aimed	to	advance	our	knowledge	in	proteomics	 of	 human	 and	 equine	 tendons	 by	 developing	 proteomic	methodologies	for	the	analysis	of	the	normal	protein	composition.		In	 order	 to	 build	 a	 proteomic	 tendon	 library	 three	 different	 protein	extraction	 protocols	 were	 considered,	 urea,	 guanidine	 and	 Rapigest.	 Results	revealed	urea	had	a	poor	extraction	ability	and	that	guanidine	and	Rapigest	had	a	 better	 success	 rate.	 Further	 work	 to	 combine	 these	 to	 agents	 would	 be	worthwhile	in	the	future.		Further	to	this	to	this	analysing	spatial	distribution	of	these	proteins	was	then	investigated	in	equine	tissue.	This	work	made	some	progress	in	optimizing	a	protocol,	finding	trypsin	digestion	worked	better	when	incubated	for	16	hours	and	also	when	the	digestion	occurred	with	an	ammonium	bicarbonate	buffer.		The	 fourth	 chapter	 investigated	whether	 it	 is	 possible	 to	 detect	 in	 vivo	changes	in	the	proteomic	composition	of	dialysis	fluid	subsequent	to	shockwave	therapy	 of	 human	 Achilles	 tendon.	 This	 study	 revealed	 that	 current	 methods	were	sensitive	enough	to	ascertain	the	protein	composition	but	further	work	is	needed	 to	 ascertain	 what	 significant	 protein	 changes	 occur	 in	 response	 to	therapy.		Finally	tendon	protein	turnover	was	explored	in	an	in-vivo	model.	Results	confirmed	 proteins	 within	 the	 non	 collagenous	 matrix	 had	 a	 higher	 rate	 of	protein	 turnover	 compared	 to	 components	 of	 the	 collagenous	matrix.	 All	 four	projects	 have	 been	 the	 first	 of	 their	 kind	 so	 optimisiation	 and	 a	 ‘look	 and	 see’	approach	 was	 required,	 which	 has	 laid	 foundations	 for	 several	 subsequent	studies.			 	
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Chapter	1,	Literature	Review	
Introduction	Tendons	 are	 highly	 organised	 connective	 tissue	 structures	 that	 have	 essential	roles	in	the	biomechanical	function	of	the	musculoskeletal	system.	These	tissues	primarily	transfer	tensile	strength	from	muscle	to	bone,	and	associated	with	this	transfer,	 are	 varying	 degrees	 of	 energy	 storage	 depending	 upon	 the	 individual	tendon.	Tendons	absorb	and	then	return	energy	reducing	the	metabolic	cost	of	locomotion	by	a	 ‘spring	board’	 effect.	As	 importantly,	 these	 tissues	also	have	a	‘positional’	 role	 to	 provide	 structural	 stability	 to	 the	 joint	 and	 limb.	 Tendon	injury	is	a	common	problem	in	both	human	and	veterinary	medicine.	Injuries	are	characterised	 by	 a	 combination	 of	 pain,	 swelling	 and	 impaired	 tendon	performance	 resulting	 in	 disability	 and	 a	 loss	 in	 productivity.	 This	 not	 only	impacts	on	the	quality	of	life	of	the	individual	but	also	has	an	economic	burden	to	the	 health	 care	 system.	 	 Epidemiological	 studies	 have	 emphasised	 the	significance	 of	 tendon	 injury	 in	 both	 humans	 and	 the	 performance	 horse.	 	 In	humans	the	prevalence	of	Achilles	tendon	(AT)	injury	in	the	general	population	under	45	years	of	age,	was	reported	to	be	3%,	which	increased	to	15-56%	in	elite	athletes	 depending	 upon	 the	 type	 of	 sport	 undertaken	 (Knobloch	 et	 al,	 2008;	Kujala	et	al,	2005).	In	the	same	study	291	elite	runners	were	monitored	over	an	8-month	period,	 it	was	documented	 that	56.6%	of	 the	 athletes	had	an	Achilles	tendon	 injury	 at	 some	 point	 during	 this	 time	 frame	 (Knobloch	 et	 al,	 2008).	 A	large	retrospective	study	 in	Thoroughbred	racehorses,	 found	 the	prevalence	of	superficial	 digital	 flexor	 tendon	 (SDFT)	tendonitis	to	 be	 11.1%	 during	 a	 12-month	time	span	(Kasashima	et	al,	2004).	In	another	study	SDFT	pathology	was	detected	 by	 ultrasonography	 in	 24%	 of	 National	 Hunt	 racehorses	 over	 two	racing	seasons	(Avella	et	al,	2009).		
In	each	of	the	above	studies,	it	was	also	noted	that	there	was	an	increased	risk	of	injury	 linked	 to	 increasing	 age	 (Thorpe	et	al	 2015).	 Injury	 is	 believed	 to	occur	due	to	an	accumulation	of	microdamage	over	a	number	of	loading	cycles	rather	than	 an	 acute	 injury	 (Riley,	 2008;	 Thorpe	 et	 al,	 2015).	 	 In	 the	 equine	 patient	injuries	are	often	localised	to	the	central	core	of	the	mid	metacarpal	region	(Pool	and	Meagher	1990;	Stromberg	and	Tufvesson	1969;	Webbon	1977).	
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As	well	 as	 a	 cause	 of	 pain	 and	morbidity,	 healing	 of	 these	 injuries	 are	 usually	slow	and	often	mechanical	properties	do	not	 return	 to	normal	after	periods	of	prolonged	rehabilitation	(Jung	et	al,	2009).			To	 date,	 no	 treatment	 methods	 have	 been	 proven	 in	 the	 re-establishment	 of	normal	 tendon	 structure	 and	 function	 due	 to	 poor	 understanding	 of	 the	underlying	 pathology	 (Ackermann,	 2015).	 The	 prevalence	 and	 significance	 of	tendinopathies	 warrants	 research	 into	 this	 area.	 The	 development	 of	 new	treatment	 strategies	 for	 tendon	 repair	 can	 only	 be	 addressed	 by	 further	understanding	of	tendon	function,	structure,	composition,	and	basic	mechanisms	of	healing.			Animal	models	 are	 often	 used	 in	 tendon	 research	 to	 allow	 the	 examination	 of	biological	processes	that	occur.	This	can	range	from	normal	homeostasis	through	to	tendon	pathology	and	repair.	Using	animal	models	is	not	without	drawbacks	as	differences	between	species	means	that	direct	comparisons	cannot	be	made,	and	 cannot	 truly	 replicate	 conditions	 seen	 in	 the	 human	 patient.	 Small	 animal	models	 do	 not	 replicate	 the	 same	 conditions	 seen	 in	 humans	 as	 different	lifestyles	mean	that	the	same	stresses	and	strains	do	not	apply.	Also	their	basic	anatomical	 structure	 is	 different,	 in	 mice	 the	 structure	 of	 the	 interfascicular	region	 is	 different	 (Kohrs	 et	 al,	 2011).	 The	 use	 of	 horses	 as	 models	 is	 quite	common	 and	 justifiable	 as	 not	 only	 does	 research	 on	 this	 tissue	 benefit	 the	species	but	 the	 equine	SDFT	 is	 also	 an	 excellent	model	 of	 exercise-induced	AT	injury	 in	 humans.	 The	 SDFT	 and	 AT	 are	 functionally	 and	 clinically	 equivalent	plus	 lifestyle	 factors	 and	 longevity	 of	 horses	 are	 comparable	 (Patterson-Kane	and	 Rich,	 2014).	 The	 relatively	 easy	 access	 to	 equine	 tissues	 has	 facilitated	important	 advances	 in	 tendon	 research.	 Examination	 of	 human	 tissue	 tends	 to	occur	during	 end	 stage	pathology,	 therefore	using	 an	 animal	model	provides	 a	host	of	opportunities	to	learn	more	about	the	normal	tendon	and	early	changes	that	develop	during	pathology.			A	 vast	 amount	 of	 knowledge	 so	 far	 has	 been	 gained	 from	 ex	 vivo	 analysis	
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however	further	advances	in	clinical	tests	may,	one	day,	allow	the	use	of	in	vivo	testing	which	would	be	a	huge	breakthrough	in	this	field.	This	literature	review	will	discuss	the	major	developments	in	tendon	research	and	highlight	the	gaps	in	the	current	knowledge	that	need	to	be	investigated.			
Tendon	function	Despite	 the	 common	 features	 that	 all	 tendons	 hold,	 there	 is	 a	 remarkable	variation	 in	 the	 morphological,	 molecular	 and	mechanical	 properties	 between	different	 tendons	within	 the	body	(Birch,	2007).	Broadly	speaking	 tendons	can	be	divided	into	two	functional	groups;	those	that	primarily	have	a	positional	role	and	those	that	also	act	as	energy	stores.	It	is	widely	documented	that	the	rate	of	injury	 to	 these	 two	 functional	 types	varies:	with	energy	 storing	 tendons,	being	injury	 prone	 in	 contrast	 to	 their	 positional	 counterparts	 (Thorpe,	 2014).	Examples	 of	 energy	 storing	 tendons	 are	 the	 SDFT	 in	 the	 horse	 and	 the	 AT	 in	humans.	 	 Positional	 tendon	 examples	 would	 be	 the	 common	 digital	 extensor	tendon	(CDET)	in	the	Horse	or	the	anterior	tibialis	tendon	(ATT)	in	humans.			
		In	order	to	understand	how	these	differences	are	achieved	it	is	necessary	to	have	an	 understanding	 of	 the	 structure	 and	 the	 mechanical	 properties	 of	 the	 two	tendon	types.	Research	 in	recent	years	has	come	a	 long	way	 in	explaining	how	tendons	 succeed	 in	 their	 individual	 roles.	 	 Energy	 storing	 tendons	 such	 as	 the	SDFT	improve	the	efficiency	of	 locomotion	by	their	ability	 to	stretch	and	recoil	under	 physiological	 loads	 to	 ensure	 efficient	 return	 of	 stored	 energy	 (Birch,	
Figure	 1.	 Diagram	 showing	
anatomy	 of	 the	 equine	
forelimb	 and	 the	 location	 of	
the	 energy	 storing	 SDFT	 and	
the	 positional	 CDET.	
Reproduced	 from	 Thorpe	 et	
al,	2013.		
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2007)	with	one	in	vivo	study	measuring	strains	of	up	to	16%	in	the	SDFT	during	galloping	(Stephens	et	al,	1989).	High	levels	of	extension	and	subsequent	recoil	can	increase	the	efficiency	of	locomotion	by	as	much	as	36%	during	high	speed	locomotion	 (Briewener,	 1998).	 In	 comparison	 a	 positional	 tendon	 needs	 to	 be	relatively	inextensible	in	order	to	allow	the	correct	placing	of	the	limb	and	also	to	 transfer	 force	 from	muscle	 to	 bone.	 In	 contrast	 to	 the	 SDFT	 in	 vivo	 studies	have	 calculated	 the	 maximum	 strains	 of	 the	 CDET	 to	 be	 approximately	 2.5%	(Birch	et	al,	2008;	Batson	et	al,	2003	and	Brown	et	al,	2003).	
Basic	tendon	composition	and	structure		In	 order	 to	 meet	 its	 functional	 requirements,	 tendon	 tissue	 has	 a	 unique	anatomical	 structural	 hierarchy.	 The	 collagen	 fibers	 are	 highly	 aligned	 in	 a	longitudinal	manner	to	create	subunits,	comprising	of,	fibrils,	fascicles	and	fibers	(Kastelic	et	al,	1978)(Figure	2).			
	The	 division	 of	 the	 tendon	 tissue	 into	 individual	 smaller	 components	 ensures	that	 minor	 damage	 does	 not	 necessarily	 spread	 to	 the	 entire	 tendon.	 (Kjaer,	2014).	 Investigations	 looking	 into	 tendon	 composition	 have	 ascertained	 that	water	makes	up	55-70%	of	the	wet	weight	(Kjaer,	2004).	The	primary	molecular	components	 are	 collagens,	 which	 make	 up	 60-85%	 dry	 weight	 (Thorpe	 et	 al,	2013).	 Approximately	 95%	 of	 this	 is	 type	 I	 collagen,	 with	 small	 amounts	 of	collagen	 types	 III,	 V,	 XII	 and	 XIV	 (Thorpe	 et	 al,	 2013;	 Birch	 et	 al,	 1999).	 The	collagen	 fibers	 are	 highly	 aligned	 in	 a	 longitudinal	manner	 to	 create	 subunits,	
Figure	2:	
Schematic	
illustrating	
the	
structure	of	
tendon	
tissue.	
Reproduce
d	from	
Kastelic	et	
al,	1978.	
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comprising	of,	fibrils,	fibers,	and	the	largest	of	which	is	the	fascicle	(Kastelic	et	al,	1978).	The	fascicle	can	vary	in	diameter	typically	ranging	from	50	to	400μm.	The	role	of	collagen	is	well	characterised	and	contributes	to	the	high	tensile	strength	that	this	tissue	requires	to	function	(Silver	et	al,	2003;	Franchi	et	al,	2008;	Kjaer	
et	al,	2009).		
As	to	be	expected	there	are	differences	in	the	compositional	components	of	the	energy	storing	tendons	and	their	positional	counterparts.	Work	has	shown	that	the	 positional	 CDET	 has	 a	 significantly	 higher	 collagen	 content	 (80.4%	 ±	 1.3)	compared	to	the	SDFT	(75.8%	±	1.5).	The	size	of	the	fascicles	also	differ,	fascicles	dissected	from	the	SDFT	were	significantly	smaller	in	cross	sectional	area	(0.12	±	0.006mm2)	than	fascicles	obtained	from	the	CDET	(0.16	±	0.09mm2)	(Birch	et	al,	2013).	The	fascicles	in	the	CDET	appeared	to	be	more	tightly	packed	than	those	in	the	SDFT	(Birch	et	al,	2013).	
A	connective	tissue	membrane,	named	the	epitenon	extends	into	and	around	the	tendon	 covering	 the	 entire	 structure	 and	 separates	 the	 fascicules.	 Where	 this	membrane	 separates	 the	 fascicules,	 it	 is	 known	 as	 the	 endotenon	 or	interfascicular	matrix	(IFM)(Figure	3).		
	
Figure	 3.	 Schematic	 and	
histological	 section	 of	 a	
bovine	 flexor	 tendon,	
revealing	 the	 collagen	 rich	
fascicles,	 termed	 fascicular	
matrix	 (FM)	 and	 the	
surrounding	 endotendon,	
termed	interfascicular	matrix 
(IFM).	 Reproduced	 from	
Speisz	et	al,	2015.		
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The	IFM	is	primarily	composed	of	macromolecules	subdivided	into	three	groups	proteoglycans,	 glycoproteins	 and	 collagens,	 (Collagen	 types	 III	 and	 VI	 are	present	 in	 low	 concentration).	 The	 remainder	 of	 the	 weight	 is	 composed	 of	cellular	proteins	and	the	fibrous	protein	elastin	(Birch,	2007;	Speisz	et	al,	2015;	Thorpe	et	al,	2015).		
Proteoglycans	 are	 composed	 of	 a	 core	 protein	 to	 which	 one	 or	 more	glycosaminoglycan	 chains	 attached.	 Two	 groups	 of	 proteoglycan’s	 have	 been	demonstrated	in	the	tendon;	small	leucine-rich	proteins	(SLRPS)	such	as	decorin,	biglycan,	fibromodulin	and	lumican	and	large	aggregating	proteoglycans	such	as	aggrecan,	lubrican	and	versican	(Rees	et	al,	2000;	Yoon	&	Halper	2005).	To	date	the	function	of	each	SLRPS	is	unclear,	however	they	are	thought	to	influence	the	mechanical	and	structural	properties	in	a	tendon	specific	manner,	by	regulating	fibrillogenesis	 and	matrix	 organisation	 (Gordon	 et	 al,	 2015).	 Studies	 involving	decorin	and	biglycan	knockout	mice	showed	altered	dynamic	and	failure	loads	of	the	 Achilles	 tendon,	 specifically	 this	 study	 detected	 a	 decrease	 in	 the	organisation	of	the	collagen	fibres	in	these	mice	(Gordon	et	al,	2015).	
The	 modular	 proteoglycans	 function	 to	 hold	 water	 so	 act	 in	 a	 spacing	 and	lubricating	role	for	the	tendon	(Thorpe	et	al,	2013).	Cartilage	oligomeric	matrix	protein	 (COMP)	 is	 an	 example	 of	 a	 glycoprotein,	 which	 resides	 predominately	within	the	fascicles.	Its	precise	function	is	unknown	but	thought	to	be	involved	in	collagen	 fibrillogenesis	 and	 tendon	 growth	 (Thorpe	 et	al,	 2013).	 Elastin,	 as	 its	name	suggest	is	a	highly	elastic	protein	capable	of	extending	by	more	than	100%	of	its	original	length,	other	relevant	properties	are	a	high	fatigue	resistance	and	the	capacity	for	energy	storage	(Aaron	&	Gosline,	1981).		It	has	been	reported	to	be	 present	 in	 concentrations	 in	 the	 range	 of	 1–10%	 of	 the	 tendon	 dry	weight	(Silver	 et	 al,	 2003;	 Korol	 et	 al,	 2007;	 Gosline	 et	 al,	 2002).	 The	 matrix	 is	maintained	 by	 small	 population	 of	 tenocytes,	 which	 are	 responsible	 for	remodelling	the	matrix	as	they	synthesise	both	the	matrix	molecules	and	also	the	enzymes	responsible	for	degradation.		Within	the	extracellular	matrix	tenoblasts	and	 tencytes	 represent	 about	 90-95%	 of	 the	 tendon	 cells,	 they	 either	 reside	between	 the	 collagen	 fibres	 within	 the	 fascicles	 or	 are	 grouped	 within	 the	
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interfascicular	matrix.	The	remaining	5-10%	of	cells	comprise	of	chrondrocytes,	vascular	cells,	synovial	cells	and	smooth	muscle	cells	(Ackermann,	2015).	
The	 paratenon	 is	 loose	 connective	 tissue	 surrounding	 the	 whole	 tendon	 and	allows	 the	 structure	 to	 glide	 against	 adjacent	 tissue.	 	 This	 structure	 contains	mostly	 fibroblastic	 cells,	 which	 are	 responsible	 for	 the	 production	 of	 the	extracellular	matrix	(Benjamin	et	al,	2008).	
Tendon	mechanics	As	 energy	 storing	 tendons	 must	 withstand	 great	 physiological	 loads,	 studies	have	 attempted	 to	 investigate	 the	 mechanics	 behind	 this	 additional	 function.	Recent	 research	 has	 established	 a	 distinctly	 specialised	 matrix	 as	 the	 protein	profile	 differs	 between	 tensile	 and	 compressive	 regions	 of	 the	 tendon.	 For	instance	 a	 region	 that	 experiences	 compressive	 loads	 has	 a	 greater	 content	 of	non-collagenous	 proteins	 such	 as	 aggrecan,	 and	 lubricin	 (Batson	 et	 al,	 2003;	Jarvinen	et	al,	2003).		Functions	of	these	proteins	are	thought	to	increase	tendon	water	content	providing	an	increased	stiffness	and	a	resistance	to	compression	(Rees	et	al,	2000).	The	levels	of	COMP	have	been	recorded	to	be	much	higher	in	structures	 subjected	 to	 higher	 strains,	 one	 study	 recorded	 levels	 of	 22.1	 ±	6.1μg/mg	 in	 the	 SDFT	 compared	 to	 1.9	 ±	 0.6μg/mg	 in	 the	 CDET	 (Birch	 et	 al,	2013).	 	 It	 has	 also	 been	 demonstrated	 that	 the	 matrix	 changes	 during	development,	maturation,	ageing	and	injury.			Another	study	looked	into	the	alignment	and	orientation	of	the	fascicles.	It	was	established	that	the	extension	and	recoil	mechanisms	differed	between	the	SDFT	and	 CDET	 fascicles.	 In	 the	 CDET	 fibre	 sliding	 was	 the	 dominant	 functional	mechanism.	 In	 comparison,	 SFDT	 fascicles	 were	 thought	 to	 contain	 a	 helical	component,	 which	 relaxed	 under	 strains	 then	 recoiled.	 This	 allows	 a	 greater	recovery	following	physiological	loads	and	a	lower	level	of	energy	loss	(Thorpe	
et	al,	2013).	
The	SDFT	needs	to	have	a	high	elasticity	(low	stiffness)	to	stretch	and	recoil,	 in	comparison,	the	CDET	needs	to	have	a	 low	elasticity	(high	stiffness)	to	transfer	forces	 quickly	 and	 efficiently.	 Mechanical	 testing	 studies	 in	 both	 tendon	 types	
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have	 scrutinised	 the	 different	 properties	 of	 both	 the	 whole	 tendon	 and	 the	material	 from	 which	 the	 tendon	 is	 composed,	 findings	 included	 that	 fascicles	from	energy	storing	tendons	were	stiffer	than	their	positional	counterparts	and	it	 was	 differences	 in	 the	 interfascicular	 region	 which	 allowed	 for	 the	specialisation	of	the	two	tendon	types.	As	stiffness	of	the	fascicular	 interface	 in	the	 SDFT	 was	 lower	 compared	 to	 the	 CDET	 (Thorpe	 et	 al,	 2012).	 Figure	 1,	demonstrates	results	acquired.		
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Figure	1.	A	 representative	 tendon	and	 fascicle	 stress–strain	 curves	 in	 the	
two	 tendon	 types,	 Used	 with	 permission	 from	 Thorpe	 et	 al,	 2012.	
Illustrating	 differences	 in	 the	 extensibility	 of	 the	 two	 tendon	 types.	 The	
SDFT	 failed	 at	 higher	 strains	 compared	 to	 the	 CDET	 demonstrating	
increased	extensibility.		However	the	opposite	was	seen	when	the	fascicles	
were	tested.		This	is	due	to	differences	in	the	interfascicular	matrix,	in	the	
SDFT	the	matrix	was	found	to	be	less	stiff	than	the	CDET	allowing	a	greater	
extensibility.	
As	mentioned	previously,	it	is	widely	known	that	the	incidence	of	tendon	injury	increases	 with	 increasing	 age;	 the	 same	 mechanical	 testing	 studies	 were	repeated	in	young	and	old	sample	groups.	This	time	there	was	significantly	less	fascicular	sliding	in	aged	SDFT	tendons	demonstrating	increased	interfascicular	matrix	stiffness.	It	is	possible	this	could	then	lead	to	the	fascicles	being	loaded	at	an	earlier	point	during	tendon	extension	(Thorpe	et	al,	2013).	In	CDET	samples	there	was	 no	 change	 in	 the	 fascicular	 sliding	 between	 young	 and	 old	 samples.	
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The	differences	demonstrated	between	the	two	tendon	types	could	be	a	basis	of	increased	injury	in	energy	storing	tendons	(Thorpe	et	al,	2013).	
From	the	 information	gathered	from	the	 literature	available	 it	can	be	surmised	that	the	increase	in	tendon	injury	in	older	individuals	is	associated	with	ageing	of	the	IFM.	Further	study	into	the	IFM	structure	and	composition	is	the	next	phase	of	 research	 as	 this	 region	 could	 potentially	 be	 a	 therapeutic	 target	 or	 used	 in	conditioning	and	rehabilitation	interventions.			
Tendon	ageing	and	injury	Several	 studies	 have	 assessed	 the	 effect	 of	 ageing	 on	 tendon	 composition.	Reported	changes	in	the	matrix	composition	include,	increased	type	III	collagen	at	 the	 core	 of	 the	 tendon,	 although	 the	 total	 collagen	 content	was	 no	different	between	old	and	young	SDFT	samples	(Thorpe	et	al,	2015).	A	difference	has	also	been	 found	 in	 the	 amount	 of	 partially	 degraded	 collagen,	 increasing	 amounts	with	 increasing	age	within	 the	SDFT	(Thorpe	et	al,	2010).	 It	 is	possible	 that	an	inability	 to	 remove	 partially	 degraded	 collagen	 from	 the	 matrix	 leads	 to	 a	reduced	mechanical	competence	that	could	account	for	the	increased	stiffness	of	the	IFM	in	energy	storing	tendons.	 	Proteomic	studies	 into	the	effects	of	ageing	have	 found	 distinct	 proteomic	 profiles	 in	 young	 and	 old	 tendon	 samples.	 The	main	 findings	were	 that	 in	 old	 tendon	 there	was	 a	 reduction	 in	 fibromodulin,	mimecan	 and	 asporin,	 which	 are	 all	 SLRPs.	 These	 proteoglycans	 have	 been	shown	 to	 regulate	 collagen	 fibrillogenesis	 and	 fibril	 diameter.	 The	 heat	 shock	protein	 27,	 histones	 and	 integrins	 also	 decreased	 in	 ageing.	 Proteins	 that	 had	increased	 with	 age	 were	 keratins,	 gap	 junction	 proteins	 and	 interfilament	proteins	(Peffers	et	al,	2014).		It	 is	 well	 documented	 that	 tendon	 injury	 occurs	 after	 an	 accumulation	 of	microdamage	over	a	number	of	loading	cycles	rather	than	an	acute	injury	(Riley,	2008;	 Thorpe	 et	al,	 2015).	 It	 is	 thought	 that	 the	 biological	 response	 to	 tendon	injury	 can	 be	 divided	 into	 three	 overlapping	 stages,	 the	 first	 stage	 involves	 an	influx	 of	 inflammatory	 cells,	 growth	 factors	 and	 endothelial	 chemoattractants	that	 enable	 the	 formation	 of	 a	 fibrin	 clot	 which	 aims	 to	 provide	 a	 temporary	
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stiffness	to	the	area.	The	second	stage	begins	two	days	after	the	initial	injury,	this	phase	 is	 directed	 by	 macrophages	 and	 tenocytes.	 Macrophages	 switch	 from	 a	phagocytic	role	to	starting	the	repairing	process	by	releasing	growth	factors	and	directing	cell	recruitment.	Tenocytes	start	to	deposit	collagen	III	which	acts	as	a	temporary	matrix.	 The	 final	 stage	 of	 tendon	 injury	 tends	 to	 occur	 1-2	months	after	 the	 initial	 injury	 and	 can	 last	 more	 than	 a	 year.	 In	 this	 stage	 collagen	 I	synthesis	is	more	prominent	and	the	extracellular	matrix	becomes	more	aligned	(Voleti	 et	 al,	 2012).	 From	 this	 research	 is	 it	 evident	 that	 there	 are	 proteomic	changes	depending	upon	what	stage	of	injury	the	tendon	is	in.			 Macroscopic	 examination	 of	 injured	 tendons	 can	 show	 the	 following	characteristics:	 collagen	 fibril	 disorganisation,	 increased	 size	 of	 the	 non	collagenous	 extracellular	 matrix,	 hypercellularity	 and	 neovascularisation	(Nourissat	et	al,	2015).	Evidence	of	degeneration	has	been	found	at	post	mortem	when	 the	 patient	 exhibited	 no	 clinical	 signs	 of	 tendon	 injury	 (Birch,	 1998).	Multiple	degenerative	changes	in	the	extracellular	matrix	have	been	detected	in	injured	 tendons.	 Equine	 SDFT	 tendons	 with	 visual	 signs	 of	 tendinopathy	 ie	abnormal	 colouration	 were	 analysed,	 changes	 repeatedly	 detected	 were	increased	 levels	of	GAG	and	 type	 III	 collagen	 in	comparison	 to	normal	 tendons	(Birch,	 1998).	 An	 increase	 in	 heat	 shock	 proteins	 has	 also	 been	 observed	 in	tendinopathy	(Millar	et	al,	2012).			Matrix	 metalloproteinases	 (MMPs)	 belong	 to	 a	 family	 of	 degradative	 enzymes	responsible	 for	matrix	breakdown.	 	 It	 thought	 that	 some	of	 these	 enzymes	are	required	for	the	general	health	and	maintenance	of	the	tendon,	as	they	remove	damaged	matrix	and	remodel	scar	tissue	in	order	to	try	and	regain	its	previous	functions	(Riley,	2005).	 	This	 is	supported	by	 the	observation	that	some	drugs,	which	are	known	to	affect	the	activity	of	MMP	can	induce	 lesions	with	patients	being	treated	for	other	conditions	(Corps	et	al,	2002).	However	some	MMPs	are	thought	 to	 be	 damaging	 if	 their	 production	 is	 uncontrolled.	 A	 study	 which	investigated	 the	 rate	 of	 collagen	 remodelling	 in	 human	 supraspinatus	 tendons	found	 a	 relatively	 high	 turnover	mediated	 by	MMP	2,	 3	 and	 1.	However	 if	 the	
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tendon	 was	 ruptured	 there	 was	 an	 increase	 in	 expression	 and	 production	 of	collagenase	(MMP-1)	and	a	down-regulation	of	stromelysin	(MMP-3)	(Clegg	et	al,	2007;	Riley	et	al,	2002).		In	conclusion	it	is	important	to	fully	characterise	these	profiles	of	enzyme	activity	in	order	to	produce	future	drug	therapies.			Tendon	 tissue	 has	 little	 intrinsic	 regenerative	 capacity	 and	 so	 healing	 is	characterized	by	 the	 formation	of	 fibrovascular	scar	 tissue	 (Galatz	et	al,	2015). This	 is	 likely	 to	be	weaker	 than	the	original	 tissue	and	often	a	re-injury	occurs	(Corr	et	al,	2009;	Marr	et	al,	1993).	Understanding	the	mechanisms	involved	in	tissue	turnover	and	response	to	 injury	 is	essential	 in	addressing	pathologies	 in	ageing,	injury	and	disease.		
Tendon	turnover	Protein	turnover	is	essential	for	the	general	health	and	maintenance	of	tissue.	In	tendons,	 it	 is	 also	 essential	 in	 the	 response	 to	 exercise,	mechanical	 strain	 and	injury.		As	mentioned	already	tendon	healing	can	be	problematic.	In	an	effort	to	learn	more,	 it	 is	useful	 to	 consider	 the	protein	 turnover	 rate	within	 the	 tissue.		An	 interesting	exploration	of	 turnover	rates	was	undertaken	 in	human	Achilles	tendon,	 on	 the	 basis	 of	 an	 increase	 in	 14C	 levels	 due	 to	 nuclear	 bomb	 tests	 in	1955-1963.	The	 levels	of	 14C	were	measured	several	decades	 later	and	showed	that	 the	 core	 of	 the	 tendon	 had	 undergone	 very	 limited	 tissue	 turnover	(Heinemeier	 et	 al,	 2013).	 This	 was	 in	 stark	 contrast	 to	 skeletal	 muscle	 tissue	which	held	no	evidence	of	14C	suggesting	a	much	higher	turnover	rate.	
Another	 turnover	 investigation	 used	 the	 racemization	 of	 aspartic	 acid	 to	calculate	the	age	of	the	collagenous	and	non-collagenous	components	of	the	two	tendon	types.	Results	revealed	that	the	mean	collagen	half-life	 in	the	SDFT	was	found	 to	 be	 197.53	 (±18.23)	 years	 and	 this	 significantly	 increased	 with	 the	horse’s	 age,	 the	 CDET	 had	 a	 collagen	 half-life	 of	 34.03	 (±3.39)	 years.	 In	comparison	the	half	life	of	the	non	collagenous	protein	was	2	years	in	the	SDFT	and	3.5	years	in	the	CDET.	It	was	hypothesised	that	the	energy	storing	tendons	were	 protected	 from	 remodelling	 in	 order	 to	 try	 and	 preserve	 its	 structural	integrity	and	mechanical	functions.	This	was	further	emphasised	when	increased	
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collagen	 degradation	markers	 were	 observed	 in	 the	 CDET	 compared	with	 the	SDFT	(Thorpe	et	al,	2010).		The	 breakdown	 and	 synthesis	 of	 proteins	 is	 crucial	 for	 cellular	 homeostasis.	Breakdown	allows	the	clearance	of	abnormal	or	damaged	proteins	 in	order	 for	regeneration	 of	 tissue.	 Protein	 turnover	 rates	 vary	 widely	 and	 are	 thought	 to	decrease	with	 age.	 One	method	 of	measuring	 protein	 turnover	 rates	 is	 to	 use	stable	 isotope	 labeling.	Mice	 are	 fed	 a	 diet	 containing	 a	 ‘heavy’	 isotope	 that	 is	stable	incorporated	into	amino	acids	and	thus	labels	newly	synthesized	proteins.	Proteins	with	higher	turnover	rates	will	reveal	a	higher	abundance	of	the	heavy	isotope.	The	ratio	between	light	and	heavy	labeled	peptides	can	be	analysed	by	mass	spectrometry.			Over	 the	 last	 decade	 significant	 advances	 in	 the	 field	 of	 tendon	 research	 have	been	 achieved	 however	 there	 is	 still	 much	 to	 learn	 especially	 regarding	 the	protein	composition	and	turnover	of	tendon.			
Introduction	to	Proteomics	Proteomics	is	the	large-scale	study	of	the	structure	and	function	of	proteins.	The	expression	and	abundance	of	all	proteins	often	mirror	physiological	processes	at	the	 cellular	 level.	 Protein	 analysis	 encompasses	 a	 variety	 of	 different	 aspects,	including	 protein	 identification,	 protein	 spatial	 distribution,	 analysis	 of	 post-translational	 modifications	 (PTMs),	 protein-protein	 interactions,	 absolute	 and	relative	quantification	of	target	proteins	and	the	rate	of	protein	turnover	(Chen	and	 Yates,	 2007).	 These	 features	 are	 fundamental	 in	 the	 investigation	 and	understanding	of	biological	processes	and	disease.	The	identification	of	proteins	plus	 determining	 how	 much	 of	 each	 protein	 is	 present,	 either	 as	 an	 absolute	value	 or	 relative	 to	 the	 same	 protein	 in	 another	 sample	 provides	 information	that	allows	us	to	understand	the	biological	activities	occurring.	This	information	can	help	 form	 theories	 into	 the	 pathogenesis	 of	 disease,	 further	 down	 the	 line	this	analysis	then	allows	the	development	of	screening	tests	for	certain	diseases.	Previous	 successes	 have	 been	 the	 discovery	 of	 biomarkers	 that	 can	 help	 to	establish	 a	 diagnosis	 or	 a	 prognosis	 of	 a	 disease	 or	 by	 developing	 a	 targeted	
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therapy.	 For	 example,	 one	 study	 that	 undertook	 proteomic	 screening	 of	 urine,	found	that	in	bikunin	loss	was	a	potential	bladder	carcinoma	marker	(Tsui	et	al,	2010).	 Research	 across	 the	 world	 is	 continually	 aiming	 to	 increase	 our	knowledge	 in	 the	 normal	 and	 diseased	 biological	 processes	 with	 the	 aim	 of	improving	healthcare.	This	section	discusses	why	proteomic	analysis	is	useful	for	the	current	investigation	and	the	theory	behind	the	techniques	used.	
Mass	Spectrometry	There	 are	 many	 commonly	 used	 technologies	 to	 study	 proteins.	 Mass	Spectrometry	(MS)	in	particular	is	commonly	used	and	more	recently	the	use	of	mass	 spectrometry	 imaging	 (MSI)	 has	 been	 developed.	 	 Simply	 put,	 MS	 is	 an	analytical	 technique	 that	helps	 identify	 the	composition	of	a	given	sample.	The	identification	of	 lipids,	peptides	and	proteins	 is	achieved	by	electron	 ionisation	and	separation	of	 the	 ions	according	to	 their	mass	 to	charge	ratio.	The	relative	abundance	of	 each	 ion	 type	 is	 recorded	 and	displayed	 as	 a	 spectrum.	 Figure	1	demonstrates	a	simplified	schematic	of	the	process		
	
Figure	1.	Schematic	of	Mass	Spectrometer	
(http://www.premierbiosoft.com.	Accessed	on	the	22.02.2016).	
	
	Frequently	used	MS	methods	are	generally	centered	on	 liquid	chromatography	coupled	 to	 different	 electrospray	 ionization	 (ESI)	 MS/MS	 techniques,	 mainly	being	ESI	and	matrix-assisted	laser	desorption	ionization	(MALDI).	The	different	types	 and	 abundances	 of	 proteins	 present	 in	 a	 given	 sample	 are	 recorded	 and	analysed	accordingly.			
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By	 using	 MS	 as	 an	 analytical	 tool	 to	 determine	 the	 chemical	 composition	 of	samples,	 the	mass	 spectra	 of	 normal	 vs	diseased	 samples	 can	be	 analysed	 and	compared	 to	 create	 profiles	 of	 a	 disease.	 	 Using	 this	 technology,	 with	 the	expectation	 that	 one	 day	 these	 tests	 could	 be	 transferred	 to	 in	 a	 clinical	laboratory	setting	and	used	as	a	diagnostic	test	(Verrills	et	al,	2006).			However	 there	are	still	many	 improvements	 to	be	made	before	 this	 transfer	 to	the	clinical	 laboratory.	Validated	and	approved	clinical	 tests	are	required	 to	be	cost	effective	and	robust.	These	samples	create	an	enormous	amount	of	data	that	needs	to	be	processed	and	analysed	so	improvements	in	the	handling	of	this	data	is	required	to	enable	cost	effectiveness	in	clinical	practice.		
Many	 terms	 are	 used	 in	 proteomics	 to	 explain	 the	 strategies	 used,	 an	understanding	of	 these	 terms	 is	 required	 to	understand	 the	 literature,	 some	of	these	will	be	explained	in	the	next	section.		
Mass	spectrometry	analysis	MS	 can	 characterise	 and	 sequence	 proteins	 via	 two	 approaches,	 a	 ‘top	 down’	approach	 ionizes	 intact	proteins,	which	are	 then	 introduced	to	a	mass	detector	and	analysed.	A	‘bottom	up’	approach	uses	a	protease	to	enzymatically	digest	the	proteins	 into	 peptides,	 digestion	 can	 be	 carried	 out	 in-solution	 or	 after	electrophoretic	 separation	 via	 SDS-PAGE	 termed	 in-gel	 digestion.	 The	peptides	are	 then	 ionised,	 separated	 according	 to	 mass	 to	 charge	 ratio	 and	 analysed.	When	 the	 characteristic	 pattern	 of	 peptides	 is	 used	 for	 the	 identification	 of	 a	protein,	 this	 is	 called	 peptide	 mass	 fingerprinting	 (PMF).	 Both	 the	 relative	abundance	 of	 peptides	 from	 each	 sample,	 and	 protein	 identifications	 can	 be	simultaneously	obtained.		Shotgun	proteomics	is	a	term	used	to	describe	bottom	up	proteomics	 in	 identifying	proteins	 in	complex	mixtures	using	a	combination	of	high	performance	liquid	chromatography	combined	with	mass	spectrometry.			The	 study	 of	 complex	 samples	 (whole	 tissue	 or	 biofluids)	 is	 often	 achieved	by	‘bottom	 up’	 proteomics	 where	 the	 proteins	 are	 solubilised	 and	 then	 digested	enzymatically,	 or	 chemically,	 into	 peptides.	 The	 term	 shot	 gun	 proteomics	 is	
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often	used	to	describe	a	‘look	and	see’	approach	and	is	often	achieved	by	utilising	the	combination	of	tandem	MS	and	database	searching.	This	can	have	limitations	such	as	loss	of	information	due	to	limited	protein	sequence	coverage.	
As	biological	samples	are	complex	mixtures	of	multiple	proteins	and	molecules	MS	 analysis	 can	 present	 problems.	 Ionisation	 techniques	 work	 well	 when	 the	sample	 contains	 an	 approximately	 equal	 amount	 of	 constituents,	 however	 in	biological	 samples	 different	 proteins	 tend	 to	 be	 present	 in	 broadly	 differing	amounts.	When	a	mixture	is	ionised	the	more	abundant	molecules	can	suppress	the	 signals	 generated	 from	 the	 less	 abundant	 ones.	 Samples	 can	 create	 very	complex	spectra	that	can	be	difficult	to	 interpret	(Verrills	et	al,	2006).	This	can	be	further	exacerbated	if	the	sample	has	been	previously	digested	as	this	creates	a	large	number	of	peptide	products.	
Mass	Spectrometry	Imaging	Mass	 spectrometry	 imaging	 combines	 the	 specificity	 of	 mass	 spectrometry	analysis	 with	 microscopic	 imaging	 capabilities	 without	 the	 need	 for	 labeling.	Detecting	 multiple	 analytes	 in	 parallel	 while	 preserving	 their	 natural	 location	enables	more	information	to	be	gleamed	from	their	exact	roles	and	functions.	It	is	 already	 established	 that	 the	 distribution	 of	 proteins	 and	 biomolecules	 is	intrinsically	related	to	their	role,	they	can	have	multiple	roles	depending	on	their	location	 (Simpson	 et	 al,	 2000).	 MS	 imaging	 so	 far	 has	 played	 a	 large	 part	 in	pharmaceutical	 research	 as	 it	 can	 give	 information	 regarding	 the	pharmokinetics,	pharmacodynamics	and	transport	properties	of	drugs	which	 is	useful	during	early	development	of	treatment	protocols	(Cobice	et	al,	2015).	The	visualisation	of	 the	distribution	of	compounds	can	answer	 important	questions	such	 as	 blood	 brain	 barrier	 penetration	 (Cobice	 et	 al,	 2015).	 In	 the	 field	 of	tendon	biology,	the	differences	between	the	fascicular	matrix	and	interfascicular	matrix	 could	 be	 examined.	 Matrix-assisted	 laser	 desorption	 ionization	 mass	spectrometry	imaging	(MALDI-MSI)	and	secondary	ion	MS	(SIMS)	are	employed	for	this	task.	The	basics	of	which	are	discussed	below.		
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Background	of	MALDI	Imaging	In	1997,	Caprioli	et	al.	demonstrated	the	use	of	MALDI	MSI	for	the	ion	imaging	of	peptides	and	proteins	in	intact	tissue	sections,	where	the	spatial	arrangement	of	specific	compounds	were	determined	in	an	untargeted	manner.		Since	then	there	have	been	significant	 improvements	with	 instrumentation	and	data	processing.	MALDI-MSI	 is	 now	 a	 developing	 technique	 used	 to	 detect	 and	 record	 intact	peptide	and	protein	distributions	of	the	mid	to	low	molecular	proteome	with	the	detectable	 mass	 range	 being	 between	 500m/z	 to	 over	 100,000m/z	 (Kaletas,	2009).	This	technique	has	several	other	benefits	such	as	a	high	sensitivity,	large	tolerance	for	salts,	label	free	detection,	the	interpretation	of	data	is	simple	as	the	majority	of	ions	are	singly	protonated	(Chungtai	and	Heeren,	2010).			The	 process	 of	 analysis	 is	 relatively	 simple,	 fresh	 frozen	 samples	 are	 thaw	mounted	 onto	 glass	 slides	 and	 then	 a	 small	 organic	 compound,	 the	 matrix,	 is	applied	 mixed	 in	 with	 a	 solvent	 solution.	 As	 the	 solvent	 evaporates,	 co-	crystallisation	of	the	analyte	and	the	matrix	compound	occurs.		As	the	analyte	is	incorporated	 into	 the	 matrix	 crystal,	 the	 molecules	 are	 separated	 from	 each	other,	 thus	minimizing	 the	 incidence	 of	 fragmentation	 (Kaletas	 et	 al,	 2009).	 A	laser	 beam	 is	 then	 aimed	 at	 the	 sample	 and	 the	matrix	 molecules	 absorb	 the	energy,	 this	 allows	 desorption	 and	 ionisation	 of	 the	 analyte	 to	 occur.	 Once	ionised,	 the	 ions	 are	 accelerated	 at	 a	 fixed	 potential	 and	 become	 separated	according	 to	 their	 mass/charge	 ratio.	 Images	 are	 created	 by	 plotting	 the	intensities	 of	 a	 given	 ion	 on	 a	 map	 of	 the	 tissue.	 MALDI	 MSI	 has	 a	 lateral	resolution	of	10-100μm	(Seeley	and	Caprioli,	2008).		Spectra	are	recorded	in	an	orderly	fashion	over	the	tissue	by	moving	the	target	plate	containing	the	sample	underneath	 a	 fixed	 laser	 beam.	 Figure	 2	 demonstrates	 a	 schematic	 diagram	of	this	process.			
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Figure	2.	Schematic	of	MALDI	Imaging	process	(Chugtai	and	Heeren,	2010).		
Background	to	SIMS	Imaging	SIMS	is	another	desorption	and	ionisation	technique	which	allows	for	a	very	high	spatial	 resolution	 imaging	 (<1um)	 the	 limits	 of	 this	 technique	 is	 that	 the	detectable	mass	range	 is	 limited	 to	1000da	or	 less	 (Seeley	and	Caprioli,	2008).	SIMS,	in	contrast	to	MALDI,	is	performed	without	any	sample	pre-treatment,	it	is	able	 to	 identify	 most	 components	 of	 biological	 systems	 of	 masses	 below	 m/z	2000,	the	highest	yields	therefore	are	obtained	for	small	molecules	such	as	lipids	and	small	metabolites.	 	This	technique	uses	a	primary	ion	beam	directed	at	the	sample	surface,	 this	beam,	which	can	be	 focused	as	sharply	as	50nm,	produces	secondary	ions.	The	primary	ion	beam	is	significantly	higher	in	energy	compared	to	the	laser	beam	used	in	MALDI	imaging	and	as	a	result	of	this,	fragmentation	of	the	service	molecules	can	occur	(Chugtai	and	Heeren,	2010).	The	secondary	ions	ejected	at	each	beam	position	are	collected	and	the	intensities	of	each	molecule	recorded.	This	 can	 then	be	used	 to	 create	 a	 composition	map	of	 the	 sample.	A	significant	advantage	of	this	method	is	that	extensive	sample	preparation	is	not	required.		The	tissue	is	loaded	onto	an	indium	tin	oxide	(ITO)	coated	glass	slide	without	any	further	washing	steps.	Figure	3	demonstrates	a	simplified	schematic	of	the	process.	A	disadvantage	to	SIMS	is	the	extensive	fragmentation	caused	by	
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the	primary	beam	can	lead	to	difficulty	in	the	interpretation	of	data	(Chugtai	and	Heeren,	2010).		
	
Figure	3	demonstrates	a	simplified	schematic	of	SIMS	(Chugtai	and	Heeren,	
2010).		The	images	produced	by	MALDI	MSI	and	SIMS	are	complementary	to	each	other	as	a	broad	range	of	molecules	can	be	detected	from	lipids	and	small	metabolites	to	peptides	and	proteins.			By	 correlating	 a	 dual	 imaging	 approach	 that	 combines	MALDI-MSI	 to	 obtain	 a	low	resolution	molecular	map	of	 the	peptides	within	 tendon	 tissue.	 I	 intend	 to	employ	 gas-phase	 ion	mobility	 separation	 to	 enhance	 the	 number	 of	 peptides	identified.	 The	 resulting	 images	 could	 then	 be	 used	 to	 direct	 subsequent	microscopic	 SIMS	 imaging	 to	 examine	 small	molecule	 distributions	 in	 areas	 of	interest	 at	 higher	 spatial	 resolution.	 This	 multimodal	 approach	 allows	multiplexed	visualisation	of	unlabeled	analytes	at	cellular	and	subcellular	levels	increasing	our	understanding	of	tendon	functional	structure	and	the	changes	in	ageing.	By	using	SIMS	as	well	as	MALDI-MSI	small	molecules	present	in	the	IFM	that	 require	 higher	 spatial	 resolution	 will	 be	 localised.	 Mass	 spectrometry	imaging	 has	 not	 been	 employed	 in	 this	 tissue	 before	 and	 so	 for	MALDI-MSI	 a	protocol	for	sample	preparation	must	be	generated	and	optimised.		
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Aims	and	objectives	for	study	Referring	back	 to	 the	start	of	 this	chapter,	 tendon	 injury	 is	a	major	problem	in	both	 human	 and	 veterinary	 medicine.	 This	 not	 only	 causes	 an	 impact	 on	 the	quality	of	 life	of	 the	patient	but	also	has	 cost	 implications	 to	go	alongside	 this.	This	 year	 long	 study	 attempts	 to	 touch	 on	 three	 areas	 where	 there	 is	 no	published	data	in	order	to	increase	our	understanding	of	tendon	biology.			To	 achieve	 an	 increased	 understanding	 of	 tendon	 biology	 it	 is	 crucial	 to	determine	 the	 composition	 of	 the	 tendon	 tissue	 and	 how	 this	 differs	 between,	not	 only,	 the	 fascicular	 matrix	 and	 interfascicular	 matrix	 but	 also	 how	 the	composition	varies	between	positional	 and	energy	 storing	 tendons.	This	 thesis	aims	to	develop	proteomic	methodologies,	which	will	enable	future	experiments	to	collect	this	data.	Initially	a	comparative	study	using	three	different	methods	of	protein	extraction	in	two	tendon	types,	in	both	human	and	equine	species,	with	the	 aim	 of	 increasing	 coverage	 of	 the	 tendon	 proteome.	 To	 extend	 our	understanding	further,	it	is	helpful	to	not	only	know	the	content	of	proteins	but	also	the	location	within	the	tendon	structure.	Using	mass	spectrometry	imaging,	allows	the	spatial	detection	of	proteins	producing	a	molecular	map	of	unlabeled	peptides,	lipids	and	small	molecules	at	cellular	and	subcellular	levels.	The	second	task	 was	 to	 devise	 an	 appropriate	 protocol	 for	 equine	 tendon	 sample	preparation	 for	 MALDI	 imaging.	 We	 hypothesise	 that	 there	 will	 be	 significant	protein	 differences	 between	 the	 interfascicular	 and	 fascicular	 matrix.	 By	extending	the	skills	 learnt	in	the	previous	two	studies	we	then	investigated	the	possibility	of	detecting	 in	vivo	changes	in	the	proteomic	composition	of	dialysis	fluid	 subsequent	 to	 shock-wave	 therapy	 of	 human	 Achilles	 tendon.	 We	hypothesised	that	if	detection	of	peptides	was	possible	in	this	media	then	there	should	be	an	increase	in	proteins	expressed	following	treatment.	Lastly	protein	turnover	 rates	 in	 mouse-tail	 tendon	 tissue	 were	 researched	 using	 the	 stable	isotope	 of	 lysine.	 We	 hypothesized	 based	 on	 previous	 research	 available	 that	there	would	be	a	higher	 rate	of	 turnover	within	 the	non-collagenous	matrix	 in	comparison	 to	 the	 collagenous	 matrix.	 Bringing	 all	 of	 this	 data	 and	 research	together	provides	a	platform	for	further	questions	to	be	answered.		
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Chapter	2,	Comparison	of	Protein	Extraction	Methods	in	Tendons	for	Mass	
Spectrometry	Analysis	
	Using	proteomic	 techniques	 to	define	 tendon	protein	profiles	and	patterns	 is	a	relatively	unexplored	field.	With	the	use	of	mass	spectrometry	the	initial	goal	in	this	study	was	to	build	a	reduced	complexity	database	of	diagnostic	peptide	ions	and	fragments,	this	can	then	be	used	to	generate	quantitative	profiles	of	protein	abundance	 in	 different	 tendon	 samples.	 The	 ability	 to	 detect	 proteins	 and	variations	 in	 their	 abundance	 will	 not	 only	 give	 information	 regarding	 the	biological	processes	that	are	occurring	but	also	these	changes	can	be	correlated	with	disease	detection	and	progression.				Biological	samples	are	complex	mixtures	of	proteins	and	in	order	to	optimise	the	data	 sets	 following	 LC	 MS/MS	 analysis,	 sample	 preparation	 must	 be	 carefully	considered.	 There	 are	 large	 variations	 in	 protein	 complexity	 within	 these	samples	 that	 can	 result	 in	 the	most	 abundant	 proteins	masking	 less	 abundant	ones.	 To	 increase	 coverage	 and	 sensitivity	 of	 data	 gained,	 techniques	 are	employed	to	reduce	the	complexity	of	the	sample	while	keeping	them	compatible	with	MS	analysis.	Alongside	this,	tendon	tissue	contains	many	protein	types,	i.e.	cellular,	membrane	proteins	and	those	contained	within	the	extracellular	matrix.	Optimising	 extraction	 of	 all	 types	 needs	 to	 be	 considered.	 It	 is	 also	 critical	 to	have	a	method	that	is	reproducible	in	order	to	detect	changes	in	the	abundance	of	proteins	between	samples.		As	 it	 is	the	detection	and	quantification	of	peptides	rather	than	proteins	that	 is	undertaken	 in	 LC	 MS/MS,	 a	 ‘bottom	 up	 approach’	 is	 employed.	 Providing	effective	denaturisation	of	the	protein	will	permit	the	digestion	enzymes	better	access	to	the	protease	specific	cleavage	sites.	Some	believe	that	an	ideal	protocol	would	achieve	a	complete	digestion	of	the	protein	as	this	could	result	in	a	better	reproducibility	 while	 improving	 the	 overall	 coverage	 of	 the	 tendon	 proteome	(Chen	et	al,	2007).		
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Various	protocols	 for	protein	denaturation	and	extraction	have	been	described	in	 the	 literature	 such	 as	 the	 use	 of	 heat,	 sonication,	 solvents,	 surfactant	 and	chaotropic	 agents	 (Proc	 et	 al,	 2010).	 Simplicity,	 cost	 effectiveness	 and	compatibility	with	down	stream	mass	spectrometry	are	all	crucial	properties	for	a	protein	extraction	protocol	(Proc	et	al,	2010).	To	increase	our	understanding	of	tendon	biology	we	must	 first	 optimise	 a	method	 to	 extract	proteins	 to	 analyse	the	 tissue	 effectively.	 Having	 knowledge	 of	 the	 biological	 processes	 that	 occur	within	healthy,	injured	and	old	tendons	will	provide	a	basis	for	future	advances	in	diagnostics	and	treatment	plans.	
Aims	and	objectives	This	is	a	comparative	study	using	three	different	methods	of	protein	extraction	in	two	tendon	types,	with	the	aim	of	increasing	coverage	of	the	tendon	proteome.		The	ability	to	produce	robust	and	effective	guidelines	in	sample	preparation	will	be	invaluable	for	future	studies	in	tendon	research.		
Materials	and	Methods	All	reagents	were	obtained	from	Sigma-Aldrich	unless	otherwise	stated.		
Sample	collection		Sample	 collection,	handling	and	dissection	of	human	 tissue	was	undertaken	by	Queen	Mary	University	London.	Samples	were	harvested	from	limbs	amputated	during	surgical	procedures	to	treat	sarcomas	at	the	Royal	National	Orthopaedic	Hospital,	 Stanmore.	 Tissue	 collection	 was	 carried	 out	 through	 the	 Stanmore	Musculoskeletal	Bio-Bank,	which	has	ethical	approval	from	the	Cambridgeshire	1	Research	 Ethics	 Committee	 (REC	 reference	 09/H0304/78)	 to	 collect	 tissue	 for	research	 into	 musculoskeletal	 conditions.	 All	 patients	 gave	 consent	 for	 their	tissue	 to	 be	 used	 for	 musculoskeletal-related	 research.	 Local	 research-and	development	 approval	 for	 this	 project	 was	 given	 by	 the	 UCL/UCLH/RF	 Joint	Research	Office	(reference	number11/0464).			Equine	 samples	 received	were	 obtained	 from	 a	 commercial	 equine	 abattoir	 so	ethical	approval	was	not	required.	No	previous	medical	histories	for	the	horses	were	 available.	 Forelimbs,	 distal	 to	 the	 carpus	were	 collected	 from	 half	 to	 full	
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Thoroughbred	horses.	A	sample	of	both	the	SDFT	and	CDET	were	dissected	from	the	mid	metacarpal	 region.	 There	were	 three	 donors	with	 a	mean	 ±SD	 age	 of	12.3±1.15	years.	Only	tendons	that	had	no	evidence	of	previous	tendon	injury	at	post	 mortem	 examination	 were	 included	 in	 this	 study.	 	 Human	 samples	 were	obtained	from	cadavers	from	three	age	groups;	a	young	male	(9yrs	old)	a	middle	aged	man	(56yrs	old)	and	an	elderly	female	(96yrs	old).	Samples	of	the	Achilles,	Anterior	 Tibialis	 and	 Posterior	 Tibial	 tendons	 were	 collected.	 Each	 individual	sample	had	three	replicates;	each	replicate	was	assigned	to	a	different	extraction	technique.	Ethical	permission	was	granted	for	this	study	by	the	NRES	committee	North	east	–	Sunderland	(Ref:	14/NE/0154).	
Protein	Extraction	For	 equine	 tendon	 samples,	 the	 mean±SD	 wet	 tissue	 sample	 size	 was	13.4±5.09mg.	For	human	tendon	samples,	the	mean	wet	tissue	sample	size	was	5.2mg,	 S.D.	1.09.	Deglycoslation	was	achieved	 in	 all	 samples	by	 the	addition	of	200	 μl	 of	 100	 mM	 Tris	 acetate,	 protease	 inhibitors	 (Complete	 Protease	Inhibitors,	 EDTA-free,	 Roche	 Applied	 Science),	 and	 0.1	 unit	 of	 chondroitinase	ABC,	 pH	 8.0	 to	 each	 Eppendorf	 and	 incubated	 at	 37°C	 for	 6	 hours.	 The	supernatant	was	removed	after	centrifugation	at	13,000	x	g	for	5	minutes.	 	The	collagenous	 and	 non-collagenous	matrix	 components	 of	 the	 tendon	were	 then	separated	by	one	of	three	methods:	-	
Method	one	–	4M	Guanidine	Protein	Extraction	Protein	extraction	was	achieved	by	the	addition	of	0.5	ml	of	guanidine	extraction	buffer	 (4	M	guanidine	hydrochloride	 (GnHCl),	65	mM	dithiothreitol	 (DTT),	and	50	mM	sodium	acetate,	pH	5.8).	Each	sample	was	sonicated	on	 ice	(3	pulses	of	10s	 each	 at	 40%	 output)	 on	 a	 ultrasonic	 processor	 (Sonoplus	 HD	 2070,	Bandelin)	and	the	extraction	performed	at	40C	for	48hours	on	an	orbital	shaker	(ThermoScientific	Max	Q).	The	supernatant	was	removed	after	centrifugation	at	15,000	x	g	@4°C	for	15	minutes.	The	final	 insoluble	 fraction	was	kept	aside	 for	further	analysis	of	the	non	collagenous	matrix	components.		
Method	two	–	7M	Urea	Protein	Extraction	Protein	 extraction	 was	 achieved	 by	 the	 addition	 of	 0.5ml	 of	 urea	 extraction	buffer	(7M	urea,	0.15M	Sodium	Chloride,	50mM	Tris	hydrochloride	and	protease	
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inhibitors	(Complete	Protease	Inhibitors,	EDTA-free,	Roche	Applied	Science)	pH	6.5).	 A	 Sonicator	 (Sonoplus	 HD	 2070,	 Bandelin)	 was	 used	 in	 an	 attempt	 to	maximize	protein	solubilization.	Each	sample	was	sonicated	on	 ice	(3	pulses	of	10s	each	at	40%	output)	the	extraction	was	then	performed	at	4°C	for	48hours	on	 an	 orbital	 shaker	 (ThermoScientific	Max	Q).	 The	 supernatant	was	 removed	after	 centrifugation	 at	 15,000	 x	 g	 @4°C	 for	 15	 minutes.	 The	 final	 insoluble	fraction	 was	 kept	 aside	 for	 further	 analysis	 of	 the	 non	 collagenous	 matrix	components.		
Method	Three	–	Rapigest	SF	Protein	Extraction	50μl	 of	 25mM	Ammonium	 bicarbonate	was	 added	 to	 each	 sample,	 which	was	then	sonicated	on	 ice	 (3	pulses	of	10s	each	at	40%	output).	Subsequently	1mg	Rapigest	 SF	 (Waters,	 UK)	was	 added	 and	 the	 solution	 incubated	@60°C	 for	 60	minutes.	Within	this	time	period	samples	were	vortexed	on	two	occasions.	The	supernatant	was	removed	after	centrifugation	at	14,000	x	g	@4°C	for	10	minutes.	The	 final	 insoluble	 fraction	 was	 kept	 aside	 for	 further	 analysis	 of	 the	 non	collagenous	matrix	components.	
Protein	Assay	Ethanol	 precipitation	 was	 performed	 on	 aliquot’s	 of	 the	 supernatant	 prior	 to	estimation	 of	 protein	 concentration	 for	 both	 urea	 and	 guanidine	 samples.	Samples	were	resolubilised	with	7M	Urea,	2M	Thiourea,	30mM	Tris,	pH	8)	then	analysed	by	 the	Bradford	assay	 read	at	660nm	using	Coomassie	PlusTM	protein	assay	reagent	(Thermo	Scientific,	Rockford,	IL)	
One-dimensional	Sodium	Dodecyl	Sulfate	Polyacrylamide	Gel	
Electrophoresis	(SDS-PAGE)	and	Silver	Staining	To	 remove	 interfering	 substances	 GdnHCL	 and	 Urea	 soluble	 extracts	 were	precipitated	 using	 Strataclean	 Resin	 (Stratagene	 R,	 Hycor	 Biomedical	 Ltd,	Edinburgh,	UK).	All	 samples	were	subsequently	separated	 in	single	dimensions	based	 on	 their	 molecular	 weight	 by	 one	 dimensional	 SDS-PAGE	 to	 compare	quantitative/qualitative	 differences	 in	 the	 protein	 profiles.	 1ug	 of	 protein	was	loaded	 in	 equal	 with	 reducing	 buffer	 (2-mercaptoethanol)	 onto	 4-12%	acrylamide	 Bis-Tris	 NuPAGE	 gels	 (Invitrogen).	 Before	 loading	 samples	 were	
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incubated	with	reducing	buffer	for	@	90°C	for	5	minutes	and	then	placed	on	ice	to	 return	 sample	 to	 room	 temperature.	 Proteins	 were	 visualised	 by	 silver	staining	(Thermo	Scientific)	according	to	the	manufacturer’s	instructions.	
Protein	Reduction/Alkylation	and	In-Solution	Trypsin	Digestion	Reduction	of	disulphide	bonds	and	alkylation	of	free	cysteines	was	achieved	by	incubation	 with	 10mM	 DTT	 (10min	 at	 60°C)	 and	 then	 50mM	 iodoacetamide	(30min	at	room	temperature	in	the	dark)	respectively.	The	soluble	fraction	was	removed	after	centrifugation	for	15	min	at	13,000	×	g	at	4°C	and	co	precipitated	with	 1µg	 of	 trypsin	 (Promega)	 at	 37°C	 overnight.	 The	 concentration	 of	 trypsin	was	chosen	as	known	workable	concentration	which	was	frequently	used	in	the	groups	 laboratory.	 To	 avoid	 auto	 digestion,	 the	 reaction	was	 stopped	with	 the	addition	 of	 1%	 trifloroacetic	 acid	 (TFA).	 To	 check	 digestion	 had	 occurred	samples	 were	 again	 combined	 in	 equal	 volumes	 with	 reducing	 buffer	 (2-mercaptoethanol)	 and	 run	 onto	 4-12%	 acrylamide	 Bis-Tris	 NuPAGE	 gels	(Invitrogen),	 gels	 were	 run	 for	 50	 minutes	 at	 200V.	 Silver	 staining	 (Thermo	Scientific)		was	used	to	check	for	complete	protein	digestion.	
	
Analysis	of	non	collagenous	matrix	components	
The	final	insoluble	fraction	from	each	of	the	extraction	methods	were	incubated	in	0.1M	acetic	acid	containing	pepsin	at	100	μg/ml	and	shaken	overnight	at	4	°C.	Samples	were	centriguged	at	13,000	x	g	for	15	minutes,	the	supernatant	was	removed,	lyophilized,	re-suspended	in	water,	re-lyophilized	and	then	heated	in	20μl	of	Laemmli	buffer	containing	50mM	DTT	for	5	min	at	95	°C.	The	material	was	resolved	using	3–8%	acrylamide	Tris	acetate	gels	(Invitrogen)	gels	were	run	for	65minutes	at	150V	then	silver	stained.		
Protein	Identification	Samples	 were	 desalted	 and	 purified	 using	 C18	 resin	 in	 the	 form	 of	 a	 ZipTip®	(Merck	Millipore,	 Rockland,	 MA,	 USA).	 Analysis	 was	 performed	 by	 LC	MS/MS.	(Orbitrap)	 using	 aliquots	 of	 tryptic	 peptides	 equivalent	 to	 200ng	 of	 tendon	
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protein.	 Protein	 identification	 was	 achieved	 by	 searching	 through	 MASCOT	Unihorse	 and	 Unihuman	 databases	 and	 by	 comparing	 samples	 using	ProgenesisTM	QI	software	(version	4,	Waters).	 	Proteins	with	2	or	more	unique	peptide	sequences	were	included	in	the	final	analysis.	
Results		
Results	compare	both	the	equine	and	human	groups	separately	
1D	SDS-PAGE		Results	can	be	found	in	Figure	1	and	2.	10ng	of	each	sample	was	loaded	onto	the	gels.	A	quantitative	comparisons	of	protein	extracted	using	these	three	protocols	cannot	be	made	as	 silver	 staining	was	performed	until	 the	molecular	 standard	lane	 was	 ‘over-developed’	 to	 allow	 maximum	 staining	 of	 proteins	 extracted.	Unfortunately	 the	results	obtained	 from	the	pepsin	protocol	were	unable	 to	be	assessed	due	to	technical	artefacts	with	the	gels.		
	
Figure	 1.	 1D-SDS-PAGE	 of	 Urea	 (U)	 Guanidine	 (G)	 and	 Rapigest	 SF	 (R)	
Human	Tendon	Samples	collected	from	9	year	old	male.	Molecular	weight	
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markers	expressed	in	KDa.	The	reduced	staining	of	the	guanidine	gel	was	
due	 to	 under	 staining.	 Quantitative/Qualitative	 assumptions	 cannot	 be	
made,	 as	 staining	 time	 varied.	 Gels	 demonstrate	 that	 the	 gross	 protein	
profiles	from	these	two	different	tendon	types	were	similar.	
	
Figure	 2.	 1D-SDS-PAGE	 of	 Urea	 (U)	 Guanidine	 (G)	 Rapigest	 SF	 (R)	 and	
Equine	 Tendon	 samples	 from	 SDFT	 and	 CDET	 samples	 from	 the	 same	
donor.	 Molecular	 weight	 markers	 in	 KDa.	 Quantitative/Qualitative	
assumptions	 cannot	 be	 made,	 as	 staining	 time	 varied.	 More	 bands	 are	
detected	with	rapigest	extraction	
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Figure	3.	Pepsin	 released	material	 from	 the	entire	 insoluble	 fraction	was	
resolved	by	Tris	acetate	3-8%	NuPage.	Urea	(U)	Guanidine	(G)	Rapigest	SF	
(R)	 human	 samples	 of	 AT	 and	 ATT	 from	 the	 same	 9	 year	 old	 donor.	
Molecular	 weight	 markers	 KDa.	 Artefacts	 due	 to	 a	 manufacturing	 fault	
within	the	gels	meant	that	Quantitative/Qualitative	assumptions	could	not	
be	made.	Possibly	this	fault	occurred	from	the	gels	being	to	dry	within	their	
packaging.	
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Figure	4.	Pepsin	 released	material	 from	 the	entire	 insoluble	 fraction	was	
resolved	by	Tris	acetate	3-8%	NuPage.	Urea	(U)	Guanidine	(G)	Rapigest	SF	
(R)	Equine	Tendon	samples	 from	SDFT	and	CDET	samples	 from	the	same	
donor.	 Molecular	 weight	markers	 KDa.	 Artefacts	 due	 to	 a	manufactering	
fault	 within	 the	 gels	 meant	 that	 Quantitative/Qualitative	 assumptions	
could	not	be	made.	
LC	MS/MS		Initial	 analysis	 came	 from	 comparing	 the	 complexity	 of	 the	 chromatograms	generated	from	LC	MS/MS.	 	A	typical	chromatogram	of	each	extraction	method	in	samples	from	the	same	donor	is	shown	for	comparison	in	figure	3.	Label-free	relative	 protein	 quantification	was	 then	 undertaken	 using	ProgenesisTM	 LC-MS	software.		To	increase	confidence	in	the	results	acquired,	the	average	number	of	significant	 proteins	 was	 adjusted	 to	 1%	 false	 discovery	 rate	 (FDR)	 on	 the	MASCOT	search,	this	reduces	the	proportion	of	false	positive	results	(Pawitan	et	
al,	 2005).	 These	 results	 can	 be	 found	 in	 Figure	 4.	 Although	 the	 guanidine	extraction	method	appeared	to	have	identified	the	greatest	number	of	significant	proteins,	 there	 was	 no	 statistical	 difference	 numbers	 of	 proteins	 identified	between	 guanidine	 and	 Rapigest	 SF	 samples.	 	 The	 urea	 extraction	 group	
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produced	the	lowest	number	of	significant	proteins.	To	illustrate	the	relationship	between	the	three	protocols	a	Venn	diagram	was	produced	for	both	equine	and	human	 samples.	 Data	 was	 searched	 within	 MASCOT	 Unihuman	 and	 Unihorse	databases.		Figure	4	demonstrates	Venn	Diagrams,	the	Venn	diagram	illustrating	human	 samples	 guanidine	 and	 Rapigest	 SF	 methods	 had	 155	 of	 the	 same	proteins	in	common,	guanidine	and	urea	methods	had	62	of	the	same	proteins	in	common	 and	 Rapigest	 SF	 and	 Urea	 methods	 had	 7	 of	 the	 same	 proteins	 in	common.	132	of	the	proteins	detected	were	common	to	all	extraction	techniques.	In	 equine	 samples	 guanidine	 and	 Rapigest	 SF	 methods	 had	 25	 of	 the	 same	proteins	in	common,	guanidine	and	urea	methods	had	61	of	the	same	proteins	in	common	 and	 Rapigest	 SF	 and	 urea	 methods	 had	 6	 of	 the	 same	 proteins	 in	common.	 There	 were	 115	 proteins	 detected	 in	 common	 to	 all	 extraction	techniques.	 	 Following	 this	 initial	 data	 analysis	 bioinformatics	 tools	 PANTHER	(protein	annotation	through	evolutionary	relationship)	and	STRING	(Search	Tool	for	 the	Retrieval	 of	 Interacting	Genes/Proteins)	were	 employed	 to	 analyse	 the	functional	 protein	 classifications	 and	 protein-protein	 interactions	 respectively	(Mi	et	al,	2015;	Franceschini	et	al,	2013).	PANTHER	is	a	classification	system	that	provides	 ontological	 information	 about	 the	 significant	 proteins	 identified.	STRING	 provides	 information	 on	 known	 and	 predicted	 protein-protein	interactions.	 Before	 the	 analysis	 with	 the	 bioinformatics	 software,	 to	 increase	confidence	 in	 the	 identification	of	proteins,	data	was	 further	 filtered	 to	 include	proteins	with	at	 least	 two	unique	peptides	and	a	FDR	1%	 in	 this	data	 set.	The	urea	extraction	protocol	did	not	achieve	any	results	that	were	within	these	strict	criteria,	hence	were	not	included	in	figures	5	and	6.	Figure	5a-d	reveals	STRING	analysis	for	each	group;	clustering	was	performed	at	a	medium	confidence	level	of	≥	0.4.	Figure	6	 reveals	PANTHER	analysis	of	proteins	 classified	according	 to	their	 location,	 this	 aims	 to	 establish	 differences	 between	 the	 types	 of	 protein	extracted,	 for	 instance	cellular	versus	extracellular	proteins.	Within	 the	human	data,	 the	 Rapigest	 SF	 extraction	 protocol	 achieved	 a	 higher	 percentage	 of	extracellular	 matrix	 components,	 53%,	 compared	 to	 the	 guanidine	 extraction	protocol,	 which	 was	 36%.	 Within	 the	 equine	 data	 set	 the	 percentage	 of	extracellular	 matrix	 components	 to	 cellular	 components	 between	 the	 two	
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protocols	were	similar.	As	there	was	a	small	sample	size	no	comparisons	could	be	made	between	subsets;	in	particular,	how	protein	profiles	may	vary	between	young	 and	 old	 samples	 and	 between	 different	 tendon	 types	 as	 there	was	 only	one	sample	in	each	group.			
	
Figure	3	–	Comparison	chromatograms	of	all	Extraction	Methods	 in	a	9yr	
Achilles	Tendon.	The	same	donor	was	used	so	a	direct	comparison	can	be	
made.	The	complexity	of	the	chromatogram	differs	between	each	method.	
The	 most	 complex	 chromatogram	 is	 from	 the	 Rapigest	 SF	 extraction	
method	 and	 the	 least	 complex	 chromatogram	 results	 from	 the	 urea	
extraction	method.		
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Figures	4a.	Venn	Diagram	of	Human	proteins.	Figure	4b.	Venn	diagram	of	
equine	 proteins.	 Shows	 the	 average	 number	 of	 significant	 proteins	 after	
adjustment	to	1%	FDR	in	MASCOT	search	against	Unihuman	and	Unihorse	
databases	 respectively.	 Results	 revealed	 that	 the	 guanidine	 method	
extracted	 the	 highest	 amount	 of	 unique	 proteins,	 and	 urea	 the	 least	
amount	in	both	human	and	equine	samples.		
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Figure	 5a-d.	 Protein-protein	 interaction	 network	 visualised	 using	 the	
bioinformatics	 tool	STRING.	Proteins	were	 filtered	 to	 include	at	 least	 two	
unique	 peptides	 and	 a	 FDR<0.01.	 These	 proteins	 were	 specific	 to	 the	
guanidine	protocol.	 A	 red	 ellipse	 on	 each	 figure	 encloses	 the	most	 stable	
and	 connected	 interactions	 within	 each	 data	 set.	 Human	 guanidine	 data	
revealed	 clusters	 involving	 intracellular	 proteins	 such	 as	 histones	 and	
ribosomal	proteins.	
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Figure	5b.	This	interaction	network	revealed	proteins	extracted	in	human	
samples	 via	 Rapigest	 SF.	 Clusters	 can	 be	 seen	 to	 involve	 extracellular	
proteins	such	as	collagens,	lumican	and	fibronectin.		
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Figure	5c.	This	 interaction	network	revealed	proteins	extracted	in	equine	
samples	via	guanidine,	this	data	clusters	heavily	with	intracellular	proteins	
such	as	histones	and	ribosomal	proteins.	
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Figure	5d.	This	interaction	network	revealed	proteins	extracted	in	equine		
samples	 via	 Rapigest	 SF.	 Interactions	 between	 collagen	 extracellular	
proteins	are	seen	here.	
		
	 44	
	
Figure	6.	 	Using	the	gene	ontology	tool	PANTHER,	proteins	were	classified	
according	to	 their	 location.	Differentially	expressed	proteins	with	at	 least	
two	unique	peptides	and	a	FDR	1%	were	included	in	this	data	set.	Profiles	
of	the	guanidine	and	Rapigest	SF	datasets	were	species	independent.	
Discussion		The	efficiency	of	enzymatic	digestion	can	vary	from	protein	to	protein;	cleavage	site	 access	 may	 be	 inaccessible	 to	 enzymes	 depending	 upon	 the	 structural	conformation	 of	 the	 protein.	 Denaturisation	 is	 the	 disruption	 of	 the	 internal	bonds	that	give	the	proteins	their	quaternary,	tertiary	and	secondary	structures.	This	is	advantageous	prior	to	proteolysis,	as	the	digestion	enzyme	has	improved	contact	with	cleavage	sites,	leading	to	a	more	efficient	digestion.	
During	 this	 study	 two	 different	 methods	 of	 protein	 denaturation	 were	investigated	by	comparing	two	chaotropic	agents	and	one	detergent.	There	are	various	protein	extraction	techniques	described	in	the	literature	(Norrgran	et	al,	2009;	Peffers	et	al,	 2014;	Wilson	et	al,	 2010)	however,	 to	date,	no	 comparison	study	has	been	undertaken	which	compares	these	methods	in	tendon	tissue.		
Three	agents	were	 chosen,	 guandidine	and	urea,	which	are	 chaotrophic	 agents	and	Rapigest	SF	which	is	a	detergent.	
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Protocols	 were	 devised	 to	 compare	 the	 solubility	 of	 proteins	 alongside	 their	abundance	 between	 conditions,	 methods	 also	 need	 to	 be	 compatible	 with	techniques	of	analysis	and	detection.	For	this	tissue,	which	is	 largely	composed	of	extracellular	matrix,	we	expect	there	to	be	mostly	collagen	proteins,	however	to	 learn	 about	 the	 biological	 processes	 within	 the	 tissue	 we	 need	 to	 devise	methods	to	detect	both	the	non	collagenous	components	of	this	matrix,	such	as	proteoglycans,	 and	 also	 to	 detect	 cellular	 proteins.	 Due	 to	 the	 fibrous	composition	of	tendon	tissue,	this	tissue	is	highly	resistant	to	extraction	(Peffers	
et	al,	2014;	Wilson	et	al,	2010).	Extrapolation	of	methods	from	previous	studies	in	musculoskeletal	 tissues	was	deemed	an	appropriate	 starting	point.	Previous	studies	 have	 used	 the	 chaotropic	 agent	 guanidine	 within	 an	 extraction	 buffer,	with	success,	for	protein	extraction	in	tendons	and	cartilage	(Peffers,	et	al,	2014.	Wilson	et	al,	2010).	Urea	was	chosen	as	an	alternative	chaotropic	agent	to	trial.			Drawbacks	 to	 these	 agents	 are	 that,	 at	 the	 concentration	 required	 to	 denature	proteins	 they	 will	 also	 reduce	 proteolytic	 activity	 of	 the	 digestion	 enzyme	 so	samples	must	be	 cleaned	up	and	 concentrations	of	 these	agents	diluted	before	digestion	occurs	(Proc	et	al,	2010).	Regarding	the	use	of	urea,	when	exposed	to	heat,	 degradation	 into	 ammonium	 cyanate	 can	 occur	 which	 leads	 to	 the	carbamylation	of	free	primary	amines	in	the	sample	being	analysed	which	needs	to	be	avoided	(Proc	et	al,	2010).	Although	heat	alone	 is	a	powerful	denaturant,	both	 the	 guanidine	 and	 urea	 extraction	 protocols	 avoided	 its	 use	 for	 reasons	described	above,	along	side	this,	protein	degradation	could	occur	which	needs	to	be	avoided.	A	previous	comparison	study	revealed	that	the	use	of	heat	alongside	guanidine	 gave	 no	 benefit	 to	 the	 end	 results.	 Interestingly,	 in	 the	 same	 study,	heat	improved	the	efficiency	of	extraction	using	urea	(Proc	et	al,	2010).	
Finally	the	surfactant	Rapigest	SF	was	chosen	for	the	third	protocol.		Rapigest	SF	is	the	brand	name	for	the	anionic	detergent	sodium	3-[(2-methyl-2-undecyl-1,3-dioxolan-4-yl)methoxy]-1-propanesulfonate.	This	agent	acts	as	a	denaturant	by	solubilising	 and	 unfolding	 the	 substrate	 protein	 and	 has	 been	 shown	 to	 have	several	 advantages.	 These	 benefits	 include:	 -	 not	 interfering	 with	 mass	spectrometry	analysis,	does	not	suppress	peptide	ionisation	and	does	not	modify	the	proteins	and	peptides	(Yu	et	al,	2003).	
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For	 all	 three	methods,	 samples	 were	 pre-treated	with	 chondroitinase	 ABC	 for	deglycosylation.	 Glycosylation	 is	 a	 post-translational	 modification	 in	 proteins	that	 makes	 the	 identification	 of	 glycoproteins	 challenging	 during	 mass	spectrometry	analysis.	As	discussed	in	the	introduction,	proteoglycans	are	one	of	the	 principal	 components	 of	 the	 non-collagenous	 matrix	 in	 tendon	 tissue.		Proteoglycans	 are	 comprised	 of	 a	 core	 protein	 plus	 one	 or	 more	glycosaminoglycan	 (GAG)	 side	 chains;	 previous	 studies	 have	 used	chrondroitinase	 ABC	 to	 effectively	 remove	 these	 side	 chains	 (Fessel	 and	Snedeker,	2011).	
The	 effectiveness	 of	 each	 method	 was	 ultimately	 assessed	 on	 the	 number	 of	identified	 peptides	 reported	 following	 LC	 MS/MS	 analysis.	 Originally,	 before	filtering,	 Rapigest	 SF	 samples	 revealed	 higher	 signal	 intensities.	 	 Using	Progenesis	QI	software	to	filter	the	data	and	threshold	the	identified	proteins	to	a	1%	FDR	 identification	 rate	with	at	 least	a	 two-fold	 change	 in	expression,	 the	guanidine	 HCL	 extraction	 yielded	 the	 greatest	 number	 of	 unique	 identified	proteins	and	urea	the	lowest.	To	increase	confidence	levels	for	the	identification	of	 proteins,	 the	data	was	 further	 filtered	 to	 only	 include	proteins	with	 at	 least	two	 unique	 peptides	 and	 a	 FDR	 less	 than	 1%.	 Applying	 these	 more	 rigorous	acceptance	thresholds	reduced	the	number	of	proteins	identified	following	urea	extraction	to	zero.		Due	to	the	poor	performance	of	urea	extraction,	subsequent	bioinformatic	 analysis	were	 only	 performed	 on	 the	 guanidine	 and	Rapigest	 SF	samples.		Proteomic	profiles	of	the	guanidine	and	Rapigest	SF	datasets	appeared	to	follow	the	 same	 pattern	 despite	 them	 being	 from	 two	 different	 species.	 Guanidine	samples	had	a	higher	amount	of	intracellular	proteins	such	as	ribosomal	proteins	and	 histones.	 Rapigest	 SF	 samples	 tended	 to	 have	 a	 roughly	 equal	 amount	 of	intracellular	 and	 extracellular	 matrix	 proteins,	 such	 as	 collagens	 and	proteoglycans.	Further	study	with	a	higher	number	of	biological	repeats	would	be	needed	to	confirm	whether	this	was	a	true	representation.		
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Possible	explanations	for	my	results	are	as	follows:	-	both	guanidine	and	urea	are	classed	as	chaotrophic	agents,	meaning	that	they	disrupt	the	non	covalent	bonds	within	 the	 proteins	 tertiary	 structure,	 it	 is	 possible	 that	 the	 poor	 extraction	efficiency	 of	 urea	 can	 be	 explained	 by	 a	 lower	 ability	 to	 solubilise	 the	 lipid	bilayer	of	membranes	and	subsequently	cell	contents	are	not	released.	This	is	in	stark	 comparison	with	 guanidine,	 which	 showed	 a	 high	 percentage	 of	 cellular	components.	 Another	 possible	 speculation	 is	 that	 urea	 causes	 a	 higher	proportion	 of	 hydrophobic	 residues	 during	 the	 unfolding	 process,	 which	 then	lead	 to	 an	 increase	 in	 protein	 aggregation	 and	 a	 subsequent	 reduction	 in	identification	hits.		There	 are	 limitations	 to	 the	 above	 study.	 Statistical	 analysis	 could	 not	 be	performed	due	to	the	small	sample	size.	Further	work	would	include	replicates	in	order	to	test	repeatability.	Also	due	to	the	small	sample	size	no	comparisons	could	 be	 made	 between	 subsets;	 in	 particular,	 how	 protein	 profiles	 may	 vary	between	young	and	old	samples	and	between	different	tendon	types.	Following	these	preliminary	results	further	work	could	also	expand	on	these	findings	to	see	whether	 combining	 methods	 could	 increase	 peptide	 recovery	 and	 overall	coverage	 of	 the	 tendon	 proteome.	 For	 instance	 it	 would	 be	 interesting	 to	combine	 extraction	 using	 guanidine	 and	Rapigest	 SF.	 If	 protein	 extraction	was	performed	by	Rapigest	SF,	 the	supernatant	removed	and	set	aside,	 then	on	 the	same	pellet	continue	with	the	guanidine	extraction	protocol,	once	completed	the	two	 protocol	 supernatants	 could	 be	 combined	 and	 analysed	 with	 LC	 MS/MS.	Different	 concentrations	 of	 Rapigest	 could	 also	 be	 trialled	 to	 see	 whether	 the	same	effects	could	be	achieved	with	lower	amounts.				Once	an	optimal	extraction	protocol	has	been	devised,	 it	would	be	beneficial	to	look	at	different	age	groups	as	previous	studies	have	found	differences	in	protein	profiles.	 One	 study	 found	 a	 reduction	 in	 the	 levels	 of	 several	 SLRPs	 and	 an	increase	 in	 intermediate	 filament	 proteins	 were	 found	 as	 a	 result	 of	 ageing	(Peffers	 et	 al,	 2014).	 These	 proteins	 are	 involved	 in	 matrix	 organisation	 and	regulation	of	 cell	 tension.	 In	 support	 of	 this,	 another	 study	detected	 a	 reduced	
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amount	 of	 neopeptides	 in	 aged	 IFM	 possibly	 indicating	 reduced	 turnover	(Thorpe	et	al,	2016)	however	 the	protein	composition	of	both	 the	 IFM	and	FM	did	 not	 show	 large	 differences	 (Thorpe	 et	 al,	 2016).	 If	 we	 can	 enhance	 the	process	 of	 extracting	 proteins	 from	 tendon	 tissue	 this	 can	 only	 lead	 to	 better	discoveries	 in	 the	 field	 of	 tendon	 proteomics	 as	 by	 establishing	 compositional	changes	between	age	groups,	this	will	provide	insights	into	tissue	mechanics	and	potentially	target	areas	for	diagnostic/therapeutic	methods																			 		 	
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Chapter	3,	Mass	Spectrometry	Imaging		(IMS)	of	tendon	tissue.	
Introduction	Proteomic	 analysis	 of	 tendons	 is	 a	 field	 that	 has	 received	 limited	 attention.	Gaining	a	clearer	insight	into	the	composition	of	tendons	will	in	time	have	great	consequences	 for	 cell	 based	 therapies	 and	 tissue	 engineering	 strategies.	 Using	Liquid	 chromatography	 Mass	 spectrometry/Mass	 spectrometry	 (LC-MS/MS)	provides	 label	 free	 analysis	 of	 our	 biological	 samples.	 However	 LC-MS/MS	analysis	ignores	the	spatial	distribution	of	molecules,	visualisation	of	the	protein	distribution	allows	the	investigation	of	differentially	expressed	proteins	in	these	areas	 (Cobice	 et	 al,	 2015).	 The	 introduction	 of	 MS	 imaging	 allows	 questions	regarding	distribution	patterns/	 functions	of	molecules	 to	be	answered.	Matrix	assisted	 laser	 desorption/ionization	 (MALDI)	 mass	 spectrometry	 allows	 the	spatial	 analysis	 of	 molecules	 <100,000Da	 whereas	 secondary	 ion	 mass	spectrometry	 (SIMS)	 provides	 analysis	 of	 the	 elements	 and	 lower	 molecular	mass	 compounds,	 <1000Da	 (Todd	 et	 al.,	 2001).	 	 The	 application	 of	 these	methods	 together	 can	 attain	 a	 considerable	 amount	 of	 information	 on	 the	biological	 functions	of	 the	 tendon	tissue	and	how	alterations	may	occur	during	ageing,	disease	and	between	different	types	of	tendon.	
Since	 the	 invention	 of	 MALDI-MS	 several	 crucial	 preparation	 steps	 of	 the	biological	 samples	have	been	 identified	 to	optimise	data	 collection.	Developing	protocols	that	have	a	high	level	of	uniformity	and	reproducibility	are	vital	in	the	development	of	future	clinical	tests	and	therapies.	In	a	complex	sample	such	as	tendon	 tissue	 the	 identification	 of	 noteworthy	 features	 can	 be	 hidden	 beneath	higher	 abundance	molecules.	 There	 are	many	 high	 abundance	 proteins,	which	may	 contain	 post-translational	modifications,	 that	 can	 interfere	with	 a	 sample	affecting	 the	 analysis.	 Sample	 clean	 up	 steps	 are	 recommended	 to	 reduce	 the	concentration	 of	 interfering	 substances.	 As	 there	 is	 no	 published	 data	 on	 the	imaging	of	tendons	it	was	necessary	to	optimise	and	adapt	protocols	previously	used	 in	 other	 tissue	 types.	 This	 chapter	will	 detail	 the	major	details	 of	 sample	preparation	according	to	the	current	literature;	these	measures	can	then	be	used	as	a	starting	point	for	the	investigation	of	a	novel	tissue	sample.		
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Aims	and	objectives	To	 devise	 an	 appropriate	 protocol	 for	 tendon	 sample	 preparation	 for	 MALDI	imaging.	 Following	 this	 to	 employ	 a	multimodal approach for the visualisation of 
unlabeled peptides, lipids and small molecules at cellular and subcellular levels of 
tendons at different risk of injury and ages.	
Materials	and	Methods	All	 reagents	 were	 obtained	 from	 Sigma-Aldrich	 unless	 otherwise	 stated.	 To	minimise	non-protein	contamination,	high	quality	reagents	HPLC	grade	solvents	and	all	glass	ware	were	pre-rinsed	with	high	quality	water.	Buffers	were	made	on	the	day.	Simplified	flow	diagram	of	methods	used	can	be	viewed	in	figure	3.		
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Figure	 3.	 Flow	 diagram	 of	 the	 methods	 used	 during	 the	 preparation	 of	 tendon	
tissue	for	MALDI	imaging.		
Sample	collection	Ethical	approval	was	not	required	for	this	study	as	samples	were	obtained	from	a	commercial	equine	abattoir.		No	previous	medical	histories	for	the	horses	were	available.	Forelimbs,	distal	 to	 the	carpus	were	collected	 from	Thoroughbred	or	Thoroughbred	crosses.	A	sample	of	both	the	SDFT	and	CDET	were	dissected	 in	duplicate	 from	 the	 mid	 metacarpal	 region	 from	 young	 skeletally	 mature	
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(<4years)	 and	 old	 horses	 (>15years).	 Only	 tendons	 that	 had	 no	 evidence	 of	previous	tendon	injury	at	post	mortem	examination	were	included	in	this	study.	Tendon	 sections	were	 then	 either	 snap	 frozen	 in	 liquid	nitrogen	 and	 stored	 at	−80	 °C	 until	 further	 analysis	 or	 stored	 in	 4%	 paraformaldehyde	 solution	 for	future	histological	analysis.	
Sample	preparation	for	SIMS	Tissue,	 which	 had	 previously	 been	 stored	 at	 -80	̊C,	 was	 transferred	 to	 the	Cryotstat	machine	(Leica	CM1860UV);	the	stage	holding	and	blade	temperature	were	set	to	-21	̊C.	Tendon	samples	were	attached	onto	a	sample	holder	with	ice.	Thickness	of	a	sample	from	each	category	were	cut	to	12	μm	and	thaw	mounted	onto	 indium	 tin	 oxide	 (ITO)	 coated	 high	 conductivity	 glass	 slides	 (Delta	Technologies,	CO,	USA)	and	frozen	at		-	20	̊C	for	later	use.		
SIMS	Experiment	Samples	were	transferred	to	a	desiccator	box,	defrosted	and	dried	in	a	vacuum	desiccator	 to	 prevent	 the	 molecular	 de-localisation.	 SIMS	 experiments	 were	performed	 in	 positive	 and	 negative	 ion	 modes	 on	 a	 Physical	 Electronics	(Chanhassen,	MN,	USA)	TRIFT	II	secondary	ion	mass	spectrometer	with	a	30	keV	Bi32+		primary	 ion	beam.	Areas	of	8.4	x	6.8	mm	were	analysed	using	the	mosaic	mode	of	21	x	17	tiles,	each	400	x	400	μm	in	size	containing	256	x	256	pixels	per	tile	(lateral	resolution	is	1.56	μm	per	pixel).	The	acquisition	time	was	24	seconds	per	tile.		
SIMS	Data	Interpretation	Raw	 data	 were	 converted	 to	 Matlab	 format	 and	 then	 spatial	 binning,	 spectral	binning	and	peak	picking	were	performed.		Principal	component	analysis	(PCA)	was	used	 to	 look	 for	 spectral	 similarities	 and	differences	between	 the	 samples	using	Maastricht	University	in	house	built	ChemoneTricks	Toolbox	for	MATLAB	version	2014b		
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Sample	preparation	for	MALDI	Imaging	
Sample	cutting	Tissue	 which	 had	 previously	 been	 stored	 at	 -80	̊C	 was	 transferred	 to	 the	Cryotstat	machine	(Leica	CM1860UV).	Tendon	samples	were	carefully	mounted	onto	 a	 sample	 holder	 and	 embedded	 in	 ice.	 The	 use	 of	 optimum	 cutting	temperature	 (OCT)	polymer	was	 avoided	 to	 prevent	 suppressed	 ion	 formation	and	 intensity	 during	 MALDI	 MSI	 analysis.	 Thickness	 of	 a	 sample	 from	 each	category	was	cut	to	12	μm	and	thaw	mounted	onto	glass	slides.	After	sectioning	the	samples	were	stored	at	-	20	̊C	for	later	use.	For	optimisation	purposes	SDFT	sample	from	a	horse	>15	years	old	was	used.	
Tissue	washing	Washing	steps	prior	 to	on-tissue	 trypsin	digestion	were	undertaken	 to	 remove	lipids,	salts	and	other	environmental	factors	that	would	reduce	the	efficiency	of	enzymatic	 digestion.	 This	was	 achieved	 by	 carefully	washing	 the	 sample	 twice	with	 70%	 ethanol	 for	 30	 seconds.	 Successively	 the	 sample	 was	 washed	 with	100%	chloroform	 for	30	seconds	and	 then	95%	Ethanol	 for	30	seconds.	These	steps	act	 to	 remove	 lipids	 that	 interfere	at	 the	 low	mass	 range.	 	 Samples	were	then	dried	in	a	vacuum	desiccator	for	10	minutes.	
On-tissue	Tryptic	digestion	Trypsin	 solution	5ug/ml	was	 reconstituted	 in	either	deionised	water	or	25mM	Ammonium	 Bicarbonate	 (AMBIC),	 both	 contained	 10mM	 n-Octyl	 β-D-glucopyranoside	 (OcGlu)	Tissue	was	 then	 coated	with	 a	 homogeneous	 layer	 of	trypsin	 solution	 with	 the	 SunCollectTM	 automatic	 sprayer	 (SunChrom,	Friedrichsdorf,	 Germany)	 or	 the	 trypsin	 was	 manually	 applied.	 Suncollect	settings	used	can	be	found	in	Table	1.	Whilst	spraying	was	carried	out,	continued	observation	 was	 necessary	 to	 ensure	 spraying	 was	 consistent	 with	 settings.	Digestion	was	performed	either	over	4	hour	or	16	hours.	 	To	prevent	 samples	from	drying	out,	 they	were	maintained	 in	a	wet/humid	environment.	This	was	achieved	 by	 incubation	 in	 a	 parafilmed	 container	 at	 37°C	 in	 a	 saturated	atmosphere	 of	 MeOH/H2O	 (1:1	 v/v).	 Following	 digestion,	 samples	 were	 again	dried	in	a	vacuum	desiccator	for	10	minutes.		
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Table	2.	Suncollect	settings	for	enzyme	application.	
Matrix	application	The	matrix	 solution,	α-Cyano-4-hydroxycinnamic	acid	 (CHCA)	 (5mg/ml	diluted	in	 50%	 acetonitrile	 and	 50%	 water	 containing	 0.2%	 trifluoroacetic	 acid,	 was	sprayed	 on	 top	 of	 the	 tissue	 section	 with	 SunCollectTM	 automatic	 sprayer	(SunChrom,	 Friedrichsdorf,	 Germany).	 Two	 spraying	 conditions	 were	 trialed	with	this	application,	Suncollect	settings	can	be	found	in	Table	2	and	3.	Manual	application	was	also	tested.		
	
Table	3.	SunCollect	Settings	for	Dryer	Matrix	Application.		
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Table	4.	SunCollect	Settings	for	Wetter	Matrix	Application.	
Experiments	run	The	 initial	phase	 in	 this	study	was	 to	 trial	a	method	 that	has	been	successfully	used	 in	 other	 tissue	 types.	 This	 experiment	 compared	 young	 and	 old	 SDFT	sections	 to	 a	 non-digested	 control	 sample.	 The	 SunCollect	 spray	was	 used	 for	both	enzymatic	application	and	the	matrix	application.	Suncollect	settings	for	the	matrix	application	were	set	to	‘dry’	parameters.			In	 order	 to	 improve	 the	 spectra	 obtained,	 a	 series	 of	 experiments	 were	undertaken	 to	 evaluate	 the	 optimal	 sample	 preparation	 protocol.	 To	 achieve	optimisation	 of	 the	 in	 situ	 digestion,	 different	 techniques	 were	 tested.	 The	experiments	can	be	viewed	in	table	1.	
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Table	 1.	 Six	 experiments	 performed	 to	 optimise	 trypsin	 reconstitution.	 These	
experiments	 also	 determined	 differences	 between	 manual	 and	 Suncollect	
application	of	both	enzyme	and	matrix.		
	
MALDI	Imaging	Digital	 optical	 scans	 of	 tissue	 sections	 were	 taken	 prior	 to	 MALDI-IMS	experiments	 using	 an	HP	 scanner.	 The	digital	 images	were	 then	 imported	 into	the	MALDI	imaging	software	HDImaging	V4.1	(Waters	Corporation,	Manchester,	UK)	 which	 was	 utilised	 to	 select	 the	 area	 to	 be	 sampled.	 The	 horizontal	 and	vertical	 step	 sizes	 between	 each	 sample	 spot	were	 set	 at	 100	 μm.	 Instrument	calibration	 was	 performed	 using	 a	 red	 phosphorous	 standard,	 in	 positive	ionisation	mode	between	m/z	100	to	m/z	5000.	Data	was	acquired	in	sensitivity	mode,	positive	polarity	and	in	the	100	to	3500	Da	mass	range.	The	quadrupole	profile	 was	 set	 to	 900Da	 and	 other	MS	 setting	were	 set	 to	 the	manufacturers	default	values.		
Data	Analysis	As	full	analysis	of	data	 is	very	time	consuming	a	broad	overview	of	the	spectra	generated	 from	 different	 conditions	 were	 compared	 and	 contrasted	 via	 the	biomap	 (Novartis,	 Switzerland)	 software.	 This	was	 to	 enable	 a	modification	 of	the	final	protocol	without	prolonged	amounts	of	time	performing	in	depth	data	analysis.		For	 full	analysis,	acquired	mass	spectra	were	combined	 into	a	single	 image-file	and	 then	processed	via	Masslynx	 (Waters),	mMass	 [30]	 and	BioMap	 (Novartis,	Switzlerland)	 software.	 Spectra	 were	 processed	 in	 MassLynxTM	 (Waters	Corporation)	by	means	of	peak	smoothing	and	baseline	subtraction.	Ion	images	were	 generated	with	 the	Biomap	3.8.0.4	 software	 (Novartis	 Pharma	AG,	 Basel,	Switzerland).	The	intensity	of	all	m/z	channels	were	normalised,	autoscaled	and	peak	picked.		The	peak	picking	was	performed	on	peaks	with	threshold	S/N	(i.e.	signal	to	noise	ratio)	≥2.	Following	this	Principal	Component	Analysis	(PCA)	and	Discriminant	Analysis	 (DA)	were	applied	 to	 reveal	 and	visualise	 the	variability	within	the	data.	
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Results	The	 first	 experiment	 assessed	 old	 SDFT	 sections	 to	 a	 non-digested	 control	sample,	results	revealed	similar	spectra	and	are	displayed	in	figure	4.			
	
Figure	 4.	 Using	 biomap	 software.	 Top	 spectrum	 represents	 in	 situ	 trypsin	
digestion	with	Dry	Matrix	settings	compared	 to	control	sample.	The	 two	spectra	
are	similar.		
	Secondly	a	comparison	was	made	between	the	old	and	young	subjects.	Principal	component	 analysis	 (PCA)	 and	 discriminant	 analysis	 (DA)	were	 applied	 to	 see	whether	 the	 two	 samples	 revealed	 any	 molecular	 differences	 based	 on	 the	tryptic	peaks	that	had	been	generated.	Results	can	be	seen	in	figure	5.				
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(A)																																																											(B)	
Figure	 5.	 Sample	 1	 =	 young	 SFDT.	 Sample	 2	 =	 Old	 SDFT	 and	 Sample	 3	 =	
control	i.e.	non	digested	SDFT	(A)	PCA	plot,	this	plot	aims	to	illustrate	any	
variation	 between	 the	 undigested	 control	 and	 the	 digested	 SDFT	 old	 and	
young	 samples.	 From	 this	 plot,	 samples	 1	 and	 2,	 show	 a	 great	 degree	 of	
variation	 in	 points	 exhibiting	 the	 digestion	 process	 as	 there	 are	 a	 larger	
number	of	peptides	in	these	samples.	However	the	difference	between	the	
two	 samples	 shows	 no	 significant	 differences.	 (B)	 Discriminant	 analysis,	
this	plot	aims	to	characterize	or	separate	the	two	groups.	Here	samples	1	
and	 2	 reveal	 no	 differences	 between	 old	 and	 young	 samples	 but	 a	
difference	is	seen	between	the	digested	and	non	digested	control.		
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(C)	
5	(C)	MALDI	Image	SDFT	Young	–	Mosaic image showing the first 18 principal 
components (PCs). The different PCs show the intra-tissue heterogeneity of the 
SDFT group. 
	
	The	PCA	and	DA	plots	reveal	that	digestion	has	occurred	however	there	was	not	a	significant	difference	between	the	age	groups.		
Enzyme	application	optimisation	Trypsin	reconstituted	in	25mM	AMBIC	was	compared	to	trypsin	reconstituted	in	deionized	 H20	 (figure	 6)	 Manual	 application	 was	 compared	 to	 SunCollect	application	 (figure	 7).	 The	 optimal	 digestion	 time	 was	 also	 studied;	 4	 hour	compared	to	16	hour	digestion	times	(figure	8)		
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Figure	 6.	 Comparison	 of	 spectra	 when	 trypsin	 was	 reconstituted	 up	 in	 25mM	
ammonium	bicarbonate	 (buffer)	 compared	 to	 the	use	of	ddH2O.	The	 top	spectra	
reveals	the	highest	intensity	and	an	increased	number	of	peaks	showing	that	this	
is	the	superior	method.	Matrix	was	applied	by	the	Suncollect	machine	on	the	wet	
settings	for	both.		
	
	
Figure	 7.	 Manual	 vs	 sprayed	 trypsin	 in	 buffer.	 Matrix	 was	 applied	 using	 the	
SunCollect	 on	 the	 wet	 settings.	 Top	 spectrum	 represents	 manual	 application	
compared	 to	 Suncollect	 application.	Higher	 intensity	peaks	 are	 seen	 throughout	
when	trypsin	was	applied	manually.		
	 61	
		
Figure	8.	Comparison	of	digestion	 times.	Top	spectrum	represents	 in	 situ	
trypsin	 4	 hour	 digestion	 (reconstituted	 in	 buffer)	 compared	 to	 16	 hour	
digestion.	 The	 longer,	 16	 hour	 digestion,	 reveals	 the	 highest	 peak	
intensities.		
Matrix	application	optimisation		Suncollect	 settings	 were	 modified	 to	 ascertain	 whether	 this	 improved	 co-crystallization	and	gave	an	increased	number	of	protein	identifications.		Dryer	vs	wetter	settings	are	compared	in	figure	9.			
	
	
Figure	 9.	 Comparison	 of	 SunCollect	 matrix	 application	 settings.	 Top	 spectrum	
represents	 ‘dryer’	 settings	 in	 comparison	 to	 the	 ‘wetter’	 settings.	 In	 this	
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comparison	the	dryer	settings	looked	marginally	better,	as	hits	were	identified	in	
1500-2000	m/z		region.	
SIMS	Analysis	
All	samples	were	measured	in	both	positive	and	negative	ion	modes.	Most	common	
peaks	 23	 (sodium),	 39	 (potassium),	 104,	 86,	 184	 (all	 originating	 from	
phosphocholine,	a	fragment	of	phospholipids),	369	(cholesterol).	 In	negative	mode,	
79	is	the	highest,	corresponding	to	phosphate,	but	also	281	and	255	which	are	free	
fatty	acids.	Which	is	demonstrated	by	figure	11.	No	significant	differences	between	
the	four	groups	were	observed.		
	
	
Figure	 10.	 	 Negative	 ion	 mode	 SIMS	 image	 and	 corresponding	 spectra	 of	 old	
energy	storing	 tendons	 (SDFT).	 Spectra	generated	came	 from	the	 interfascicular	
matrix	region.	No	significant	differences	were	detected	between	samples.	
	
Adjacent	sections	were	prepared	with	haematoxylin-eosin	(H&E)	staining	for	optical	
microscopy,	 this	 enabled	 the	 verification	 of	 where	 the	 interfascicular	 matrix	 was	
located	 and	 revealed	 artifacts	 in	 the	 tissue	 sections	 which	 assisted	 with	 accurate	
data	analysis.	CDET	young	sample	showed	slightly	different	spectra;	most	likely	due	
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to	 artifacts	within	 the	 tissue	 caused	 by	 the	 freeze	 thaw	process.	 However	 looking	
over	all	four	groups,	the	peaks	detected	revealed	no	significant	difference. 
Discussion	In	this	study	we	investigated	the	use	MALDI	and	SIMS	as	a	novel	method	for	the	proteomic	 analysis	 of	 tendon	 tissue	 of	 different	 ages	 and	 types.	 Results	demonstrated	for	both	techniques	that	sample	preparation	protocols	have	yet	to	be	fully	optimised.			The	 first	 objective	 of	 this	 study	 was	 to	 determine	 the	 most	 efficient	 sample	preparation	 for	MALDI	 imaging	 of	 tendon	 tissue.	The	data	was	processed	pre-processed	 and	 visualized	 using	 Masslynx	 (Waters),	 mMass	 and	 biomap	(Novartis,	 Switzerland)	 software.	 Firstly	 a	 comparison,	 using	biomap	 software,	was	made	between	an	 In	situ	 trypsin	digestion	of	 an	 SDFT	old	 tendon	and	 the	non-digested	 control.	 Results	 revealed	 similar	 spectra	 so	 different	 conditions	were	trialed	in	the	attempt	to	reveal	the	peptides	we	were	looking	for.			For	MALDI-IMS	investigations	revealed:	1) Trypsin	 reconstituted	 in	 25mM	 Ammonium	 bicarbonate	 was	 seen	 to	generate	more	peaks	compared	to	deionised	H2O.	2) Although	 manual	 application	 of	 trypsin	 yielded	 better	 results	 than	 the	SunCollect	 application	 for	 comparable	 results	 the	 robotic	 sprayer	 is	superior	 as	 the	 repeatability	 was	 considered	 to	 be	more	 consistent.	 As	spectra	seen	revealed	increases	in	intensity	of	peaks	identified.		3) The	optimal	trypsin	digestion	time	was	found	to	be	16	hours.		During	 this	 study,	no	differences	were	detected	between	 tendon	 types	and	age	groups.	It	is	likely	that	methodologies	were	not	fully	refined	however	it	is	also	a	possibility	 that	 results	 obtained	 are	 true	 findings.	 Further	 work	 needs	 to	 be	undertaken	to	optimise	sample	preparation	before	full	analysis	between	sample	types	 can	 be	 undertaken.	 Potential	 areas	 of	 improvement	 are	 in	 situ	 tissue	digestion,	matrix	application	and	data	collection.			
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Determining	methods	 to	maximize	 the	 efficiency	of	 this	 in-situ	 tissue	digestion	should	 increase	 the	 amount	 of	 peptides	 visualised.	 By	 performing	 on-tissue	digestion	more	protein	identifications	may	be	made,	while	preserving	the	spatial	distribution	of	proteins.	Currently	the	most	commonly	used	enzyme	is	trypsin,	it	generates	peptides	compatible	with	MS	by	cleaving	mainly	at	the	carboxyl	side	of	the	amino	acids	lysine	or	arginine.	Studies	have	been	undertaken	to	improve	in	situ	 proteolysis	 and	 research	 has	 revealed	 that	 digestion	 is	 improved	 by	 the	addition	 of	 a	 detergent	 (Patel	 et	 al,	 2015).	 In	 this	 study	 n-octyl	 glucoside	was	used	to	aid	digestion	of	hydrophobic	proteins	as	these	proteins	can	be	resistant	to	 enzymatic	 digestion	 due	 to	 inaccessible	 cleavage	 sites.	 An	 alternative	detergent	 that	 could	be	 trial	 is	N-Octanoyl-N-methylglucamin	 (MEGA-8)	as	 this	has	also	been	shown	to	achieve	efficient	proteolysis	and	is	compatible	with	mass	spectrometry.	 Another	 possibility	 is	 to	 include	 the	 addition	 of	 Rapigest	 SF	(Waters	 Corporation,	Manchester,	UK)	 to	 the	 in	situ	 digest,	 this	 has	 previously	been	used	with	success	in	trypsin	digestions.	One	study	demonstrated	that	when	RapiGest	was	used	in	conjunction	with	trypsin	digestion	an	increased	number	of	peptide	 peaks	 were	 generated	 in	 comparison	 to	 experiments	 with	 trypsin	digestion	 alone	 was	 used	 (Patel	 et	 al,	 2015).	 Previous	 work	 has	 also	demonstrated	 that	when	using	 this	surfactant	 there	 is	no	 interference	with	MS	analysis.	 In	 the	 previous	 chapter	 Chrondroitinase	 ABC	 was	 used	 to	 remove	glycosaminoglycan	(GAG)	side	sides	as	they	are	difficult	to	analyse	and	can	cause	ion	suppression	of	other	molecules.		One	of	the	reasons	this	occurs	is	due	to	the	negative	 charge	 that	 these	 side	 chains	 carry	 (Thanawiroon	 et	 al,	 2004).	 A	pretreatment	 with	 chrondroitinase	 ABC	 could	 be	 considered.	 	 Finally	 an	alternative	 enzyme	 such	 as	 collagenase	 could	 be	 considered,	 as	 tendons	 are	primarily	composed	of	collagens	this	may	enable	a	greater	number	of	peptides	to	be	 generated.	 Proteins	 would	 then	 be	 identified	 on	 MS/MS	 fragmentation	pattern.		
 The	 type	 of	matrix	 chosen	 is	 influenced	 by	 the	 size	 of	 the	 analyte.	 Commonly	sinapinic	 acid	 (SA)	 is	 used	 for	 the	 analysis	 of	 larger	 peptides	 and	 proteins	(>10kDa)	(Meetani	and	Voorhees,	2005)	α-Cyano-4-hydroxycinnamic	acid	CHCA	
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is	often	used	for	the	detection	of	smaller	peptides	(Chughtai	and	Heeren,	2010).	By	 substituting	CHCA	with	SA,	whole	proteins	would	be	detected	which	would	eliminate	the	need	for	a	digestion	step.		
Data	was	acquired	in	sensitivity	mode,	positive	polarity	and	in	the	100	to	3500	Da	mass	range.	The	majority	of	peaks	were	observed	below	m/z	1000,	there	was	a	 substantial	 amount	of	 these	peaks	 that	originated	 from	 the	matrix	molecules	themselves.		Improvements	could	result	from	changing	the	mass	range	in	which	data	 is	 acquired,	 e.g.	 in	 the	 900-3500Da	 mass	 range.	 This	 could	 reduce	background	spectra	and	possibly	allow	a	detection	of	peptides	in	the	higher	mass	range.	
For	 SIMS	 Analysis,	 Mass	 spectrums	 presented	 were	 focused	 on	 the	interfascicular	 matrix.	 The	 abundant	 peaks	 were	 fragments	 of	 phospholipids,	which	 represent	 a	 major	 class	 of	 lipids	 and	 are	 a	 component	 of	 the	 cellular	membrane.	Other	peaks	detected	were	of	fatty	acids	and	cholesterol,	again	these	are	 components	 of	 the	 cellular	 membrane.	 These	 results	 correspond	 with	 a	recently	published	study	comparing	proteomic	profiles	of	the	IFM	and	fascicular	matrix	 (FM)	 it	 was	 demonstrated	 that	 the	 IFM	 contained	 more	 proteins	 and	protein	 fragments	 (neopeptides)	 in	 comparison	 with	 the	 FM	 (Thorpe	 et	 al,	2016).	 Using	 label	 free	 quantification	 this	 study	 showed	 that	 the	 majority	 of	proteins	with	higher	abundance	 in	 the	 IFM	were	cellular	proteins	compared	to	the	 FM	 which	 contained	 a	 higher	 abundance	 of	 ECM	 proteins	 (Thorpe	 et	 al,	2016).			There	was	reduced	signal	on	the	CDET	young	sample	potentially	due	to	artifacts	created	during	the	freezing	process.	It	has	been	described	that	different	parts	of	the	tissue	can	cool	at	different	rates,	this	can	lead	to	the	formation	of	ice	crystals	that	 then	 lead	 to	 fragmentation	 of	 the	 sample	 to	 be	 analysed	 (Chughtai	 and	Heeren,	2010).	During	this	 investigation	a	protocol	of	snap	freezing	the	sample	in	 liquid	nitrogen	was	used	in	order	to	try	and	prevent	this	occurring.	This	not	only	 prevents	 the	 sample	 from	 biological	 degradation,	 it	 also	 preserves	 tissue	morphology.	 Extra	 samples	 were	 taken	 for	 validation	 of	 MS	 by	 histological	
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staining,	so	that	the	morphological	information	could	be	correlated	between	the	two	techniques,	this	proved	that	there	was	fragmentation	within	the	tissue	and	removal	 of	 background	 spectra	was	 easier	when	 SIMS	 images	were	 correlated	with	H	and	E	stained	images	of	tissue.	
A	brief	comparison	of	the	four	sample	groups	revealed	little	differences	between	the	 spectra.	 As	 there	was	 only	 one	 sample	 representing	 each	 group	 a	 general	conclusion	cannot	be	made.	It	is	possible	that	the	results	seen	in	this	study	are	a	true	 impression.	 However,	 looking	 at	 previous	 studies,	 one	 investigation	revealed	a	decrease	mRNA	expression	of	proteoglycan	4,	which	was	confirmed	by	immunostaining	(Kostrominova	and	Brooks,	2013).	In	conjunction	with	this,	other	 research	 groups	 have	 detected	 differences	 in	 the	 proteomic	 profiles	between	these	types	of	sample	groups	(Peffers,	2014),	 it	would	be	advisable	to	alter	sample	preparation	and	to	look	again.		
To	 reduce	 fragmentation	of	 the	 sample	would	be	difficult	 as	 all	 attempts	were	made	 to	 avoid	 this,	 however,	 an	 increase	 in	 sample	 numbers	 in	 each	 group	would	 give	more	 accurate	 overview.	Another	 option	 could	be	 to	 employ	metal	assisted	SIMS	by	depositing	a	gold	coating	to	the	sample	tissue	with	the	hope	of	increasing	ion	yields	of	higher	mass	molecules	(McDonnel	and	Heeren,	2006). 
 Further	work	is	necessary	in	this	area	and	suggestions	have	been	made.	Another	avenue	 that	could	be	explored	 is	 the	use	of	 laser	microdissection	 to	selectively	isolate	 the	 region	 of	 choice	 ie	 the	 interfascicular	 matrix,	 then	 using	 methods	discussed	 in	 chapter	 2	 to	 perform	 Liquid	 chromatography	 mass	spectrometry/mass	 spectrometry	 LC	 MS/MS.	 This	 study	 has	 already	 been	undertaken	and	results	were	discussed	previously	(Thorpe	et	al,	2016)	however	future	 analysis	 via	 MALDI–IMS	 or	 SIMS	 could	 also	 be	 performed	 on	 isolated	sections	once	optimum	sample	preparation	methods	are	defined.							
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Chapter	4,	Dialysis	Tendinopathy	is	a	broad	term	use	to	describe	a	tendon	disorder	characterised	by	a	combination	of	pain,	 swelling	and	 impaired	performance.	Tendinopathies	are	often	associated	with	overuse	tendon	injuries	and	pose	a	major	problem	for	the	human	 and	 equine	 patient.	 There	 is	 some	 debate	 concerning	 the	 role	 of	inflammation	in	tendon	injury.		
Some	investigations	have	indicated	little	or	no	inflammation	present	in	tendons	exposed	 to	 overuse	 (Andres	 and	Murrell,	 2008;	 Khan	 et	al,	 1999;	Wilson	 and	Best,	2005).	This	could	be	a	true	finding	or	could	be	inaccurate	due	to	the	time	of	patient	 presentation,	 poorly	 sensitive	 techniques	 or	 the	 definition	 of	inflammation	 based	 purely	 on	 cellular	 components	 (Dakin	 et	al,	 2013).	Whilst	inflammation	is	necessary	after	injury,	if	this	process	persists,	fibrosis	is	thought	to	occur	which	can	add	to	the	risk	of	subsequent	reinjury.	 	The	development	of	effective	protocols	in	managing	the	injured	tendon,	and	also	preventing	reinjury,	is	 dependant	 upon	 the	 full	 understanding	 of	 tendon	 pathology	 and	 the	 role	 of	inflammation.	 Many	 treatment	 options	 include	 the	 use	 of	 anti-inflammatories,	firstly	 to	 manage	 the	 associated	 pain	 but	 also	 to	 reduce	 the	 harmful	 effects	inflammation	causes	however	 there	are	known	adverse	consequences	(Shier	et	
al,	1996).	Therefore	this	treatment	option	may	or	may	not	be	the	most	effective	choice	of	treatment.	Further	research	is	needed	into	the	mechanisms	of	disease	pathogenesis,	therapeutic	interventions	and	their	efficiencies.			There	 are	 a	 number	 of	 alternative	 conservative	 treatment	 options	 available	 to	the	 physician	 each	 having	 various	 efficiencies,	 one	 of	 which	 is	 extracorporeal	shock	 wave	 therapy	 (ESWT).	 During	 this	 treatment,	 acoustic	 shockwaves	 are	passed	 through	 the	 skin	 to	 the	 affected	 area.	 The	 mechanism	 by	 which	 this	treatment	works	has	not	 been	 fully	 determined,	 but	 it	 is	 thought	 to	 accelerate	the	 healing	 process	 by	 increasing	 blood	 flow	 to	 the	 area;	 by	 having	 a	 direct	suppressive	effect	on	nociceptors,	hence	causing	an	degree	of	denerving	and	by	activating	 interstitial	 and	 extracellular	 biological	 responses	 (Notarnicola	 and	Moretti,	2012).	 
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Repeated	mechanical	 loading	or	 injury	to	 the	tendon	causes	an	upregulation	of	MMP’s	 which	 lead	 to	 degradation	 of	 the	 ECM	 which	 in	 time	 can	 lead	 to	 a	recurring	 injury	 and	 chronic	 tendinopathy.	 It	 has	 been	 demonstrated	 by	 one	investigation	 that	 after	 shockwave	 stimulation	 there	was	 a	 down	 regulation	of	cytokines	 and	MMPs	 (Han	 et	al,	 2009).	 It	 has	 also	 been	 hypothesized	 that	 the	mechanical	 stimulus	 which	 is	 provided	 by	 this	 therapy	 might	 aid	 in	 tendon	remodeling	 by	 stimulating	 the	 inflammatory	 and	 catabolic	 processes	 that	 are	required	for	removing	any	damaged	matric	constituents	(Waugh	et	al,	2015).	A	study	which	explored	the	effects	of	ESWT	to	normal	tendinous	tissue	found	that	there	was	a	disorganization	of	the	matrix	structure	and	changes	were	observed	in	the	amount	of	degraded	collagen	present.	An	upregulation	of	COL1	expression	was	noted	6	weeks	after	the	treatment	which	was	hypothesized	to	be	indicative	for	repair	(Bosch	et	al,	2009).		Possible	side	effects	that	have	been	mentioned	in	the	literature	are	pain	during	the	procedure,	reddening	of	the	skin	and	bruising	(Haake	et	al,	2002). 	This	technique	has	also	been	used	successfully	in	the	fields	of	urology,	to	disintegrate	 uroliths,	 and	 in	 orthopaedics	 to	 induce	 tissue	 repair	 and	regeneration	(McClure	and	Dorfmüller,	2003).	Until	recently	the	use	of	ESWT	in	tendinopathies	was	controversial,	however	a	recent	review	of	ESWT	found	this	procedure	 to	 be	 a	 successful	 alternative	 conservative	 treatment	 in	tendinopathies	(Mani-Babu	et	al,	2014).		Proteomic	 analysis	 by	 mass	 spectrometry	 has	 the	 ability	 to	 reveal	 both	 the	different	 types	 and	 abundances	 of	 proteins	 in	 a	 sample.	 From	 the	 author’s	knowledge,	 to	 date,	 it	 has	 been	 mainly	 ex	 vivo	 investigations	 that	 have	 been	undertaken	 to	 characterize	 the	 tendon	 proteome.	 A	 significant	 development	would	 be	 the	 ability	 to	 detect	 in	 vivo	 changes	 in	 the	 proteomic	 composition,	leading	 to	clearer	and	more	direct	understanding	of	 the	efficiency	of	 therapies.	Biological	 samples	 can	 vary	 in	 complexity,	 and	 minimization	 of	 interfering	substances	 through	 sample	 handling	 and	 cleaning	 can	 drastically	 improve	 the	resolved	 peptide	 spectra.	 During	 this	 investigation,	 samples	 of	 microdialysis	media	 from	 the	 peritendinous	 space	 of	 the	 Achilles	 tendon	 pre	 and	 post	
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shockwave	therapy	were	used	to	establish	whether	the	in	vivo	identification	and	quantification	of	proteins	was	possible.	
Aims	and	objectives	To	 determine	 whether	 current	 methods	 for	 proteomic	 analysis	 using	 mass	spectrometry	 are	 sensitive	 enough	 to	 ascertain	 the	 protein	 composition	 of	dialysis	 fluid	 following	 ESWT	 in	 human	 tendinopathy.	 	 To	 determine	 any	alterations	 in	 differentially	 expressed	 proteins	 in	 pre	 and	 post	 shockwave	dialysis	samples.	
Materials	and	Methods	All	reagents	were	obtained	from	Sigma-Aldrich	unless	otherwise	stated.		
Sample	collection		Sample	 collection	 and	 handling	 was	 undertaken	 by	 Queen	 Mary	 University	London.	 The	 full	 details	 of	 the	 experimental	 protocol,	 ethical	 permissions	 and	methods	 used	 can	 be	 found	 in	 Waugh	 et	 al,	 2015.	 Thirteen	 participants	 with	healthy	 tendons	 with	 no	 previous	 history	 of	 tendinopathy	 (7	 men,	 6	 women,	aged	25.7	±	7.0	years).	Six	patient	participants	(6	men,	aged	39.0	±	14.9	years)	with	 established	 (i.e.	 symptomatic	 for	 >	 6	 months)	 mid-portion	 Achilles	tendinopathy,	diagnosed	by	a	suitably	qualified	healthcare	professional.	Patients	were	 excluded	 from	 participation	 if	 they	 had	 received	 steroid,	 platelet-	 rich	plasma	or	high-volume	image-guided	injections	in	the	previous	6	months,	or	had	previous	 tendon	 surgery.	 Each	 patient	 was	 screened	 for	 a	 history	 of	 systemic	inflammatory	conditions,	anti-inflammatory	medication	prescriptions.		
A	microdialysis	 catheter	was	 placed	 under	 strict	 aseptic	 technique.	within	 the	peritendinous	 space	 (plantar	 to	 the	 Achilles	 tendon).	 For	 healthy	 participants,	the	 skin	 either	 side	 of	 the	 free	 Achilles	 tendon	 was	 anaesthetised	 using	subcutaneously	 injected	 Lidocaine	 (0.4-0.7	 mL,	 20	 mg/mL),	 approximately	 25	mm	proximal	to	the	calcaneal	bone.	For	patient	participants,	the	skin	either	side	of	the	site	with	most	pain	and/or	tendon	thickening	on	palpation,	depending	on	proximity	to	bony	structures.	The	area	was	perfused	with	sterile	lactated	ringers	solution.	 Due	 to	 a	 possible	 immediate	 biological	 response	 from	 the	 trauma	 of	placing	 the	catheter	a	60-minute	wait	period	was	 introduced	prior	 to	dialysate	
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collection.	 Collection	 then	 occurred	 every	 30	minutes	 and	 samples	 pooled	 for	two	 hours,	 ESWT	 was	 administered	 to	 each	 tendon	 mid-portion	 (mean	treatment	size	of	1-2	cm2)	in	a	single	session	using	a	British	kite-marked	device	(Swiss	DolorClast	Classic,	Electro	Medical	Systems,	Nyon	Switzerland)	and	radial	hand	piece.	Treatment	was	given	perpendicular	 to	 the	 longitudinal	 tendon	axis	without	anaesthesia	and	consisted	of	2500	 impulses	administered	at	8	Hz.	The	total	 energy	 delivered	 was	 160	mJ/mm.	 After	 ESWT	 treatment,	 dialysate	 was	collected	 every	 60	 min	 for	 the	 following	 4	 h	 (Waugh	 et	 al,	 2015).	 This	 study	included	 healthy	 patients	 and	 patients	 diagnosed	 with	 established	 (i.e.	symptomatic	 for	 greater	 than	6	months)	Achilles	 tendinopathy	diagnosed	by	 a	suitably	 qualified	 healthcare	 professional.	 What	 sample	 group,	 our	 samples	belonged	to	is	unknown.	
Methods	Six	microdialysis	samples	were	obtained	from	human	patients,	donor	signalment	and	 history	 was	 unknown.	 Two	 samples	 were	 pre	 shockwave	 therapy,	 two	samples	 were	 post	 shockwave	 therapy	 and	 two	 samples	 were	 from	 unknown	groups.	 The	 initial	 protein	 concentrations	 in	 all	 samples	 were	 measured	 and	recorded	 with	 the	 NanoDrop	 2000c	 spectrophotometer	 (Thermo	 Fisher	Scientific).	 Sample	 volume	 was	 limited,	 so	 in-solution	 tryptic	 digestion	 was	undertaken	 following	 loading	 onto	 StrataClean™	 resin	 (Agilent,	 USA).	 This	enabled	digestion	of	 equal	protein	amounts	of	 the	 samples	 and	 the	 removal	of	potential	interfering	substances	(to	the	in-line	chromatography).	The	in-solution	trypsin	 digestion	 was	 performed	 with	 the	 prior	 addition	 of	 1%	Rapigest	 SF	solution	 (Waters,	 UK)	 (incubated	 at	 80°C	 for	 10	 minutes)	 to	 improve	 the	efficiency	 of	 digestion.	 	Reduction	 of	 disulphide	 bonds	 and	 alkylation	 of	 free	cysteines	was	achieved	by	incubation	with	10	mM	DTT	(10min	at	60°C)	and	then	50mM	 iodoacetamide	 (30min	 at	 room	 temperature	 in	 the	 dark)	 respectively.	Samples	 were	 digested	 overnight	 using	 1µg	 of	 trypsin	 (Promega)	 at	 37°C.	 To	avoid	 auto	 digestion,	 the	 reaction	 was	 stopped	 with	 the	 addition	 of	 1%	trifloroacetic	 acid.	 Figure	 1	 demonstrates	 schematic	 of	 methods	 used.	 One-dimensional	 SDS-PAGE	 to	 compare	 quantitative/qualitative	 differences	 in	 the	protein	profiles	could	not	be	performed,	as	sample	size	was	limited.		
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Mass	Spectrometry	methods	Trypsin-digested	 peptides	 were	 separated	 using	 an	 Ultimate	 3000	 RSLC	(Thermo	Scientific)	nanoflow	LC	system.	Using	an	ESI	Easy	Spray	source	at	50°C	~	0.5	µg	protein	was	 loaded	with	a	 constant	 flow	of	5	µl/min	onto	an	Acclaim	PepMap100	nanoViper	C18	trap	column	(100	µm	inner-diameter,	2cm;	Thermo	Scientific).	After	trap	enrichment,	peptides	were	eluted	onto	an	Acclaim	PepMap	RSLC	 nanoViper,	 C18	 column	 (75	 µm,	 50	 cm;	 ThermoScientific)	 with	 a	 linear	gradient	of	2–40%	solvent	B	(80%	acetonitrile	with	0.08%	formic	acid)	over	65	min	 with	 a	 constant	 flow	 of	 300	 nl/min.	 The	 HPLC	 system	 was	 coupled	 to	 a	linear	ion	trap	Orbitrap	hybrid	mass	spectrometer	(LTQ-Orbitrap	Velos,	Thermo	Scientific)	 via	 a	 nanoelectrospray	 ion	 source	 (Thermo	 Scientific).	 The	 spray	voltage	was	set	to	1.6	kV,	and	the	temperature	of	the	heated	capillary	was	set	to	250	 °C.	 Full-scan	 MS	 survey	 spectra	 (m/z	 335–1800)	 in	 profile	 mode	 were	acquired	 in	 the	 Orbitrap	 with	 a	 resolution	 of	 60,000	 after	 accumulation	 of	1,000,000	 ions.	The	 fifteen	most	 intense	peptide	 ions	 from	the	preview	scan	 in	the	 Orbitrap	 were	 fragmented	 by	 collision-induced	 dissociation	 (normalised	collision	energy,	35%;	activation	Q,	0.250;	and	activation	time,	10	ms)	in	the	LTQ	after	 the	accumulation	of	10,000	 ions.	Maximal	 filling	 times	were	1,000	ms	 for	the	 full	 scans	 and	 150	 ms	 for	 the	 MS/MS	 scans.	 Precursor	 ion	 charge	 state	screening	was	enabled,	and	all	unassigned	charge	states	as	well	as	singly	charged	species	 were	 rejected.	 The	 lock	 mass	 option	 was	 enabled	 for	 survey	 scans	 to	improve	 mass	 accuracy	 (Olsen	 et	 al,	 2004).	 Data	 were	 acquired	 using	 the	Xcalibur	software.	
Data	analysis	The	 Orbitrap	 Velos	 raw	 files	 were	 loaded	 into	 Proteome	 Discoverer	 (Version	1.4.0.288)	and	searched	against	Mascot	Search	Engine	(Version	2.3.2).		
Enzyme	specificity	was	set	to	that	of	trypsin,	allowing	for	cleavage	N-terminal	to	proline	 residues	 and	 between	 aspartic	 acid	 and	 proline	 residues.	 Other	parameters	 used	 were:	 (i)	 variable	 modifications,	 methionine	 oxidation,	methionine	 dioxidation,	 protein	 N-acetylation,	 gln	 à	 pyro-glu;	 (ii)	 fixed	modifications,	 cysteine	 carbamidomethylation;	 (iii)	 database:	 IPI-HUMAN_20130120);	 (iv)	 MS/MS	 tolerance:	 FTMS-	 10ppm,	 ITMS-	 0.6	 Da;	 (v)	
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maximum	peptide	 length,	 6;	 (vi)	maximum	missed	 cleavages,	 2;	 and	 (vii)	 false	discovery	rate,	1%.		
Label	free	quantification	For	label	free	quantification	the	raw	files	of	the	acquired	data	were	analysed	by	the	Progenesis	QI™	software	(Version	4,	Nonlinear	Dynamics).	After	selection	of	the	 reference	 sample,	 the	 retention	 times	 of	 the	 other	 samples	 were	 aligned.	These	were	 then	 exported	 and	 searched	 in	 UniHuman	 database	with	MASCOT	server	 (Version	 2.3.01).	 The	 following	 search	 parameters	 were	 used:	 peptide	mass	 tolerance	 of	 10ppm,	 fragment	 mass	 tolerance	 of	 0.6Da,	 one	 missed	cleavage,	 fixed	 modification,	 carbamidomethylation;	 variable	 modifications,	methionine	oxidation;	 a	 false	discovery	 rate	of	1%	was	used	before	 the	 search	results	 were	 re-imported	 back	 into	 Progenesis	 QITM.	 	 Statistical	 analysis	 was	performed	 on	 all	 detected	 features	 using	 transformed	 normalised	 abundances	for	one-way	analysis	of	variance	(ANOVA).	All	peptides	(with	Mascot	score	>36	and	 p	 <	 0.05)	 of	 an	 identified	 protein	were	 included,	 and	 the	 protein	 p	 value	(one-way	 analysis	 of	 variance)	 was	 then	 performed	 on	 the	 sum	 of	 the	normalized	abundances	for	all	runs.	Adjusted	analysis	of	variance	values	of	p	<	0.05	 and	 additionally	 regulation	 of	 >2-fold	 or	 <0.5-fold	 were	 regarded	 as	significant.	
Removal	of	lost	labeled	samples	To	 ensure	 the	 highest	 confidence	 in	 the	 data,	 the	 initial	 analysis	 was	 carried	out	excluding	 the	 two	 samples	with	 lost	 labels.	 Unfortunately,	 within	 both	 the	pre	and	post	dialysis	groups	the	sample	variation	was	too	great	to	allow	effective	processing	 with	 Progenesis	 software,	 when	 only	 the	 4	 labeled	 samples	 were	anlysed.		PEAKS	software	was	also	 trialed	but	 the	combination	of	 large	 sample	variation	and	low	sample	number	prevented	any	significant	expression	changes	from	 being	 determined.	 This	 is	 a	 discovery	 project	 with	 the	 main	 aim	 of	determining	 whether	 current	 methods	 for	 proteomic	 analysis	 using	 mass	spectrometry	 are	 sensitive	 enough	 to	 ascertain	 the	 protein	 composition	 of	dialysis	 fluid.	Therefore	analysis	was	continued	using	 the	data	of	all	6	 samples	and	the	unlabeled	samples	were	speculatively	grouped	by	how	they	clustered	in	principal	components	analysis.	
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Protein	identification	and	ontology	The	resulting	significant	protein	lists	were	then	entered	into	bioinformatics	tools	PANTHER	 (protein	 annotation	 through	 evolutionary	 relationship)	 and	 STRING	(Search	 Tool	 for	 the	 Retrieval	 of	 Interacting	 Genes/Proteins)	 to	 analyse	 the	functional	 protein	 classifications	 and	 protein-protein	 interactions	 respectively	(Mi	 et	 al,	 2005)	 (Franceschini	 et	 al,	 2013).	 PANTHER	 is	 a	 classification	 system	that	 provides	 ontological	 information	 about	 the	 significant	 proteins	 identified.	STRING	 provides	 information	 on	 known	 and	 predicted	 protein-protein	interactions.	Tendon	tissue	has	a	large	proportion	of	extracellular	matrix	(ECM)	compared	 to	 other	 tissues,	 so	 protein	 hits	 were	 entered	 into	 the	 Matrisome	Database	which	 provides	 live	 cross-referencing	 to	 gene	 and	 protein	 databases	for	every	ECM	and	ECM-associated	genes	
Results	Initial	protein	concentrations	were	measured	and	recorded	with	the	NanoDrop	2000c	spectrophotometer	(Thermo	Fisher	Scientific).	Samples	1	and	6	were	pre	dialysis;	 samples	 2	 and	 5	 were	 post	 dialysis.	 Sample	 size	 was	 too	 small	 to	perform	a	protein	assay.	Results	are	displayed	in	Table	1.		
Sample	number	 Protein	Concentration	ug/ul	1	 0.02	2	 0.7	3	 0.49	4	 0.48	5	 0.6	6	 0.08		
Table	 1.	 Protein	 quantification	 in	 dialysis	 fluid	 assayed	 using	 NanoDrop	
Spectrophotometer.			Due	to	a	problem	with	labeling,	sample	numbers	3	and	4	could	not	be	identified,	and	 were	 from	 unknown	 groups.	 From	 initial	 protein	 concentration	measurements	 it	 could	 be	 predicted,	 but	 not	 conclusively,	 that	 both	 of	 these	samples	 belonged	 in	 the	 post-ESWT	 dialysis	 group.	 	 After	 in	 solution	 trypsin	digestion,	 equal	 amounts	of	proteins	were	 loaded	onto	 the	LTQ-Orbitrap-Velos	mass	spectrometer.	Total	ion	currents	were	comparable	and	a	definite	difference	
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in	complexity	exists	between	the	two	groups.	Chromatograms	from	samples	are	displayed	in	Figure	2.								
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Figure	 2	 Comparison	 of	 chromatograms	 from	 liquid	 chromatography	
tandem	 mass	 spectrometry	 (LC-MS/MS)	 in	 the	 pre	 and	 post	 shockwave	
samples.	 An	 increase	 in	 chromatogram	 complexity	 is	 evident	 in	 post	
therapy	samples.		
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Identification	of	proteins	In	order	 to	 identify	what	proteins	were	present	 in	our	samples,	 raw	data	 from	MS/MS	 runs	 were	 imported	 into	 Progenesis	 QI.	 This	 software	 performed	 a	multitude	of	tasks,	and	the	main	findings	from	this	analysis	are	shown	as	follows.		Principal	 Component	 Analysis	 (PCA)	 was	 employed	 to	 check	 for	 consistent	behavior	 within	 the	 two	 experimental	 conditions:	 the	 pre	 and	 post	 ESWT	samples.	Figure	3	reveals	there	was	a	clear	difference	between	the	pre	and	post	shockwave	 therapy	 groups,	 from	 this	 analysis,	 unknown	 samples	 3	 and	 4	naturally	 fell	 into	 the	 pre	 and	 post	 shockwave	 therapy	 category	 respectively.	This	was	in	contrast	with	the	protein	concentration	measurements	in	which	both	samples	looked	to	be	in	the	post	ESWT	group.	
	
	
	
	
Figure	 3.	 Principal	 component	 analysis	 (PCA)	 of	 filtered	 proteins	 P<0.01	
and	 two	 fold	 change	 in	 expression	 were	 identified	 in	 MASCOT	 and	
reimported	 back	 into	 ProgenesisQI.	 PCA	 was	 used	 to	 search	 for	
correlations	between	the	two	groups.	This	approach	clearly	discriminated	
between	pre	and	post	shockwave	therapy.	The	two	unlabelled	samples	are	
circled.	
	
Protein	identification	and	ontology	Protein	 identifications	 included	 ECM	 proteins	 such	 as	 collagens	 and	proteoglycans,	 and	 cellular	 proteins.	 After	 filtering,	 in	 total	 there	 were	 93	quantifiable	 proteins	 identified,	 of	 these	 80	 proteins	 had	 a	 p<0.05	 and	 2	 fold	change	difference	as	a	consequence	of	treatment;	61	higher	and	19	lower	in	post	shock	 wave	 therapy.	 The	 80	 significant	 proteins	 were	 processed	 through	 the	matrisome	database,	 of	 these,	 18	were	 recognised	 and	 are	detailed	 in	Table	1.	
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Functions	 of	 these	 proteins	 included	 roles	 in	 the	 clotting	 cascade	 and	 roles	relating	to	cell	adhesion.	
	
Table	1.	The	80	proteins	detected	with	p<0.05	and	2	fold	change	difference	
were	processed	through	the	matrisome	database,	18	were	recognised	and	
are	displayed.	Functions	of	these	proteins	ranged	from	roles	in	the	clotting	
cascade	to	roles	in	cell	adhesion.		In	the	following	analysis,	to	increase	confidence	in	the	identification	of	proteins,	data	 was	 filtered	 to	 include	 proteins	 with	 at	 least	 two	 unique	 peptides	 and	 a	FDR<0.01	in	this	data	set.	The	following	set	of	analysis	uses	this	data	set:	-		Table	2	lists	the	top	10	increased	proteins	found	by	MASCOT	to	be	differentially	expressed	 in	 the	 post	 shockwave	 therapy	 samples.	 The	 top	 protein,	peroxiredoxin-6,	 plays	 a	 role	 in	 protection	 against	 oxidative	 injury.	 The	 other	proteins	found	had	roles	in	the	immune	system	and	cell	transport.		Figure	4	demonstrates	protein	classification	according	to	their	biological	process	using	 PANTHER.	 Results	 reveal	 higher	 proportion	 of	 cellular	 proteins	 and	 a	response	to	external	stimulus	is	evident.	Figure	5	demonstrates	STRING	analysis	on	 the	 same	 data	 set.	 This	 provides	 information	 on	 known	 and	 predicted	protein-protein	 interactions.	 As	 this	 data	 is	 from	post	 shockwave	 therapy	 it	 is	
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reassuring	 to	 find	 that	 41%	 of	 these	 proteins	 are	 known	 to	 be	 involved	 in	 a	response	to	an	external	stimulus	(figure	5).		
	
	
		
		
Table1.	 Top	 10	 differentially	 expressed	 proteins	 following	 shock	 wave	
therapy	 (those	 with	 at	 least	 two	 unique	 peptides	 and	 a	 FDR<0.01	 were	
included	 in	 this	 data	 set).	 Top	 protein	 Peroxiredoxin-6	 plays	 a	 role	 in	
protection	against	oxidative	injury.	
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Figure	4.	Using	 the	gene	ontology	 tool	PANTHER,	differentially	 expressed	
proteins	 from	 post	 ESWT	 samples	 were	 classified	 according	 to	 their	
biological	process.	
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Figure	 5.	 Protein-protein	 interaction	 network	 visualised	 by	 the	
bioinformatics	tool	STRING	using	differentially	expressed	proteins	with	at	
least	two	unique	peptides	and	a	FDR<0.01	in	post	EWST	samples.	Clustered	
proteins	seen	are	normally	involved	in	response	to	an	external	stimulus	
		There	 were	 19	 proteins	 that	 were	 downregulated	 in	 the	 post	 ESWT	 section,	biological	processes	 analysed	via	 STRING	analysis	 revealed	 that	 these	proteins	were	 involved	 in	 the	 establishment	 of	 skin	 barriers,	 skin	 development	 water	homeostasis	and	 the	 regulation	of	body	 fluid	 levels.	Figure	6	demonstrates	 the	Protein-protein	interaction	network	generated.		
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Figure	 6.	 Protein-protein	 interaction	 network	 visualised	 by	 the	
bioinformatics	tool	STRING	of	down	regulated	proteins.	Using	differentially	
expressed	 proteins	with	 at	 least	 two	 unique	 peptides	 and	 a	 FDR<0.01	 in	
post	EWST	samples.	Clustered	proteins	seen	are	normally	involved	in	skin	
development	
	
Discussion	The	 main	 aim	 of	 the	 current	 study	 was	 to	 establish	 if	 current	 methods	 for	proteomic	analysis,	using	mass	spectrometry,	are	sensitive	enough	to	ascertain	the	protein	composition	of	dialysis	fluid	following	ESWT	in	human	tendinopathy.		If	this	was	achieved	then	the	next	step	was	to	analyse	any	alterations	that	were	observed	 between	 the	 two	 sample	 sets.	 Prior	 to	 discussing	 results	 acquired	during	this	investigation,	it	is	interesting	to	review	previous	findings	within	this	area	 of	 research.	 Firstly	 this	 investigation	 is	 unique,	 in	 that,	 to	 the	 author’s	knowledge,	 no	 study	 using	 mass	 spectrometry	 has	 been	 performed	 on	 these	types	of	samples	before.		So	the	following	discussion	targets	related	research.	
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As	 mentioned	 earlier	 histopathological	 changes	 of	 tendinopathy	 have	 been	recorded	 to	 include	 collagen	 fibril	 disorganisation,	 increased	 size	 of	 the	 non-collagenous	 extracellular	 matrix,	 hypercellularity	 and	 neovascularization	(Nourissat	 et	 al,	 2015).	 However,	 the	 molecular	 driver	 responsible	 for	 these	changes	is	unknown.	Proteomic	analysis	of	healthy	and	injured	superficial	digital	flexor	tendons	of	Thoroughbred	horses	revealed	increased	matrix	degeneration	and	 fragmentation	 in	 injured	 tendons	 compared	 to	 healthy	 samples.	 A	 large	number	 of	 neopeptides	 were	 identified	 for	 proteoglycans	 and	 collagens	 in	injured	 tendon	 (Peffers	 et	 al,	 2014).	 	 Another	 study	 detected	 the	 pro-inflammatory	 cytokines	 IL-1α,	 IL1-β,	 TNF-α	 and	 IFN-γ	 in	 injured	 equine	 SDFT	tissue	 by	 immunohistochemistry,	 the	 same	 cytokines	 were	 not	 detected	 in	normal	tendon	samples	(Hosaka	et	al,	2002). 
The	samples	used	during	 this	 study	came	 from	 the	 investigation	performed	by	Waugh	et	al,	samples	were	analysed	by	cytometric	bead	array	and	zymography.	It	 was	 determined	 that	 interleukins	 6,	 8	 and	 the	 zymogen	 forms	 of	 matrix	metalloproteinase		(MMP)	2	and	9	were	increased	following	ESWT.		The	authors	provisionally	 concluded	 that	 this	 treatment	 aids	 tendon	 remodeling	 by	promoting	 the	 inflammatory	 and	 catabolic	 processes	 that	 are	 responsible	 for	removing	 damaged	 matrix	 constituents	 (Waugh	 et	 al,	 2015).	 During	 this	investigation	we	did	not	identify	any	of	these	proteins.	This	could	have	been	due	to	 inadequate	 protein	 loading,	 the	 sensitivity	 of	 the	 instrument	 or	 ion	suppression	due	to	other	peptide	components.			Data	gained	from	this	 investigation	 is	promising.	 It	was	established	that	the	 in-
vivo	 identification	 and	 quantification	 of	 proteins	 was	 possible	 from	 samples	taken	 from	 the	 peritendinous	 region	 following	 dialysis.	 This	 is	 a	 promising	outcome,	as	the	ability	to	perform	in	vivo	analysis	will	allow	assessment	of	 the	efficiency	of	treatments	and	give	a	real	time	analysis	of	how	biological	processes	are	occurring.	However	this	experiment	should	be	repeated	with	a	larger	sample	size	to	confirm	the	conclusions	drawn.			
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	From	using	the	data	analysis	available,	we	were	able	to	detect	changes	between	the	pre	 and	post	ESWT	samples.	An	upregulation	of	 proteins	was	 seen	 in	post	shockwave	therapy	samples,	corresponding	with	previous	investigations	results	(Waugh	et	al,	2015).	Types	of	protein	 that	were	up	regulated	were	 involved	 in	oxidative	injury,	transport	and	the	immune	response.	Many	of	the	proteins	that	were	 higher	 in	 the	 post	 ESWT	 samples	 are	 abundant	 proteins	 in	 serum.	 This	could	signify	serum	leakage	following	treatment.			Limitations	in	this	investigation	included	small	sample	size	and	poor	labeling	of	two	 of	 the	 samples.	 Therefore	 the	 data	 determining	 differences	 between	treatments	 should	 not	 be	 relied	 on,	 as	 there	 is	 uncertainty	 in	 the	 exact	provenenace	 of	 these	 two	 unlabeled	 samples.	 However	 the	 PCA	 plot	 grouped	them	 into	 labeled	 and	unlabeled	 groups.	Also	no	 information	was	 available	 on	sample	 phenotype	 such	 as	 age/sex/healthy/patient.	 Knowing	 information	 on	sample	phenotype	would	have	provided	additional	information	on	this	aspect	of	tendon	biology.	This	unreliability	of	 the	data	 should	not	detract	 from	 the	 central	 aim	of	this	 chapter,	which	was	 to	 determine	whether	 proteomic	methodologies	 could	be	used	to	profile	microdialysis	fluids.	This	could	easily	be	improved	upon	with	larger	sample	sizes	to	enable	a	more	accurate	analysis	of	protein	changes.	This	small	study	has	proved	that	continuing	with	proteomic	analysis	of	dialysis	fluid	is	worthwhile.	A	larger	sample	sizes	would	increase	the	accuracy	of	results	and	hopefully	 identify	 additional	 evidence	 on	 what	 biological	 processes	 are	generated	for	healing.	There	was	no	identification	of	MMP	proteins,	which	may	just	 be	 due	 to	 the	 small	 sample	 numbers,	 due	 to	 the	 levels	 of	 abundance	 and	sampling	 handling	 alternatively	 this	 could	 be	 a	 real	 finding.	 	 By	 repeating	 the	investigation	 with	 increased	 sample	 numbers	 this	 could	 be	 examined	 further.	Alongside	this,	results	could	be	validated	by	using	a	different	technique	such	as	western	blot	analysis.	This	could	used	to	confirm	the	proteomic	data	of	interest	generated	 by	 mass	 spectrometry.	 An	 alternative	 approach	 for	 a	 sensitive	 and	specific	quantification	of	targeted	proteins	would	be	to	employ	multiple	reaction	monitoring	(MRM).	This	technique	uses	a	directed	MS/MS	approach,	which	then	
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reinjects	 a	 selection	 of	 peptides	 to	 supplement	 the	 identifications	 acquired	(Ademowo	 et	 al,	 2014).	 This	 process	 enhances	 the	 lower	 detection	 limit	 for	peptides	 and	 so	would	 be	 a	 valuable	 tool	with	 discovery	 of	 biomarkers	 in,	 for	instance,	tendinopathy	or	during	the	healing	process.		The	 other	 factor	 to	 consider	when	 analyzing	 these	 results	 is	 that	 the	 samples	were	collected	from	the	peritendinous	region	via	saline	dialysis.	This,	of	course,	will	give	a	different	view	of	the	biological	process	compared	to	taking	a	sample	of	the	 tendon	 itself	 and	 performing	 LC	MS/MS.	However	more	 invasive	 sampling	such	as	a	biopsy,	in	a	tissue,	which	is	known	to	have	poor	healing	abilities,	is	far	from	ideal	and	alongside	this,	using	this	method,	would	make	the	identification	of	 less	 abundant	 proteins	 seen	 in	 this	 study	 difficult	 to	 detect	 due	 to	 the	 high	level	of	extracellular	matrix	seen	in	tendon	tissue.		This	type	of	analysis	could	be	used	in	the	future	to	help	in	the	understanding	of	tendinopathy,	 monitor	 the	 effectiveness	 of	 treatments,	 and	 identify	 the	mechanisms	that	are	responsible	for	the	clinical	success	of	ESWT.																									
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Chapter	5,	Tendon	protein	turnover		
Introduction	In	 this	 thesis	 so	 far,	 we	 have	 aimed	 to	 develop	 our	 understanding	 of	 the	biological	 function	 and	 processes	 occurring	 in	 tendon	 tissue	 by	 protein	identification	and	quantification.	However	another	important	issue	is	the	rate	at	which	 these	 proteins	 are	 synthesised	 and	 degraded.	 The	 study	 of	 protein	turnover	 has	 long	 been	 realised	 as	 an	 extremely	 important	 feature,	 as	 a	dysfunction	 in	 protein	 turnover	 can	 underlie	 certain	 pathological	 phenotypes.	This	 dysfunction,	 can	 occur	 by	 various	 means,	 such	 as	 an	 accumulation	 of	damaged	 proteins	 from	 reduced	 quality	 control,	 or	 from	 misfolding	 or	 a	reduction	 in	 the	 amount	 of	 particular	 required	 proteins	 (Kim	 et	 al,	 2012).	 To	have	 a	 dynamic	 understanding	 of	 metabolism	 in	 normal	 tissue,	 allows	 us	 to	understand	changes	that	occur	during	different	physiological	and	environmental	conditions.	With	 increased	 knowledge	 of	what	 is	 occurring	 in	 pathologies,	 this	should	lead	to	the	creation	of	new	biotechnologies	for	diagnosis	and	treatment,	as	well	as	development	of	novel	approaches	to	prevent	diseases.			Turnover	 rates	are	 specific	 to	 the	 individual	protein	and	can	vary	widely	 from	minutes	to	years	(Price	et	al,	2010).	Previous	research	of	tendon	tissue	turnover	has	been	described	within	the	first	chapter.	Briefly,	studies	so	far	have	indicated	that	 tendon	 tissue	 undergoes	 very	 limited	 turnover	 in	 comparison	 to	 other	tissues	 types	 (Heinemeier	 et	 al,	 2013)	 and	 there	 are	 documented	 turnover	differences	in	the	collagenous	and	non-collagenous	components	of	tendon	tissue.	For	instance,	the	collagenous	components	of	the	equine	superficial	digital	flexor	tendon	 are	 relatively	 inert	 197.53	 (±18.23)	 years	 compared	 to	 the	 non	collagenous	components,	which	had	a	turnover	rate	of	2	years	for	(Thorpe	et	al,	2010).		However,	data	on	this	subject	is	limited	and	needs	further	work	to	validate	and	develop	 previous	 data.	 The	 investigation	 of	 ‘proteome	 dynamics’	 has	 been	undertaken	by	numerous	methods,	which	are	reviewed	in	the	paper	by	Beynon,	2004.	The	main	approach	to	measure	the	flux	of	amino	acids	through	the	protein	
	 86	
pool	 is	by	employing	a	metabolic	 tracer.	Stable	 isotope	 labeling	of	mammals	 to	examine	 the	 rate	 of	 protein	 synthesis	 and	 protein	 degradation	 is	 a	 well	recognised	technique.		The	 feeding	 of	 an	 essential	 stable	 isotope	 amino	 acid	 such	 as	 13C6	 lysine	 to	experimental	animals,	 such	as	mice,	allows	 the	exploration	of	processes	within	metabolic	 pathways;	 this	 heavier	 form	 isotope	 allows	 the	 differentiation	between	 preexisting	 and	 newly	 synthesized	 proteins	 by	 analysis	 with	 mass	spectrometry.	This	method	is	not	thought	to	cause	harm	to	the	treated	animals,	consequently	 data	 can	 be	 achieved	 in	 a	 safe	 and	 ethical	manner	 (Doherty	 and	Beynon,	 2006).	 	 As	 mentioned	 previously,	 biological	 samples	 can	 vary	 in	complexity,	 and	 minimization	 of	 this	 through	 sample	 handling	 can	 drastically	improve	 the	 resolved	 peptide	 spectra.	 During	 this	 investigation	 filter	 assisted	sample	 preparation	 (FASP)	methods	were	 employed	 to	 increase	 the	 reliability	and	 accuracy	 of	 results	 by	 increasing	 the	 quality	 and	 consistency	 of	 the	 final	samples.		
Aim	and	objectives	To	determine	 if	dietary	 supplementation	of	 the	essential,	 stable,	 labeled	amino	acid	 lysine	 can	 be	 used	 to	 ascertain	 turnover	 rates	 in	 tendon	 proteins.	 To	determine	 the	 potential	 to	 compare,	 collagenous	 and	 non-collagenous	 protein	turnover.	
Materials	and	methods	
Ethics	statement	The	procedures	 involving	 animals	were	 carried	out	 in	 accordance	with	 the	UK	Animals	 (Scientific	 Procedures)	 Act	 1986,	 and	 authorised	 on	 personal	 and	project	licenses	issued	by	the	UK	Home	Office.	
Materials	All	reagents	were	obtained	from	Sigma-Aldrich	unless	otherwise	stated.		
Sample	collection	Sample	 collection	 was	 undertaken	 by	 John	 Waters,	 Mammalian	 Behaviour	 &	Evolution	 Group	 in	 the	 Institute	 of	 Integrative	 Biology,	 The	 Unversity	 of	
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Liverpool.	Male	adult	C57	BL/6	mice	were	housed	individually	in	polypropylene	cages	(48	x	15	 x	 13	 cm	 North	 Kent	 Plastic	 Cages	 Ltd	 UK)	 containing	 substrate	 (Corn	 Cob	Absorb	 10/14	 substrate)	 and	 paper	wool	 nest	material.	 Food	 and	water	were	provided	 ad	 libitum	 (LabDiet	 5002	 Certified	 Rodent	 diet	 purina	Mills	 St	 Louis	MO,	USA)	Animals	were	kept	in	an	environment	with	no	stressors,	temperature	was	set	 to	21	+/-	1°C	and	a	 reversed	photo	period	 (light	17h	and	dark	7h).	All	mice	 were	 acclimatised	 to	 a	 reconstituted	 semi-synthetic	 diet	 which	 was	prepared,	in	house,	based	on	their	usual	diet	plus	supplementation	of	12C6	Lysine	at	a	quantity	equal	to	the	natural	lysine	content	of	the	diet	(1.18%	w/w))	for	7	days	prior	to	the	start	of	the	experiment.	The	‘light’	diet	was	then	replaced	with	an	identical	diet	apart	from	the	substitution	of	the	crystalline	amino	acid	by	13C6	lysine	 at	 a	 relative	 isotope	 abundance	 (RIA)	 of	 0.5.	 Animal’s	weight,	 food	 and	water	intake	was	recorded	throughout.	An	outline	of	when	mice	were	introduced	into	 the	study	 is	displayed	 in	 table	1.	 	At	 the	end	of	 the	study	all	animals	were	humanely	 killed.	 The	 tail	 was	 transected	 at	 its	 base	 and	 the	 skin	 removed.	Lengths	of	tendon	were	removed	with	careful	attempts	to	avoid	the	collection	of	muscle.	 The	 tissue	was	washed	 in	 chilled	 saline	 and	 then	 stored	 in	 -80oC	until	needed.				
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Table	 1.	 Outline	 of	 study,	 each	 mouse	 was	 introduced	 to	 the	 diet	 at	
different	 time	 points	 between	 day	 0,	 M11	 and	 day	 30,	 M1.	 During	 this	
investigation	only	 two	 time	points	were	processed	which	 are	highlighted	
above.	The	other	samples	have	been	kept	for	future	analysis.	
	
Methods	
Protein	extraction		The	 wet	 weight	 of	 each	 tail	 section	 was	 recorded.	 Protein	 extraction	 was	achieved	by	the	addition	of	0.5	ml	of	guanidine	extraction	buffer	(4	M	guanidine	hydrochloride	 (GdnHCl),	 65	 mM	 dithiothreitol	 (DTT),	 and	 50	 mM	 sodium	acetate,	pH	5.8)	and	 the	extraction	performed	at	40C	 for	48hours	on	an	orbital	shaker	 (ThermoScientific	 Max	 Q).	 The	 supernatant	 was	 removed	 after	centrifugation	 at	 15,000	 x	 g	@4oC	 for	 15	minutes.	 The	 final	 insoluble	 fraction	was	retained	for	future	analysis	of	the	non	collagenous	matrix	components.	
Protein	assay	Ethanol	 precipitation	 was	 performed	 on	 aliquots	 of	 the	 supernatant	 prior	 to	estimation	of	protein	 concentration.	 Samples	were	 resolubilised	with	7M	Urea,	2M	 Thiourea,	 30mM	 Tris,	 pH	 8)	 then	 analysed	 by	 the	 Bradford	 assay	 read	 at	
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660nm	 using	 Coomassie	 PlusTM	 protein	 assay	 reagent	 (Thermo	 Scientific,	Rockford,	IL)	
One-dimensional	Sodium	Dodecyl	Sulfate	Polyacrylamide	Gel	
Electrophoresis	(SDS-PAGE)	and	Coomassie	blue	staining	To	 remove	 interfering	 substances,	 GdnHCL	 soluble	 extracts	 were	 precipitated	using	 Strataclean	 Resin	 Filtration	 (Stratagene	 R,	 Hycor	 Biomedical	 Ltd,	Edinburgh,	UK).	All	 samples	were	subsequently	separated	 in	single	dimensions	based	 on	 their	 molecular	 weight	 by	 one	 dimensional	 SDS-PAGE	 to	 compare	quantitative/qualitative	differences	 in	 the	protein	profiles.	25ug	of	protein	was	loaded	 with	 reducing	 buffer	 (2-mercaptoethanol)	 onto	 4-12%	 acrylamide	 Bis-Tris	 NuPAGE	 gels	 (Invitrogen).	 Before	 loading	 samples	 were	 incubated	 with	reducing	buffer	for	@	900C	for	5	minutes	and	then	placed	on	ice.	Proteins	were	visualised	 by	 Coomassie	 Blue	 staining	 (Thermo	 Scientific)	 according	 to	 the	manufacturer’s	instruction.	
Filter	aided	sample	preparation	(FASP)		50	 μg	 GdnHCL	 soluble	 extract	 was	 loaded	 onto	 the	 filter	 unit,	 (VivaCon	 500	10kDa	 MWCO	 HydroSart	Filter	 units	 (VN01H01)	 from	 Sartorius), which	 had	been	pretreated	with	100	μL	of	1%	(v/v)	Formic	acid	(FA),	and	centrifuged	at	14	000g	for	15	min.	The	protein	extracts	were	washed	through	with	200µl	of	urea	buffer	(8M	Urea,	100mM	Tris	pH	8.5	(using	HCL))	centrifuge	 for	15	minutes	at	12,500rpm	x	3.	Reduction	of	disulphide	bonds	was	achieved	by	 the	addition	of	100μL	 8mM	 Dithiothreitol	 (DDT)	 solution	 to	 the	 filter	 unit,	 mixed	 by	 gentle	vortex	and	incubate	in	the	dark	at	56oC	for	15	min.	The	unit	was	then	centrifuged	for	 10	min	 at	 12,500rpm.	 To	 remove	 the	 DTT,	 samples	were	washed	 through	with	200µl	of	urea	buffer	centrifuge	for	15	minutes	at	12,500rpm	x	3.	Alkylation	of	 free	 cysteine	 residues	 was	 undertaken	 by	 incubation	 with	 100	 of	 50mM	iodoacetamide	(IAA),	mixed	by	gentle	vortexing	and	incubated	in	the	dark	at	20	min	at	room	temperature.	Again	the	sample	was	centrifugation	at	12,500rpm	for	10	 min.	 To	 remove	 IAA	 the	 sample	 was	 washed	 with	 100µl	 of	 urea	 buffer	centrifuge	 for	15	minutes	 at	 12,500rpm	x	3.	Taking	 care	 that	 the	 entire	buffer	had	passed	through	by	the	end	cycle.	Buffer	exchange	occurred	by	adding	100µl	
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of	50mM	Ammonium	Bicarbonate	(AMBIC)	to	the	filter	and	then	centrifuged	for	10	min	at	12,500rpm	x	3,	 taking	care	that	all	buffer	had	passed	through	by	the	end	cycle.			For	the	digestion	step,	a	new	collection	low	bind	tube	was	obtained,	which	had	been	 pre	 washed	with	 500ul	 1%	 FA.	 	 Trypsin	 (Promega)	 0.4µg	 was	 added	 in	AMBIC	 solution,	 gently	 vortexed	 and	 digested	 overnight	 at	 37oC	 in	 a	 moist	chamber.	It	was	then	centrifuged	at	12,500rpm	for	10	min,	and	the	flow	through	collected.	A	further	addition	of	40µl	of	ammonium	bicarbonate	was	added	to	the	filter	 and	 spun	 at	 12,500rpm	 for	 10	min.	 The	 flow	 through	was	 collected	 and	pooled.	To	avoid	auto	digestion,	 the	 reaction	was	 stopped	with	 the	addition	of	10%Trifloroacetic	acid	solution.	The	tendon	FASP	sample	was	diluted	20-fold	in	0.1%(v/v)	TFA/3%(v/v)	acetonitrile	and	run	on	a	50min	LC-MS	gradient.	Figure	1	demonstrates	a	simplified	schematic	of	this	process.		
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Figure	1.	Schematic	of	FASP	protocol.		
LC	Separation	All	 peptide	 separations	were	 carried	 out	 using	 an	 Ultimate	 3000	 nano	 system	(Dionex/Thermo	Fisher	Scientific).	For	each	analysis	the	sample	was	loaded	onto	a	 trap	 column	 (Acclaim	 PepMap	 100,	 2cm	 x	 75mm	 inner	 diameter,	 C18,	 3mm,	100Å)	 at	 5mL/min	 with	 an	 aqueous	 solution	 containing	 0.1%(v/v)	 TFA	 and	2%(v/v)	 acetonitrile.	 After	 3min,	 the	 trap	 column	 was	 set	 in-line	 with	 an	analytical	 column	 (Easy-Spray	 PepMap®	 RSLC	 50cm	 x	 75mm	 inner	 diameter,	C18,	2mm,	100Å)	(Thermo	Fisher).	Peptide	elution	was	performed	by	applying	a	mixture	 of	 solvents	A	 and	B.	 Solvent	A	was	HPLC	grade	water	with	0.1%(v/v)	formic	acid,	and	solvent	B	was	HPLC	grade	acetonitrile	80%(v/v)	with	0.1%(v/v)	formic.	 Separations	 were	 performed	 by	 applying	 a	 linear	 gradient	 of	 3.8%	 to	40%	solvent	B	over	30	min	at	300nL/min	followed	by	a	washing	step	(5min	at	
	 92	
99%	solvent	B)	and	an	equilibration	step	(10	min	at	3.8%	solvent	B).		
Analyses	on	a	Quadrupole-Orbitrap	instrument	The	Q	Exactive	instrument	was	operated	in	data	dependent	positive	(ESI+)	mode	to	automatically	switch	between	full	scan	MS	and	MS/MS	acquisition.	Survey	full	scan	 MS	 spectra	 (m/z	 300-2000)	 were	 acquired	 in	 the	 Orbitrap	 with	 70,000	resolution	(m/z	200)	after	accumulation	of	 ions	 to	1x106	target	value	based	on	predictive	 automatic	 gain	 control	 (AGC)	 values	 from	 the	 previous	 full	 scan.	Dynamic	exclusion	was	set	to	20s.	The	10	most	intense	multiply	charged	ions	(z	≥	2)	were	sequentially	 isolated	and	fragmented	in	the	octopole	collision	cell	by	higher	energy	collisional	dissociation	(HCD)	with	a	fixed	injection	time	of	100ms	and	35,000	 resolution.	Typical	mass	 spectrometric	 conditions	were	 as	 follows:	spray	 voltage,	 1.9kV,	 no	 sheath	 or	 auxillary	 gas	 flow;	 heated	 capillary	temperature,	 275°C;	 normalised	 HCD	 collision	 energy	 30%.	 The	 MS/MS	 ion	selection	threshold	was	set	to	2	x	104	counts.	A	2	m/z	isolation	width	was	set.	
Calculation	of	relative	isotope	abundance	(RIA)	and	turnover	rates	Thermo	raw	MS	data	files	from	both	samples	were	analysed	using	the	Progenesis	QI™	software	(Version	4,	Nonlinear	Dynamics,	Newcastle,	UK)	These	were	then	exported	 and	 searched	 in	 UniMouse	 database	 with	 MASCOT	 server	 (Version	2.3.01).	The	 following	search	parameters	were	used:	peptide	mass	 tolerance	of	10ppm,	 fragment	 mass	 tolerance	 of	 0.6Da,	 one	 missed	 cleavage,	 fixed	modification,	 carbamidomethylation;	 variable	 modifications,	 methionine	oxidation	and	13C6	lysine;	a	false	discovery	rate	of	1%	was	used	before	the	search	results	were	re-imported	back	into	Progenesis	QITM.		Statistical	 analysis	 was	 performed	 on	 all	 detected	 features	 using	 transformed	normalized	abundances	for	one-way	analysis	of	variance	(ANOVA).	All	peptides	(with	Mascot	score	>36	and	p	<	0.05)	of	an	identified	protein	were	included,	and	the	protein	p	value	 (one-way	analysis	of	 variance)	was	 then	performed	on	 the	sum	 of	 the	 normalized	 abundances	 for	 all	 runs.	 Adjusted	 analysis	 of	 variance	values	 of	 p	 <	 0.05	 and	 additionally	 regulation	 of	 >2-fold	 or	 <0.5-fold	 were	regarded	as	significant.		
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Tissue	 at	 the	 start	 of	 the	 experiment	will	 have	 a	RIA	 of	 zero,	 the	 label	 is	 then	introduced	 into	 the	 diet	 and	 incorporation	 into	 the	 protein	 pool	 is	monitored	over	 time.	 The	 flux	 of	 isotopic	 labels	 through	 the	 protein	 pool	 varies	 between	protein	types	and	should	be	determined	by	calculations	based	on	Heavy	+	Light	isotopic	ratios		There	were	 two	 time	 points	 available	 for	 analysis	 (time	 0	 and	 time	 30	 days).	Extracted	ion	chromatograms	were	performed	for	heavy	labeled	peptides	using	Xcalibur	2.0	software	(Thermo	-Electron,	Hemel	Hempstead,	UK).	Using	mascot,	the	 total	 peptide	 intensity	 was	 used	 to	 determine	 the	 relative	 isotopic	abundance.	To	allow	the	determination	of	RIA	the	following	calculation	was	used	
																																																											RIA	=	H/[H+L]	(H=	heavy	isotope	relative	abundance	L=unlabeled	isotope	abundance)	Figure	 2	 demonstrates	 the	 possible	 outcome	 that	 could	 occur	 from	 this	experiment.				
	 94	
	
Figure	 2	 demonstrates	 a	 schematic	 diagram	 of	 potential	 outcomes,	 i.e.	 a	
high	abundance	and	high	turnover	protein	will	have	a	spectrum	revealing	
high	intensity	peaks	which	are	separated	by	3m/z	for	a	double	charged	ion.	
As	a	50:50	heavy:light	diet	was	used	to	increase	palatibility,	this	meant	that	
that	the	highest	possible	Relative	Isotopic	Abundance	is	0.5,	heavy	isotope	
peaks	will	always	be	no	more	than	50%	of	the	light	form	of	the	peptide.			
Results	
Using	the	GnHCL	protein	extracts	samples	were	run	on	1D	SDS	PAGE.	Results	can	be	
found	in	figure	3	and	demonstrate	that	protein	profiles	are	very	similar	between	the	
different	 time	 points	 and	 the	 control.	 The	majority	 of	 bands	 are	 of	 a	 higher	mass	
range,	 which	 could	 be	 due	 to	 the	 sample	 being	 heavily	 composed	 of	 collagen	
proteins.	Subsequent	to	LC	MS/MS	analysis	raw	data	was	filtered	using	the	MASCOT	
search	engine	 for	 the	 two	 time	points.	A	 list	 of	 top	 ten	proteins	based	on	mascot	
score	are	listed	in	tables	2	and	3.		
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Figure	3.	Coomassie	stained	1D-SDS-PAGE	of	all	guanidine	soluble	 tendon	
protein	 samples	 from	 each	 time	 point	 (M1-M10)	 and	 control	 (M11).	 The	
majority	 of	 proteins	 are	 found	 in	 the	 higher	 molecular	 weight	 range	
suggesting	 that	 the	 sample	 primarily	 consists	 of	 collagen	 proteins.	 The	
gross	 protein	 profiles	 for	 the	 different	 time	 points	 and	 the	 control	 are	
similar.	
	
	
	
	
	
	
	
Table	 2.	Day	 0,	mouse	 tail	 tendon	 sample.	 Top	 10	proteins	 identified	by	Mascot	
according	to	Mascot	score.	As	expected,	no	13C	labeled	peptides	were	identified.	
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Table	3.	Day	30,	mouse	tail	 tendon	sample.	Top	10	proteins	 identified	by	Mascot	
according	 to	Mascot	 score.	As	 expected,	 13C	 labeled	peptides	were	 identified	 in	
mainly	the	non	collagenous	proteins.	However	one	 labeled	peptide	was	detected	
in	collagen	alpha-1	(XII)	Chain.		
	
	Analysis	 of	 labeled	 peptides	 was	 then	 undertaken.	 Looking	 at	 the	 top	 10	significant	proteins	detected	on	day	0	(table	2)	and	day	30	(table	3),	13C	labeled	peptides	were	investigated	by	calculating	the	RIA	and	subsequently	percentage	turnover	 rate	 by	 comparing	 light	 to	 heavy	 ratios.	 Of	 the	 top	 10	 proteins,	 4	proteins,	 Cochlin,	 Decorin,	 Vimectin	 and	 Fibromodulin	 revealed	 evidence	 of	labeling.	 However	 collagen	 alpha-1	 (XII)	 Chain	 also	 showed	 one	 peptide	 to	 be	labeled,	this	is	likely	to	be	a	false	positive,	significant	labeling	is	deemed	only	to	be	present	when	all	of	the	lysine	cleaved	peptides	are	labeled,	which	wasn’t	the	case	here.	Figures	4	demonstrates	one	of	the	labeled	peptides	seen	for	Cochlin	on	day	30,	figure	5	demonstrates	the	same	peptide	on	day	0,	proving	no	labeling	has	occurred.	Figures	6-8	exhibit	spectra	for	the	remaining	labeled	proteins,	Decorin,	Vimectin	 and	 Fibromodulin.	 Table	 4	 reveals	 the	mean	RIA	 calculated	 from	 the	labeled	peptides,	Cochlin	had	the	highest	turnover	rate	at	38%	and	vimentin	the	lowest	at	24%.		
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Figure	 4.	 Spectra	 demonstrating	 13C6-lysine	 labeling	 of	 Cochlin	 peptide	
K.DVLFAIK.E	at	day	30,	with	doubly	charged	ions.	Unlabeled	peak	is	seen	at	
m/z	403.24	and	labeled	peak	is	seen	at	m/z	406.25.	RIA	=	0.16	equating	to	
a	32%	turnover	rate,	for	this	peptide,	taking	RIA	0.5	to	be	100%	turnover.	
	
	
	
Figure	5.	Spectra	demonstrating	Cochlin	peptide	K.DVLFAIK.E	at	day	0,	with	
doubly	 charged	 ions.	 Unlabeled	 peak	 is	 seen	 at	mass	 472.76	 and	 labeled	
peak	is	seen	at	mass	475.7.	
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Figure	 6.	 Spectra	 demonstrating	 13C6-lysine	 labeling	 of	 Decorin	 peptide	
K.GLINLSK.L	at	day	30,	with	doubly	charged	ions.	Unlabeled	peak	is	seen	at	
m/z	372.73	and	labeled	peak	is	seen	at	m/z	375.74.	RIA	=	0.17	equating	to	
a	34%	turnover	rate,	for	this	peptide,	taking	RIA	0.5	to	be	100%	turnover.	
	
	
	
	
	
Figure	 7.	 Spectra	 demonstrating	 13C6-lysine	 labeling	 of	 Vimentin	 peptide	
R.FANYIDK.V	at	day	30,	with	doubly	charged	ions.	Unlabeled	peak	is	seen	at	
m/z	434.73	and	labeled	peak	is	seen	at	m/z	437.71.	RIA	=	0.12	equating	to	
a	24%	turnover	rate,	for	this	peptide,	taking	RIA	0.5	to	be	100%	turnover.	
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Figure	 8.	 Spectra	 demonstrating	 13C6-lysine	 labeling	 of	 Fibromodulin	
peptide	R.LDGNEIKR.S	at	day	30,	with	triply	charged	ions.	Unlabeled	peak	
is	seen	at	m/z	315.51	and	 labeled	peak	 is	seen	at	m/z	317.51.	RIA	=	0.16	
equating	 to	 a	 32%	 turnover	 rate,	 for	 this	 peptide,	 taking	 RIA	 0.5	 to	 be	
100%	turnover.	
	
	
	
	
	
		
Table	 4,	 mean	 RIA	 for	 each	 of	 the	 proteins	 displaying	 labeling	 and	 the	
resultant	mean	 turnover	 rate.	 Cochlin	 had	 the	 highest	 turnover	 rate	 and	
vimentin	the	lowest.		
Discussion	During	this	investigation,	the	dietary	administration	of	the	stable	isotope	lysine	was	used	to	assess	protein	turnover	rates	in	mouse	tendon	tissue.			
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The	main	achievements	of	this	small	study	were		
• The	identification	of	well	known	tendon	tissue	compositional	components	such	as	collagens	and	proteoglycans	
• Labeling	of	 the	non	collagenous	component	 in	30	days.	Tendon	tissue	 is	renowned	for	its	poor	healing	ability	and	a	slow	turnover	rate,	in	30	days	is	was	possible	to	label	the	non	collagenous	component,	this	study	prove	that	further	work	would	be	worthwhile	in	this	area.		
• Confirmation	that	the	collagenous	component	is	relatively	inert.		
• Identification	 of	 higher	 turnover	 protein	 components	 of	 tendon	 tissue,	which	is	consistent	with	previous	studies.		The	 basis	 of	 this	 investigation	was	 to	measure	 the	 protein	 turnover	 in	 tendon	tissue.	Once	accurate	baseline	turnover	rates	are	achieved	for	the	compositional	components	of	healthy	young	tissue	these	could	be	compared	to	rates	in	injured,	aged,	 exercised	 or	 from	 a	 chronic	 disease	 such	 as	 in	 diabetes.	 Further	 to	 this	turnover	 rates	 could	 be	 calculated	 after	 treatments	 e.g.	 anti-inflammatory	mediators	 or	 physiotherapy.	 Turnover	 rates	 could	 then	 be	 used	 to	 monitor	tendon	 response	 to	 certain	 treatments.	The	end	objective	would	be	 to	use	 this	information	 to	 then	 develop	 new	 approaches	 for	 the	 treatment	 of	 tendon	diseases	and	injuries	in	patients.			A	 50:50	 heavy:	 light	 diet	 was	 chosen,	 as	 a	 completely	 heavy	 diet	 would	 be	unpalatable,	 hence	 having	 a	 50:50	 diet	 increases	 palatability.	 Animals	 were	firstly	acclimated	to	a	diet	containing	the	same	levels	of	non-labeled	amino	acid,	and	 then	 transferred	 to	 the	 labeled	 diet	 at	 different	 time	 points.	 The	 essential	amino	 acid	 lysine	 was	 used	 to	 measure	 protein	 turnover	 as	 the	 RIA	 is	uncomplicated	 by	 de	 novo	 synthesis.	 Labeling	 with	 13C6	 also	 removes	complications	 seen	with	 15N	 labeling	 due	 to	 the	 latters	 increased	 incidence	 of	generating	partially	unlabeled	peptides	(Beynon	and	Pratt,	2005).		
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During	this	study,	time	was	restricted,	hence	only	two	time	points	were	included,	day	30	and	day	0.	As	a	50:50	heavy:light	diet	was	used,	this	meant	that	that	the	highest	possible	RIA	would	be	0.5.		It	 was	 established	 that	 the	 non	 collagenous	 matrix,	 which	 consists	 of	proteoglycans,	had	a	higher	rate	of	protein	turnover	compared	to	components	of	the	collagenous	matrix.	Results	are	consistent	with	previous	studies	conducted	in	this	area.	(Heinemeier	et	al,	2013;	Thorpe	et	al,	2010).	
The	 proteins	 identified	 during	 this	 investigation	 largely	 correspond	 with	previous	work	 done	 in	 this	 area.	 As	 expected	 there	were	 a	 high	 percentage	 of	collagen	 proteins	 in	 both	 day	 0	 and	 day	 30	 samples.	 Non	 collagenous	components	in	day	0	were	cochlin,	fibrillin,	prolargin	and	vimentin.	Day	30	non	collagenous	 proteins	 identified	 were	 cochlin,	 fibrillin,	 decorin,	 vimentin	 and	fibromodulin.	 For	 both	 samples	 some	 of	 these	 components	 were	 just	 as	expected.	Peffers	et	al,	2014	identified	both	decorin	and	fibromodulin,	which	are	thought	 to	 be	 involved	 in	 fibrillogenesis.	 Studies	 that	 used	 decorin	 knockout	mice,	 revealed	 a	 difference	 in	 the	 dynamic	 and	 failure	 loads	 of	 the	 Achilles	tendon.	This	study	also	discovered	a	decrease	in	the	organisation	of	the	collagen	fibres	 in	 these	mice	 (Gordon	et	al,	 2015).	Another	 study	demonstrated	 that	 an	absence	of	 fibromodulin	also	decreases	 collagen	 fibril	organization	and	 tendon	strength	 (Kalamasjski	et	al,	 2014).	Fibrillin,	 a	 glycoprotein	 found	 in	 connective	tissue	 has	 been	 isolated	 in	 tendon	 proteomic	 studies,	 one	 study	 identified	fibrillin-2	 only	 in	 the	 fascicular	 matrix	 (Thorpe	 et	 al,	 2016).	 This	 protein	 is	fundamental	in	providing	a	scaffold	matrix	for	the	deposition	of	elastin	(Ritty	et	
al,	 2003).	 Prolargin	 is	 a	 class	 II	 SLRPs	 and	has	 been	detected	 in	 tendon	 tissue	before,	this	protein,	binds	to	type	I	collagen	and	is	thought	to	anchor	basement	membranes	to	the	connective	tissue	(Peffers	et	al,	2014).	Vimentins	are	class-III	intermediate	 filaments	 found	 in	 various	 non-epithelial	 cells,	 especially	mesenchymal	 cells.	 It	 is	 also	 involved	 in	 the	 stabilisation	 of	 type	 I	 collagens	mRNAs	 for	 CO1A1	 and	 COL1A2	 (www.uniprot.org)	 Vimentin	 has	 also	 been	localized	 in	 the	 rat	 suprapatella,	 which	 is	 a	 fibrocartilage	 that	 resists	 the	compression	 of	 the	 quadriceps	 tendon	 against	 the	 femur	 in	 the	 flexed	 knee	
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(Benjamin	 et	 al,	 1991).	 Cochlin	 was	 the	 most	 unusual	 of	 proteins	 to	 be	discovered	here,	 to	 the	authors	knowledge	 this	 is	 the	 first	work	 to	 identify	 the	presence	of	Cochlin	within	tendon	tissue.	This	protein	plays	a	role	in	the	control	of	 cell	 shape	 and	 motility	 in	 the	 trabecular	 meshwork	 (www.uniprot.org).	 Its	presence	in	these	samples	could	be	due	to	contamination	or	could	be	a	genuine	finding	as	the	role	cochlin	has,	is	biologically	plausible	in	tendon	tissue..	
One	peptide	 from	 collagen	 alpha	1	 (XII)	 chain	 revealed	 a	 labeled	peptide,	 this,	almost	certainly	is	a	false	positive	as	all	of	the	other	lysine	cleaved	peptides	were	unlabeled.	With	this	result	removed,	it	was	shown	that	there	was	no	evidence	of	turnover	 identified	 in	 any	 of	 the	 collagenous	 proteins.	 This	 was	 expected,	however	previous	studies	have	hypothesised	that	the	IFM	may	contain	a	pool	of	more	labile	collagen	(Thorpe	et	al,	2016),	it	would	be	worthwhile	extending	the	sample	numbers	and	the	length	of	this	study	to	see	whether	this	hypothesis	can	be	 backed	 up.	 	 It	 would	 have	 also	 been	 useful	 to	 study	 a	 larger	 number	 of	proteins	 in	 this	 study,	 much	 more	 information	 would	 have	 been	 gained	 from	looking	 at	 the	 top	 20	 proteins	 however	 as	 this	was	 the	 last	 study	 undertaken	during	the	year,	time	was	very	restricted	and	so	it	was	decided	to	just	use	the	top	10	proteins	which	was	unfortunate	but	necessary	in	order	to	finish	the	work	in	time.		In	regards	to	the	methods	used	in	this	study,	this	analysis	of	tendon	tissue	was	actually	performed	alongside	 another	 study,	which	 looked	at	 turnover	 rates	 in	different	tissue	types.	Hence	the	methodology	used	here	was	slightly	different	to	previous	chapters,	by	doing	this	 it	will	be	possible	to	compare	the	dataset	with	other	tissue	types	in	the	future.	Guanidine	was	chosen	as	the	extraction	agent	as	this	method	 has	 been	 used	 in	 previous	 published	 studies	 (Peffers	 et	 al,	 2014;	Wilson	et	al,	 2010)	 therefore	using	 this	method	was	decided	upon	 rather	 than	expanding	upon	the	work	undertaken	in	chapter	2	and	adding	in	the	surfactant	Rapigest.			The	use	of	animal	models	for	investigations	into	human	disease	and	treatments	is	not	without	its	drawbacks.	Mouse	tail	tendon	is	not	an	ideal	comparison	model	
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for	 humans	 or	 horses,	 as	 their	 basic	 anatomical	 structure	 is	 different.	 This	tendon	does	not	have	to	withstand	high	strains	and	the	interfascicular	region	is	different	 (Kohrs	et	al,	 2011).	 Labeling	 studies	 are	expensive	even	 in	 these	 tiny	animals	so	to	use	a	more	relevant	larger	animal	model,	such	as	the	horse,	would	be	 unrealistic.	 	 The	 rat	 model	 may	 be	 better	 as	 their	 basic	 anatomy	 is	 more	comparable	to	humans	and	they	can	be	used	as	a	model	of	tendinosis	which	has	been	confirmed	by	previous	studies,	in	contrast	to	the	mouse	model,	meaning	a	superior	overall	comparison	can	be	made	(Warden,	2007)		As	no	study	has	been	undertaken	in	this	area	before,	the	preparation	of	samples	collected	from	other	time	points	is	warranted.	Including	more	time	points	would	allow	 a	 greater	 accuracy	 in	 the	 turnover	 calculations.	 Due	 to	 the	 known	 slow	turnover	rate	of	the	collagenous	part	of	tendon	tissue	it	would	be	interesting	to	perform	 the	 study	 over	 a	 longer	 time	 period	 such	 as	 over	 100	 days.	 This	will	improve	accuracy	of	results	however	collagens	are	predicted	to	have	such	a	low	turnover	rate	that	the	incorporation	of	the	isotopic	label	would	be	predicted	to	occur	over	many	years,	so	results	specific	to	the	collagenous	matrix	may	not	be	too	dissimilar	to	this	study.		In	 conclusion,	 it	 has	 been	 established	 that	 the	 non	 collagenous	 matrix	 which	consists	 of	 proteoglycans	 had	 a	 higher	 rate	 of	 protein	 turnover	 compared	 to	components	 of	 the	 collagenous	 matrix.	 If	 repeated,	 as	 suggested,	 it	 will	 be	possible	to	use	results	gained	as	a	baseline	of	normal	tendon	turnover.	This,	 in	the	future,	could	be	compared	to	injured	tissue	to	assess	comparisons.	Another	possibility	is	to	use	this	research	to	assess	the	tendon	tissues	response	to	certain	treatments	 with	 the	 end	 objective	 in	 discovering	 new	 biotechnologies	 for	 the	treatment	of	diseases/injuries	in	humans	and	animals.				 	
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Chapter	6,	General	Discussion		 	Tendon	 injury	 is	 an	 ever-increasing	 problem	 to	 the	 individual	 and	 the	 health	service	 that	 provides	 for	 them.	 It	 has	 been	 documented	 that	 injuries	 to	 the	Achilles	 tendon	 are	 becoming	 common	 in	 athletes	 and	 sedentary	 individuals	alike	(Uquillas	et	al,	2015).	The	same	is	true	in	our	equine	patients;	tendon	injury	is	a	significant	cause	of	morbidity	and	performance	loss.		Any	 type	 of	 tendon	 injury	 can	 be	 a	 challenge	 to	 treat	 and	 so	 further	 work	 is	warranted	 into	 the	 mechanisms	 that	 are	 occurring	 in	 tendon	 injury,	degeneration	 and	 healing.	 Although	 a	 seemingly	 far	 off	 vision,	 advances	 that	enable	the	recovery	of	tissue	function	would	revolutionise	current	therapeutics	models.		Further	methodologies	to	identify	tendon	injury	at	an	early	stage	could	lead	to	advances	in	injury	diagnosis	and	prevention.		Over	the	past	year	we	have	aimed	to	gain	further	understanding	into	the	field	of	tendon	biology,	with	an	end	sight	of	contributing	to	the	developments	made	by	other	 research	 groups	 in	 recent	 years.	 Our	 objective	 was	 to	 increase	understanding	of	tendon	biology	by	developing	proteomic	methodologies,	which	will	 enable	 future	 experiments	 to	 determine	 the	 composition	 of	 the	 tendon	tissue	and	how	 this	varies	between	 tendon	 types	and	within	 the	 tendon	 tissue	itself.	 As	 the	 reader	 knows,	 this	 thesis	 was	 split	 into	 four	 preliminary	investigations	 and	 here	 we	 discuss	 limitations	 and	 problems	 encountered	 for	each	one.			The	protein	extraction	investigation	was	a	comparative	study	investigating	two	types	of	protein	denaturants,	the	chaotropic	agents,	guanidine	and	urea	and	the	detergent	Rapigest.	Experiments	were	performed	in	two	tendon	types,	positional	vs.	 energy	 storing	 and	 in	 two	 species,	 human	 vs.	 equine.	 The	 aim	 was	 to	maximize	 proteins	 removed	 from	 the	 tendon	 fascicles	 to	 allow	 the	 accurate	definition	of	the	tendon	proteome	via	mass	spectrometry.		The	 digestion	 process	 varies	 from	 protein	 to	 protein	 due	 to	 differences	 in	primary	and	secondary	structures.	Difficulty	in	digestion	can	mean	that	there	is	a	
	 105	
reduction	in	the	access	to	cleavage	sites	for	the	digestion	enzyme.	So	agents	that	disrupt	 the	protein	structure	can	 increase	 the	efficiency	of	digestion.	Currently	there	 are	 no	 published	 studies	 that	 have	 compared	 efficiencies	 of	 protein	extraction	 methods	 in	 tendon	 tissue.	 However	 we	 can	 study	 other	musculoskeletal	 tissues	 for	 general	 comparisons.	 Wilson	 et	 al	 performed	 a	protein	extraction	comparison	study	in	articular	cartilage	that,	like	tendon,	has	a	dominance	 of	 poorly	 soluble	 matrix	 components.	 This	 study	 investigated	proteomic	 differences	 within	 juvenile	 cartilage	 and	 neocartilage,	 the	 most	applicable	 aspect	 of	 this	 study	 to	 our	 investigation	 is	 that	 they	 compared	 the	efficiencies	of	the	chaotropic	agent	guanidine	and	saline	in	these	tissues.	Results	revealed	 that	 both	 conditions	 had	 specific	 proteins	 that	 were	 significantly	enriched.	 Mature	 cartilage	 had	 lower	 levels	 of	 identifiable	 likely	 due	 to	 the	tightly	interacting	ECM	network.	Guanidine	samples	generated	a	higher	yield	of	proteins	 in	 mature	 cartilage.	 From	 this	 we	 can	 devise	 that	 guanidine	 has	 the	denaturing	 ability	 in	 this	 poorly	 soluble	 tissue	 therefore	 should	 be	 a	 suitable	agent	 for	 protein	 extraction	 in	 tendon	 tissue.	 Subsequent	 to	 this	 study,	 a	proteomic	 study	 in	 tendon	 tissue	 used	 the	 chaotropic	 agent	 guanidine	 with	success	 (Peffers	 et	 al,	 2014).	 For	 this	 investigation	 guanidine	 was	 a	 definite	contender	to	trial.	Rapigest	is	an	agent,	which	has	had	success	within	proteomics	due	 to	 its	 compatibility	mass	 spectrometry	 so	would	 offer	 a	 simple	method,	 if	effective	for	tendon	tissue.			Although	 there	were	 no	 statistically	 significant	 results,	 noticeable	 trends	were	identified	which	 enabled	 broad	 conclusions	 to	 be	 drawn.	 For	 instance	 protein	extraction	 using	 the	 chaotropic	 agent	 urea,	 yielded	 the	 lowest	 number	 of	significant	 protein	 hits	 in	 both	 human	 and	 equine	 samples	 and	 guanidine	HCL	yielded	 highest.	 	 Using	 the	 PANTHER	 database,	 guanidine	 also	 yielded	 the	highest	amount	of	intracellular	proteins,	possibly	as	this	agent	is	able	to	disrupt	cellular	membrane	proteins	in	a	more	effective	manor,	which	is	consistent	with	other	 studies	 findings	 where	 guanidine	 was	 thought	 to	 disrupt	 the	 outer	membrane	of	cells	causing	permeabilization	(Naglak	and	Wang,	1990).		Rapigest	SF	 samples	 tended	 to	 have	 a	 roughly	 equal	 amount	 of	 intracellular	 and	
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extracellular	matrix	proteins,	revealing	 this	has	 the	ability	 to	denature	some	of	the	most	resistant	proteins.	
 This	 study	 offered	 preliminary	 data	 that	 offers	 foundations	 for	 new	investigations,	 such	 as,	 repeating	 with	 a	 larger	 sample	 size	 and	 combining	denaturants	to	see	whether	this	permits	greater	peptide	recovery.	For	 instance	using	 a	 protocol	which	 firstly	 extracts	 proteins	with	 guanidine	 and	 then	 using	rapigest	 on	 the	 resulting	 insoluble	 pellet.	 This	 may	 increase	 the	 protein	 yield	further	as	well	as	less	waste	from	both	a	sample	collection	and	a	financial	point	of	 view.	 Alternatively	 different	 experiements	 could	 be	 run	 depending	 on	 the	proteins	of	interest.	It	is	known	from	this	investigation	and	from	Wilson	et	al	that	different	conditions	can	yeild	different	unique	proteins.	Two	experiments	could	be	devised,	one	with	a	 focus	of	 extracting	 cellular	proteins	and	another	with	a	focus	of	 extracting	extracellular	matrix	proteins	and	 the	 results	 read	alongside	each	other.	This	would	allow	a	fuller	picture	to	be	visualised	and	in	time	advance	the	 proteomic	 extracellular	 matrix	 world	 by	 paving	 the	 way	 for	 differential	analysis	of	normal	and	pathological	tendon	tissue	
From	previous	studies,	 it	can	be	surmised	that	 the	 increase	 in	 tendon	 injury	 in	older	individuals	is	associated	with	ageing	of	the	interfascicular	matrix	(Thorpe	
et	al,	2013).		Further	study	into	the	IFM	structure	and	composition	is	warranted,	as	 this	 region	 could	 potentially	 be	 a	 diagnostic	 or	 therapeutic	 target.	 A	 dual	imaging	 approach	 that	 combined	 matrix-assisted	 laser	 desorption/ionization	mass	spectrometry	imaging	(MALDI-MSI)	and	secondary	ion	mass	spectrometry	(SIMS)	of	young,	old,	energy	storing	and	positional	tendon	tissue	was	evaluated.	The	aim	was	to	obtain	molecular	maps	of	peptides,	lipid	and	small	molecules	and	to	compare	the	spatial	variation	between	groups.	This	was	a	challenging	task	as	there	was	no	previous	published	data	on	equine	tendon	imaging	to	offer	known	workable	 methods.	 As	 before,	 looking	 to	 previous	 investigations	 in	 other	musculoskeletal	 tissues	 is	 helpful.	 Starting	 in	 a	 laboratory,	 which	 had	 limited	experience	 in	 the	 direct	 imaging	 of	 tissues	 using	 MALDI,	 meant	 progress	 was	slow	 and	 first	 attempts	 failed	 as	 all	 spectra	 collected	were	 that	 of	 the	matrix.	Fortunately	 a	 three-week	 visit	 to	 the	 University	 of	 Maastricht	 under	 the	
	 107	
supervision	 of	 Professor	 Ron	 Heeren	 provided	 expert	 collaboration	 and	assistance	 on	 the	 subject.	 This	 laboratory	 previously	 had	 performed	 MSI	 on	cartilage	and	 synovial	 tissue	 (Cillero-Paster	et	al,	 2014;	Peffers	et	al,	 2014).	 So	this	provided	a	starting	point	for	protocols	for	sample	preparation,	but	different	conditions	needed	to	be	trailed	for	tendon	tissue,	each	step	of	the	protocol	used	had	 to	 be	 trialled	 and	 progress	 was	 made.	 Results	 revealed	 that	 Trypsin	reconstituted	 in	 25mM	 Ammonium	 bicarbonate	 was	 seen	 to	 generate	 more	peaks	 compared	 to	 dionised	 H2O.	 Previous	 studies	 have	 highlighted	 the	importance	 of	 the	 buffer	 solution	 used	 in	 the	 dissolution	 of	 trysin.	 The	 use	 of	water	is	thought	not	to	be	ideal	for	efficient	tryptic	digestion	(Cillero-Paster	and	Heeren,	 2014).	 The	 reason	 for	 this	 could	 be	 because	 the	 ideal	 pH	 range	 for	tryptic	digestion	is	7.5-8.5	(Worthington,	2011),	therefore	using	a	buffer	solution	which	 provides	 this	 is	 optimal.	 Scober	 et	 al	 showed	 that	 using	 ammounium	bicarbonate	as	the	trypsin	buffer	had	a	greater	compatibility	compared	to	Tris-Hydrochloride,	 as	 this	 buffer	 had	 a	 greater	 compatibility	 with	 the	 subsequent	matrix	 application.	 This	 buffer	 would	 also	 be	 better	 for	 the	 downstream	 MS	analysis	(Proc	et	al,	2010).		
During	this	study	the	optimal	trypsin	digestion	time	was	found	to	be	16	hours.	This	 overnight	 digestion	 time,	 previously	 has	 been	 used	 largely	 due	 to	 the	convenience.	 A	 study	 conducted	 in	 plasma	proteins	 revealed	 similar	 results	 to	this	 study	where	9	hour	or	16	hour	digestion	period	were	superior	 to	4	hours	(Proc	et	al,	2010).	
The	biggest	limitation	during	this	study	was	the	time	available,	overall	I	detected	no	differences	between	the	four	sample	groups	being	analysed	using	both	MALDI	and	 SIMS.	 However,	 as	 only	 one	 sample	 of	 each	 group	 was	 evaluated,	 results	should	be	reviewed	with	this	in	mind,	future	studies	should	be	undertaken	with	a	larger	sample	size.	 	It	 is	possible	that	this	representation	is	a	true	finding	but	based	 on	 previous	 immunohistochemistry	 results	 it	 is	worth	 persevering	with	sample	preparation	optimisation.	However,	progress	was	achieved	with	 in	 situ	trypsin	digestion.	 
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For	 the	 final	 two	 studies	 of	 this	 thesis	 we	 were	 collecting	 data	 rather	 than	developing	methods	of	analysis.	Both	of	them	produced	promising	data.	Chapter	4	 investigated	whether	 the	 in	vivo	 identification	 and	 quantification	 of	 proteins	was	 possible	 from	 samples	 of	 microdialysis	 media,	 collected	 from	 the	peritendinous	space	of	the	Achilles	tendon	pre	and	post	shockwave	therapy.	This	was	an	innovative	investigation	as	most	tendon	studies,	so	far,	have	been	limited	to	 in	 vitro	 systems.	 Although	 enormously	 useful,	 there	 are	 limitations	 with	 in	vitro	 analysis,	 as	 the	 real	 time	 characterization	 of	 dynamic	 protein	 variations,	which	 fluctuate	 in	 different	 biological	 conditions	 such	 as	 diseases	 or	 ageing,	cannot	be	achieved.			Previous	 investigations	 using	 microdialysis	 fluid	 have	 been	 successful,	 for	instance,	 comparative	 studies	 into	 peritoneal	 dialysate	 before	 and	 after	 the	occurrence	of	a	peritonitis	episode	by	mass	spectrometry.	This	study	observed	10	 proteins,	 which	 were	 significantly	 differentially	 expressed	 in	 the	 dialysate	before	and	after	peritonitis.	The	 functional	 categories	 that	 these	proteins	were	from	 included	 binding/transport,	 blood	 coagulation/hemostasis,	 and	 acute	phase/immune	 response	 (Tyan	 et	 al,	 2013).	 Cerebral	 microdialysis	 media	 has	also	 been	 used,	 with	 success,	 to	 investigate	 brain	 metabolism	 after	 traumatic	brain	 injury.	This	study	revealed	a	differential	proteome	that	 indicated	cellular	destruction	 during	 the	 acute	 phase	 of	 illness	 (Lakshmanan,	 2010).	 Using	 the	above	 two	 studies	 as	 a	 small	 example,	 proteomic	 analysis	 of	 dialysis	 fluid	 has	been	 performed	 successfully	 for	 analysis	 for	 other	 organs,	 however	 this	technique	has	never	been	employed	in	the	field	of	tendon	biology.	As	described	in	Chapter	1,	tendon	tissue	is	primarily	composed	of	extracellular	matrix	with	a	small	population	of	tenocytes	(Waggett	et	al,	1998).	So	it	was	quite	possible	that	the	detection	of	proteins	within	microdialysis	media	wouldn’t	be	as	easy.			The	fact	that	this	study	was	able	to	detect	peptides	 in	both	pre	and	post	ESWT	sample	 and	 in	 addition	 to	 this,	 an	 upregulation	 of	 proteins	 was	 seen	 in	 post	shockwave	therapy	samples	provides	us	with	a	great	opportunity	to	explore	this	subject	further.		Many	of	the	proteins	that	were	higher	in	the	post	ESWT	samples	
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are	 abundant	 proteins	 in	 serum.	 This	 could	 signify	 serum	 leakage	 following	treatment.			During	this	investigation,	samples	were	kindly	received	from	a	study	undertaken	by	Waugh	et	al,	this	study	detected	cytokines	IL-1β,	IL-2,	IL-6	and	IL-8,	with	IL-6	and	 IL-8	 becoming	 significantly	 elevated	 for	 four	 hours	 post	 ESWT.	 Alongside	this	 Pro-	 forms	 of	MMP-2	 and	 -9	were	 increased	 after	 ESWT.	 It	was	 proposed	that	ESWT	might	promote	 tendon	 remodeling	by	promoting	 inflammatory	 and	catabolic	 processes	 that	 are	 associated	 with	 removing	 damaged	 matrix	constituents.	 During	 our	 discovery	 mass	 spectrometry	 proteomic	 analysis,	 we	did	 not	 identify	 any	 interleukins	 or	MMPs,	 possibly	 due	 to	 inadequate	 protein	loading,	the	sensitivity	of	the	instrument	or	ion	suppression	due	to	other	peptide	components.	 In	 previous	 tendon	 Mass	 Spectrometry	 proteomic	 studies	 MMPs	have	been	identified	(Sereysky	et	al,	2013).		It	is	possible	that	MMPs	and	IL	proteins	were	present	but	the	amount	within	the	sample	was	 too	 low	 to	 be	 detected.	 However	 the	 proteins	 that	 were	 detected	during	 this	 study,	 do	 concur	with	 the	Waugh	 et	 al	 study	 in	 that	 there	was	 an	upregulation	 of	 proteins	 involved	 in	 inflammatory	 pathways	 such	 as	complements	C3,	C4	and	Immunoglobulin	chains,			Overall	 this	 investigation	 should	 be	 repeated	 with	 a	 larger	 sample	 size.	 This	would	 give	 more	 information	 and	 hopefully	 statistically	 significant	 results.	Advancing	our	knowledge	of	the	biology	of	treatment	efficiencies	may	accelerate	the	discovery	of	novel	protein	biomarkers	for	numerous	treatment	applications.	The	development	of	accurate	 in	vivo	analytical	methods	will	steer	research	into	the	next	stage	of	 investigations	hopefully	bringing	us	a	step	closer	to	providing	better	medical	care	and	treatments	for	injuries,	diseases	and	aging.			Finally,	 an	 investigation	 into	 tendon	 turnover	 was	 carried	 out	 but	 time	 was	limited	 and	 only	 two	 time	 points	 could	 be	 studied.	 It	was	 established	 that	 the	non	 collagenous	 matrix	 which	 consists	 of	 proteoglycans	 had	 a	 higher	 rate	 of	
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protein	 turnover	 compared	 to	 components	 of	 the	 collagenous	 matrix.	 Which	gave	similar	conclusions	to	other	research	group’s	data	(Thorpe	et	al,	2010).	As	hoped	 common	 tendon	 proteins	 were	 identified,	 mainly	 collagens	 and	glycoproteins.	 Data	 can	 be	 improved	 by	 increasing	 time	 points	 and	 sample	numbers,	 if	 this	 occurs	 then	 data	 can	 be	 analysed	 more	 scientifically	 with	degradation	 rates	 and	 turnover	 curves	 (Hammond	 et	 al,	 2016).	 	 During	 this	study	 the	 top	 10	 proteins	 were	 discussed	 however	 other	 important	 proteins	known	to	tendon	were	present.	Thrombospondins	are	glycoproteins,	which	are	involved	 in	 multiple	 roles	 of	 mediating	 cell-cell	 and	 cell-matrix	 interactions.	Thrombospondin	 4	 has	 been	 detected	 in	 multiple	 tendon	 analysis	 studies	(Frolova	 et	 al,	 2014:	 Little	 et	 al,	 2014:	 Mueller,	 2015)	 therefore	 its	 detection	could	be	a	potential	marker	in	this	tissue.	Mueller,	2015	also	identified	serpin	in	tendon	 tissue,	 this	 is	 a	 secreted	 protein,	 which	 inhibits	 angiogenesis	 and	 has	been	detected	 in	previous	 tendon	tissue	studies	 (Farhat	et	al,	2012)	and	hence	could	be	another	potential	 tendon	marker.	Extending	 the	 research	 to	 look	 into	the	turnover	rates	for	these	proteins	would	be	useful.		The	 long	 term	 aim	 for	 this	 part	 of	 the	 investigation	 would	 be	 to	 identify	 the	proteomic	components	of	tendon	tissue,	and	to	calculate	the	rate	of	turnover	for	each	 of	 these.	 Having	 a	 normal	 baseline	 would	 be	 invaluable	 as	 then	 further	turnover	 studies	 could	 be	 conducted	 in	 this	 area	 where	 an	 intervention	 was	given	 i.e.	 a	 treatment	 process,	 such	 as	 EWST	 or	 medicine	 e.g.	 an	 anti-inflammatory	and	then	turnover	of	the	protein	recalculated.			Over	the	course	of	this	yearlong	research	project,	time	was	a	limiting	factor	in	all	of	 these	 studies	with	plenty	of	 further	work	 to	be	undertaken	on	each	project.	The	 proteomic	 analysis	 of	 biological	 processes	 has	 the	 potential	 to	 provide	extremely	valuable	 information	 regarding	 the	mechanisms	of	 action	 that	occur	on	a	daily	basis.	The	identification	of	proteins	and	their	abundances	can	be	used	to	indicate	protein	roles	and	interactions.	Comparing	sample	types	i.e.	disease	vs.	healthy	can	give	further	insight	into	the	pathophysiology	that	occurs,	potentially	providing	 ways	 in	 which	 treatments	 and	 therapies	 can	 be	 developed.	 Efforts	
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have	already	been	made	to	investigate	the	tendon	proteome;	however	there	are	many	gaps	in	our	knowledge	and	this	thesis	makes	a	start	at	addressing	them,	as	there	 are	 many	 questions	 to	 be	 answered	 each	 chapter	 could	 be	 extended	further.	 	 If	 time	had	permitted	 I	 certainly	would	have	 increased	 the	number	of	proteins	 analysed	 in	 the	 tendon	 turnover	 study	 and	 also	 looked	 at	 other	 time	points	which	would	advance	this	work	further.		Then	once	this	data	set	had	been	completed	 I	 could	have	progressed	 to	adding	 in	a	 treatment	and	assessing	any	differences	in	turnover	that	may	occur.			In	summery	the	general	outline	of	this	thesis	was	that	the	first	two	chapters	of	the	thesis	focused	mainly	on	developing	and	optimising	these	techniques.	As	the	ability	to	produce	robust	and	effective	guidelines	in	sample	preparation	will	be	invaluable	for	future	studies	in	tendon	research.	Before	results	are	acquired,	the	techniques	in	which	they	are	gained	must	be	developed	and	then	optimised.	For	the	final	two	studies	of	this	thesis	we	were	collecting	data	rather	than	developing	methods	 of	 analysis,	 however	 the	 skills	 gained	 for	 protein	 extraction	investigation	were	then	extrapolated	for	analysis	in	both	the	dialysis	chapter	and	protein	 turnover	 chapter.	 Time	 limitation	 was	 the	 main	 problem	 when	performing	 experiments	 for	 MALDI	 and	 SIMS	 imaging.	 Hopefully	 with	 further	work,	 data	 can	 be	 collected	 and	 it	 would	 be	 interesting	 to	 see	 whether	differences	are	established,	this	could	then	be	extended	to	 injured	samples	and	results	compared	with	other	studies	such	as	in	vivo	dialysis	study	to	see	whether	the	same	proteins	are	present	or	with	older	injuries	how	the	peptide	picture	has	changed.	 	Protein	turnover	studies	in	tendon	tissue	will	then	allow	information	to	 be	 gleamed	 about	 the	 efficiency	 of	 treatments,	 for	 instance	 if	 a	 treatment	increases	the	turnover	of	a	known	protein	involved	in	a	healing	process.		We	 aimed	 to	 build	 a	 tendon	proteomic	 library	 of	 proteins,	 to	 discover	 specific	tendon	protein	markers	and	look	for	markers	of	ageing/disease	and	repair.	If	we	learn	about	protein	function,	abundance,	localization	and	turnover	rates,	this	will	all	 assist	 in	 the	 end	 objective	 in	 discovering	 new	 biotechnologies	 for	 the	treatment	of	diseases/injuries	in	humans	and	animals.	
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